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Influenza A is an enveloped, negative sense RNA virus which causes annual epidemics 
and major pandemics. Assembly and budding of new viral particles is a complex and 
multistep process, of which many aspects remain unclear despite many years of 
research. The Influenza virus M2 protein is a homotetrameric transmembrane protein, 
containing three domains: ecto domain, transmembrane domain and cytoplasmic tail 
(CT). In the final stage of budding it has been shown that M2 mediates membrane 
scission through an amphipathic helix (AH), which is formed by the first 17 amino 
DFLGVRIWKHSURWHLQ¶V&7KRZHYHUWKHH[DFWPHFKDQLVPE\ZKLFKPHPEUDQHVFLVVLRQ
is triggered was not known.  
Using a collection of biochemical and biophysical techniques we have investigated 
the structure of the M2 AH and assessed its function in viral assembly and budding. 
We have shown that the M2 AH is formed upon lipid binding and remains unstructured 
in solution. It preferentially binds to membranes with high positive membrane 
curvature, which is detected by sensing the associated lipid packing defects. There are 
many cationic residues in the polar face of the M2 AH which could interact with 
anionic lipid headgroups, however charged interactions do not significantly affect the 
M2 AH interactions with the membranes. When inserted into the membrane the M2 
AH increases lipid ordering. The M2 AH also induces positive membrane curvature 
and mediates membrane scission, which is the last step of Influenza virus budding, 
allowing for release of newly formed virions in to the environment.  
Membrane scission is a crucial step not only in viral budding but also in many 
biological processes, such as endocytosis. Many proteins have been associated with 
cellular membrane scission; however, the underlying molecular details are still not 
known. We have shown that AHs in some cellular peptides, such as Arf 1, Endophillin 
A3 and Epsin 1, which mediate membrane scission in biological processes, appear to 
work in a similar manner to the M2 AH.  They represent a new protein motif that is 
capable of sensing curvature, inducing curvature and altering membrane fluidity, 





TABLE OF CONTENTS:  
ABBREVIATIONS ................................................................................ 6 
1. INTRODUCTION ............................................................................ 10 
1.1 SIGNIFICANCE OF INFLUENZA VIRUS................................ 11 
1.2 VIRION MORPHOLOGY AND STRUCTURE ......................... 12 
1.2.1 The Matrix protein 2 (M2) ..................................................... 13 
1.3 VIRION ASSEMBLY ................................................................. 16 
1.3.1 Lipid rafts as site of assembly ................................................ 16 
1.3.2 Assembly of the viral envelope proteins ................................. 16 
1.3.3 Recruitment of the viral core .................................................. 18 
1.4 BUDDING AND MEMBRANE SCISSION ............................... 21 
1.4.1 Assembly and budding ........................................................... 22 
1.4.2 Membrane scission ................................................................. 24 
1.4.3 Model of influenza budding ................................................... 25 
1.5 AIMS OF THE PROJECT .......................................................... 27 
2. MATERIALS AND METHODS ...................................................... 28 
2.1 MATERIALS .............................................................................. 29 
2.1.1 Peptides ................................................................................. 29 
2.1.2 Lipids ..................................................................................... 32 
2.1.3 Cells, plasmids, viruses and antibodies ................................... 35 
2.1.4 Oligonucleotides .................................................................... 36 
2.2 METHODS ................................................................................. 37 
2.2.1 Liposomes .............................................................................. 37 
2.2.1.1 Small Unilamellar Vesicles (SUVs) ......................... 37 




2.2.1.3 Giant Unilamellar Vesicles (GUVs) ......................... 38 
2.2.1.4 Dynamic Light Scattering (DLS) ............................. 38 
2.2.2 Nuclear Magnetic Resonance (NMR) Spectroscopy ............... 38 
2.2.3 Peptide binding assay ............................................................. 39 
2.2.4 Circular Dichroism (CD) Spectroscopy .................................. 40 
2.2.5 Immunofluorescence microscopy ........................................... 40 
2.2.6 Molecular Dynamics Simulations ........................................... 41 
2.2.6.1 Simulation parameters ............................................. 41 
2.2.6.2 Lipid bilayer equilibration ....................................... 42 
2.2.6.3 Membrane buckling and peptide addition ................. 42 
2.2.6.4 Membrane alignment and peptide tracking ............... 42 
2.2.7 Laurdan assay for membrane order ......................................... 44 
2.2.8 Differential Scanning Calorimetry (DSC) ............................... 44 
2.2.9 Transmission Electron Microscopy (TEM) ............................. 45 
2.2.10 GUV budding system ........................................................... 45 
2.2.11 GUV microinjection system ................................................. 46 
2.2.12 Supported bilayers with excess membrane reservoir (SUPER) 
templates system ............................................................................. 46 
2.2.13 Immunoblotting .................................................................... 47 
2.2.14 Repeated virus passaging ..................................................... 48 
2.2.14.1 Virus growth .......................................................... 48 
2.2.14.2 Plaque assay .......................................................... 48 
2.2.14.3 RNA extraction and reverse transcription ............... 49 
2.2.14.4 Sequencing ............................................................ 49 
3. RESULTS ........................................................................................ 50 
3.1 STRUCTURE OF THE M2 AMPHIPATHIC HELIX ................ 51 




3.1.2 M2 AH formation upon membrane binding ............................ 52 
3.1.3 M2 AH membrane interactions............................................... 61 
3.1.4 Summary................................................................................ 67 
3.2 M2 AMPHIPATHIC HELIX INTERACTIONS WITH THE 
MEMBRANE ................................................................................... 68 
3.2.1 Introduction ........................................................................... 68 
3.2.2 Binding to lipid membranes ................................................... 68 
3.2.3 Alpha helix stabilisation upon binding.................................... 71 
3.2.3.1 Detection of secondary structure .............................. 71 
3.2.3.2 Structural changes in different environments............ 75 
3.2.3.3 A/England/09 and AH mutants ................................ 79 
3.2.4 Summary................................................................................ 83 
3.3 EFFECTS OF THE LIPID ENVIRONMENT ON M2 
AMPHIPATHIC HELIX ± MEMBRANE BINDING ....................... 86 
3.3.1 Introduction ........................................................................... 86 
3.3.2 Charge interactions ................................................................ 87 
3.3.2.1 Different anionic lipids ............................................ 87 
3.3.2.2 Absence of anionic lipids ......................................... 91 
3.3.2.3 Ionic strength ........................................................... 94 
3.3.3 Effects of cholesterol .............................................................. 95 
3.3.4 Effects of PIP2 ....................................................................... 97 
3.3.5 Effects of lipid domain line tension ...................................... 100 
3.3.6 Effects of membrane curvature ............................................. 103 
3.3.6.1 Standard membranes .............................................. 103 
3.3.6.2 Absence of anionic lipids ....................................... 108 





3.4 EFFECTS OF THE M2 AMPHIPATHIC HELIX ON THE 
MEMBRANE ................................................................................. 119 
3.4.1 Introduction ......................................................................... 119 
3.4.2 Ordering of lipids in the membrane ...................................... 120 
3.4.2.1 M2 AH .................................................................. 120 
3.4.2.2 A/England/09 and AH mutants .............................. 123 
3.4.2.3 Different membrane compositions ......................... 124 
3.4.3 Alteration of membrane phase-transition temperatures ......... 128 
3.4.4 Induction of positive membrane curvature ............................ 129 
3.4.5 Summary.............................................................................. 130 
3.5 M2 AMPHIPATHIC HELIX MEDIATED BUDDING                
IN VITRO ........................................................................................ 133 
3.5.1 Introduction ......................................................................... 133 
3.5.2 GUV budding ....................................................................... 133 
3.5.3 GUV microinjections ........................................................... 137 
3.5.4 SUPER templates and membrane scission ............................ 141 
3.5.5 Summary.............................................................................. 143 
3.6 M2 AMPHIPATHIC HELIX MEDIATED BUDDING                
IN VIVO .......................................................................................... 145 
3.6.1 Introduction ......................................................................... 145 
3.6.2 Virus-like particles (VLP) release......................................... 145 
3.6.3 Restoration of viral growth ................................................... 147 
3.6.4 Summary.............................................................................. 153 
3.7 FUNCTIONALLY HOMOLOGOUS SCISSION HELICES IN 
CELLULAR PROTEINS ................................................................ 154 
3.7.1 Introduction ......................................................................... 154 




3.7.2.1 Structural changes in different environments.......... 155 
3.7.2.2 Anionic lipids and positive membrane curvature effect 
on cellular AH formation ................................................... 158 
3.7.2.3 Effect of line tension on cellular AH formation ...... 163 
3.7.2.4 Ordering of the lipids in the membrane .................. 165 
3.7.2.5 Induction of positive membrane curvature ............. 166 
3.7.3 Summary.............................................................................. 167 
4. DISCUSSION ................................................................................ 170 
4.1 STRUCTURE OF THE M2 AH ................................................ 171 
4.2 MECHANISM OF ACTION..................................................... 173 
4.2.1 Membrane binding ............................................................... 173 
4.2.2 Membrane activity ............................................................... 174 
4.2.3 Membrane scission ............................................................... 179 
4.3 M2 AH AS A PART OF A BIGGER PROTEIN FAMILY ....... 182 
4.4 CONCLUSIONS AND FUTURE WORK ................................ 184 
5. REFERENCES ............................................................................... 187 
6. APPENDIX .................................................................................... 198 
6.1 Restriction map of pCAGGS plasmid encoding M2 protein from A/Udorn/72 
strain ................................................................................................................ 198 
6.2 Ramachandran plots ................................................................................... 199 
6.3 DLS data .................................................................................................... 201 
A. Standard vesicles ...................................................................... 201 
B. Vesicles without anionic lipids ................................................. 203 
6.4 Laurdan assay titration ............................................................................... 209 






1D - one-dimensional  
2D - two-dimensional  
A - alanine 
AH - amphipathic helix 
ALPS - amphipathic lipid packing sensor 
ATP - adenosine triphosphate 
BAR - Bin-Amphiphysin-Rsv  
BSA - bovine serum albumin 
CD - circular dichroism 
Ch - cholesterol 
CRAC - cholesterol recognition amino acid consensus 
CT - cytoplasmic tail 
DeisPC - 1,2-dieicosenoyl-sn-glycero-3-phosphocholine 
DEPC - 1,2-dierucoyl-sn-glycero-3-phosphocholine 
DLS - dynamic light scattering 
DMEM - 'XOEHFFR¶VPRGLILHGHDJOHPHGLXP 
DMPC - 1,2-dimyristoleoyl-sn-glycero-3-phosphocholine 
DNA - deoxyribonucleic acid 
DOPC - 1,2-dioleoyl-sn-glycero-3-phosphocholine 
DOPE - 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine 
DPPC - 1,2-dipalmitoleoyl-sn-glycero-3-phosphocholine 
DSC - differential scanning calorimetry 




DSPE - 1,2-distearoyl-sn-glycero-3-phosphoethanolamine 
EDTA - ethylenediaminetetraacetic acid 
ER - endoplasmic reticulum  
ESCRT - endosomal sorting complex required for transport 
FBS - fetal bovine serum 
FITC - fluorescein isothiocyanate 
GP - JHQHUDOLVHGSRODULVDWLRQ 
GTP - guanosine triphosphate 
GUV - giant unilamellar vesicles 
HA - hemagglutinin  
HEK 293T - human embryonic kidney 293T  
HEPES - 4-(2-Hydroxyethyl) piperazine-1-ethanesulfonic acid 
HIV - human immunodeficiency virus 
ILV - intralumenal vesicles 
K - lysine 
LUV - large unilamellar vesicles  
M1 - matrix protein 1 
M2 - matrix protein 2 
MD - molecular dynamic 
MDCK - Madin-Darby canine kidney  
MLV - multilamellar vesicles 
MOI - multiplicity of infection 
MVB - multi-vesicular bodies 




NAT - N-acetyl trypsin 
NEP/NS2 - nuclear export protein/ non-structural protein 2 
NGC - negative Gaussian curvature 
NMR - nuclear magnetic resonance 
NOE - nuclear Overhouser effect  
NOESY - nuclear Overhouser effect spectroscopy 
NP - nucleoprotein 
NS1 - non-structural protein 1 
ORF - open reading frame 
PA - 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphate 
PB1 - polymerase basic 1 
PB2 - polymerase basic 2 
PBS - phosphate buffered saline 
PC - 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
PE - 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine 
PFU - plaque forming units 
PG - 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-1-rac-glycerol 
PGC - positive Gaussian curvature 
PIP2 - SKRVSKDWLG\OLQRVLWROELVSKRVSKDWH 
ppm - parts per million 
PS - 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine 
PVDF - polyvinylidene difluoride 
rmsd - root mean squared deviation 




RNP - ribonucleoprotein 
rpm - revolutions per minute 
RT-PCR - reverse transcriptase polymerase chain reaction 
SM - sphingomyelin 
STD NMR - saturation-transfer difference nuclear magnetic resonance 
SUV - small unilamellar vesicles  
TBE - tris-base, boric acid and EDTA 
TEM - transmission electron microscopy 
TFA - trifluoroacetic acid 
TFE - 2,2,2-trifluoroethanol 
TMD - transmembrane domain 
TOCSY - total correlation spectroscopy 
TX-100 - Triton X-100 
UTR - untranslated region 
VLP - virus-like particle 
VMD - visual molecular dynamics 
vRNA - viral ribonucleic acid 








































1.1 SIGNIFICANCE OF INFLUENZA VIRUS 
 
 
Influenza virus causes annual epidemics and occasional major pandemics. It is a major 
cause of morbidity and mortality worldwide. There are three influenza virus subtypes: 
A, B and C; but only A and B are pathogenic for humans and influenza A is most 
predominant worldwide. Statistical data shows that in the USA the estimated annual 
influenza related deaths was over 50,000 in the period from 1990 to 1999, with 
mortality mostly associated with influenza A virus in those older than 65 (Thompson 
et al. 2003). Influenza virus continuously changes its antigenic properties by 
accumulation of mutations in viral antigens in a SURFHVVFDOOHG³DQWLJHQLFGULIW´ZKLFK
leads to annual epidemics. Occasionally influenza virus causes global pandemics, due 
to introduction into the human population of a new virus subtype. Pandemic strains, 
which rapidly spread around the world, arise mainly by reassortment of the segmented 
genome of human and avian influenza virus co-infecting one cell, in process called 
³DQWLJHQLFVKLIW´(Strauss and Strauss 2008). In the 20th century three main influenza 
pandemics arose. The most dreadful influenza pandemic was the ³6SDQLVK´ IOX
outbreak at the end of the First World War: in one year influenza virus caused the 
death of approximately 50 million people around the world, which was greater than 
the total number of war victims (Johnson and Mueller 2002). The following two 
SDQGHPLFV³$VLDQ´IOXLQDQG³+RQJ.RQJ´Ilu in 1968, were much milder than 
³6SDQLVK´ IOX EXW HYHQ VR FDXVHG DSSUR[LPDWHO\ RYHU  PLOOLRQ DQG  WR 1 
million deaths worldwide, respectively (Kilbourne 2006). The first pandemic in the 
21st FHQWXU\DURVHLQDQGZDVFDOOHG³6ZLQH´IOXGXHWRRULJLQRIWKHYLUXV7KH
³6ZLQH´Ilu outbreak was relatively mild however, in the USA alone over 22 million 
people were infected (Rossman and Lamb 2010). Each influenza outbreak has an 
impact on society, not only in terms of mortality and morbidity but also in financial 








1.2 VIRION MORPHOLOGY AND STRUCTURE 
 
Influenza A virus is an enveloped virus with negative-sense, single-stranded RNA 
genome and belongs to the Orthomyxoviridae family. It contains eight RNA segments, 
which encode for at least 17 proteins, including 10 structural and non-structural 
proteins and their truncated versions. The viral envelope is a host derived lipid 
membrane, which anchors three transmembrane-domain containing proteins: 
hemagglutinin (HA), neuraminidase (NA) and matrix protein 2 (M2) (Fig. 1.2-1). 
These proteins form characteristic spikes on the surface of the virus particles as seen 
by electron microscopy (Fujiyoshi et al. 1994). HA is the most abundant envelope 
protein, with about 500 copies per virion and has a receptor binding and fusion 
activity. NA is less numerous, has enzymatic activity and is involved in viral release. 
M2 is the least abundant protein in viral envelope, with only about 20-60 copies per 
virion, and is involved in virus entry, assembly and budding (Wilschut et al. 2006).  
On the inside of the viral envelope there is a layer of matrix protein 1 (M1), which is 
the most abundant structural protein of the influenza virus. M1 interacts with surface 
glycoproteins (Enami and Enami 1996, Ali et al. 2000) and the ribonucleoprotein 
complexes (RNPs) (Watanabe et al. 1996), and plays a role in nuclear export, assembly 
and budding. The viral core contains RNPs which consist of the viral RNA (vRNA) 
segment, three polymerase proteins: polymerase basic 1 (PB1), polymerase basic 2 
(PB2) and polymerase acid and the nucleoprotein (NP) (Palese and Shaw 2007 ). A 
number of strains produce an additional protein, PB1-F2. This protein has a pro-
apoptotic activity and is transcribed from a second open reading frame (ORF) in the 
segment encoding the PB1 protein (Wilschut et al. 2006). Non-structural protein 1 
(NS1) is multi- functional and plays a role in evasion of the host immune system. A 
nuclear export protein (NEP/NS2) is involved in nuclear export of viral RNPs. 
Previously it was considered as a non-structural protein, however, it was later found 
in the virus particle in low quantities (Richardson and Akkina 1991).  
Influenza viruses are pleomorphic, some isolates form spherical virions, which have a 
diameter of approximately 100 nm, and others form filamentous particles, which also 
are approximately 100 nm in diameter, but up to 20 µm in length. Most of the strains 




mainly form filamentous virions (Chu et al. 1949). There is not much known about 
how filaments are produced, transmitted between the cells, or how they enter the host 
cell; however the ability to form filamentous virions is a genetic attribute of each strain 
(Kilbourne and Murphy 1960). 
 
 
                                  
Figure 1. 2 - 1 Model of influenza virus (Wilschut et al. 2006). 
 
 
1.2.1 The Matrix protein 2 (M2) 
The M2 protein is encoded by a spliced mRNA from segment 7 of the influenza 
genome. It is a 97 amino acid long protein that in the native form is a homotetramer. 
As mentioned before, only a few copies of the M2 protein are present in the virion, 
however, the protein is abundantly expressed in the plasma membrane of infected cells 
(Lamb et al. 1985). The M2 protein contains three domains, as shown in Figure 1.2-2: 
the ecto domain at the N-terminus (residues 1-24), the transmembrane domain (TMD) 
(residues 25-43) and the cytoplasmic tail (CT) at the C-terminus (residues 44-97) 









Figure 1. 2 - 2 Structural motifs of the M2 protein and sequence of the cytoplasmic tail with 





TMD has an ion channel activity which is highly selective for H+ ions (Zebedee et al. 
1985, Pinto et al. 1997) and plays a role in virus uncoating allowing for proton influx 
from acidified endosome inside viral particle which results in disassociation of RNPs 
form the M1 protein. Structure of the full length protein has not been solved up to date 
however, structure of the TMD with fragments of the ecto domain and CT has been 
intensively studied showing formation  of the amphipathic helix (AH) on the 
beginning of the CT (between residues 51-59) that is nearly perpendicular to the TMD 
helices which are forming a pore and act as an ion channel  (Schnell and Chou 2008). 
The M2 AH has been shown to play an important role in virus assembly and budding 
(Zebedee et al. 1985, Rossman et al. 2010b) and in formation of filamentous virions 
(Rossman et al. 2010a). It has been proposed that the M2 AH stabilises forming virions 
during assembly process and mediates budding by membrane scission (Rossman and 
Lamb 2011, Martyna and Rossman 2014). The M2 AH has a hydrophobic and polar 
face which contains a few highly conserved cationic residues (lysine and arginine) as 












                           
 
Figure 1. 2 - 3 A and B: Helical wheel plot of the 18 and 16 amino acid long influenza M2 AH 
based on A/England/09 and A/Udorn/72 strain respectively generated by HeliQuest (Gautier et al. 
2008) found at http://heliquest.ipmc.cnrs.fr/. Positively charged polar residues are shown in blue, 
negatively charged polar residues are in red, polar uncharged residues are in purple, glycine is 
shown in grey, and hydrophobic residues are in yellow. Two faces of the helix are separated by 












1.3 VIRION ASSEMBLY 
 
1.3.1 Lipid rafts as site of assembly 
Influenza virus assembles and buds from lipid raft domains in the apical plasma 
membrane of polarized epithelial cells (Takeda et al. 2003, Leser and Lamb 2005, 
Chen et al. 2007). Lipid rafts are microdomains in the plasma membrane, which are 
enriched in sphingolipids and cholesterol (Brown 2001). The two viral glycoproteins, 
HA and NA, are associated with lipid rafts (Takeda et al. 2003, Leser and Lamb 2005, 
Chen et al. 2007). In contrast, the third viral envelope protein, M2, is excluded from 
lipid rafts, which may explain its low number in virus particles (Takeda et al. 2003, 
Leser and Lamb 2005, Chen et al. 2007). The site of viral assembly and budding is 
thought to be determined by the accumulation of individual viral envelope proteins at 
a specific site on the membrane. All of the influenza envelope proteins have been 
shown to accumulate in the apical plasma membrane when they are individually 
expressed (Roth et al. 1983, Jones et al. 1985, Hughey et al. 1992). However, a single 
amino acid change in HA cytoplasmic domain caused the protein to be sorted to the 
basolateral membrane (Brewer and Roth 1991). Later studies showed that basolateral 
sorting in HA-mutated viruses did not significantly affect the apical budding of the 
virus. Most of the viral particles containing mutated HA were still budding from the 
apical plasma membrane (Mora et al. 2002, Barman et al. 2003). This shows that 
determination of the site of viral assembly and budding depends on multiple factors.  
 
1.3.2 Assembly of the viral envelope proteins  
The transport and sorting of viral envelope proteins to lipid rafts in the apical plasma 
membrane is one of the best known parts of the influenza virus assembly and budding 
process. These proteins are synthesised by ribosomes bound to the endoplasmic 
reticulum (ER) DQGWKHQHQWHUWKHKRVWFHOO¶VVHFUHWRU\SDWKZD\,Q(5SURWHLQVDUH
folded, HA into trimers and NA and M2 into tetramers, and HA and NA undergo 
glycosylation. Later they are transported to the Golgi apparatus and in the cis-Golgi 
network cysteine residues on HA and M2 are palmitoylated (Chen et al. 2005). 
Subsequently, the viral envelope proteins are transported through the trans-Golgi 




HA and NA have been well characterised and studied in detail (Scheiffele et al. 1997, 
Barman and Nayak 2000, Zhang et al. 2000, Takeda et al. 2003, Chen et al. 2005). In 
contrast, the sorting signal for M2 has not been characterised yet.  
Both, HA and NA contain two apical sorting signals, one in the ectodomain and second 
in the TMD. Additionally, the TMD of both glycoproteins contain signals for lipid raft 
association of the proteins. Analysis of the TMD of NA revealed that an apical sorting 
signal in this protein was present in multiple regions of the TMD and that a 19 amino 
acid sequence of the TMD of NA was enough to direct protein to the apical plasma 
membrane (Barman and Nayak 2000). The same studies had shown that the C-terminal 
of the NA TMD was involved in lipid raft association. Both signals, for apical 
transport and lipid raft association, are present in the TMD of NA and overlap each 
other, however, they are not identical (Barman and Nayak 2000). Other studies have 
shown that deletion of the CT of NA resulted in reduced lipid raft association of the 
protein (Zhang et al. 2000). Lipid raft association of HA is mediated by the TMD and 
CT, which contain three, highly conserved cysteine residues (Scheiffele et al. 1997, 
Takeda et al. 2003, Chen et al. 2005). Studies showed that mutations in these domains 
cause loss of lipid raft association of the protein and, consequently, a reduction in viral 
replication and assembly (Chen et al. 2005). Another study also showed that the CT 
of HA plays an important role in lipid raft association. Similarly as in case of NA, 
deletion of the CT of HA decreased lipid raft association but did not affect the apical 
transport of the protein (Zhang et al. 2000). 
Assembly and budding of influenza virus is a complicated process, which depends on 
multiple factors. Previous studies, using temperature sensitive mutants, have shown 
that HA is not required for virus assembly and budding from infected cells (Pattnaik 
et al. 1986). Subsequently, studies of NA-deficient influenza viruses showed that the 
mutant virus assembles normally but forms large aggregates on cell surface due to lack 
of enzymatic activity of NA. Additionally, when this mutated virus was administered 
to mice, low virus titres were recovered and cytotoxic T-cells were generated, 
indicating that cellular infection had occurred. This suggested that NA is not required 





In contrast, research using virus-like particle (VLP) system, in which membrane 
budding is assessed following transfection and expression of individual viral proteins, 
has shown that, in presence of sialidase activity, HA can be released from cells without 
need for expression of any other viral protein (Chen et al. 2007). Correspondingly, 
expression of NA (Lai et al. 2010) and M2 (Chen et al. 2007) alone also caused release 
of VLPs, which suggest that viral envelope proteins play a role in virus assembly and 
budding. Moreover, co-expression of all three viral envelope proteins increased VLP 
release (Chen et al. 2007). Each viral envelope protein can cause budding in a VLP 
system, but all appear to be required for efficient virus budding. The reasons for the 
difference between in vitro budding system and virus infected cells are not known 
however, it is probable that in infected cells, presence of additional viral proteins may 
alter localization and protein interactions comparing to VLP system and have an effect 
on budding (Martyna and Rossman 2014). Other studies have shown that another viral 
protein, M2, is essential for virus assembly and budding. Recombinant viruses with 
deleted M2 protein (Cheung et al. 2005) or mutations in the cytoplasmic tail (McCown 
and Pekosz 2005, Iwatsuki-Horimoto et al. 2006, McCown and Pekosz 2006) were 
generated. These mutations caused a decrease in infectious virus titres, a reduction in 
the amount of packed vRNA and a decrease in virus budding.  Additionally, mutation 
of the cytoplasmic tail of M2 caused a change in viral morphology (Iwatsuki-Horimoto 
et al. 2006). These data suggest that all three viral envelope proteins play an important 
role in virus assembly and budding.  
 
 
 1.3.3 Recruitment of the viral core 
Whereas, assembly of the viral envelope proteins is a well known process, the 
knowledge about recruitment of the remaining viral components is relatively low. M1 
LVWKHPRVWDEXQGDQWSURWHLQDPRQJDOOYLUDOSDUWLFOHFRPSRQHQWV,WDFWVDVD³EULGJH´
between viral envelope proteins and viral core; therefore it interacts with most of the 
viral proteins. Previous studies have shown that M1 is a major driving force in 
influenza budding and it is essential for VLP formation and when expressed alone it 
assembles into virus-like budding particles (Gomez-Puertas et al. 2000). However, 
recent studies suggest that M1 by itself fails to form VLPs and interactions of M1 with 




incorporate into virions (Wang et al. 2010). M1 interacts also with the NEP protein 
(Ward 1995) and viral RNPs (vRNPs) (Watanabe et al. 1996), however, it does not 
interact with NP when expressed in the absence of viral infection (Zhao et al. 1998).  
Details about interactions in M1/RNP complexes are not fully understood. A model 
has been proposed in which M1 interacts with vRNA to form a M1/RNP complex. It 
is supported by the fact that vRNP is a helical complex and as a result, part of the 
vRNA is exposed outside and is accessible for M1 binding.  
Additionally, M1 does not interact with NP protein alone (Zhao et al. 1998) and 
interaction between M1 and vRNPs inhibits transcription (Watanabe et al. 1996). 
However, other studies have shown that the C-terminal fragment of M1 can bind to 
the vRNPs but cannot bind to the vRNA and the N-terminal fragment can bind to the 
vRNA but cannot bind to the vRNPs (Baudin et al. 2001). Moreover, only whole M1 
protein, containing C- and N- terminal fragments can inhibit transcription (Baudin et 
al. 2001). M1 also interacts with itself, which is very important in many aspects of 
virus budding (Ruigrok et al. 2001). On the other side, the M1 protein interacts with 
viral envelope proteins. However, initial experiments on direct interaction resulted in 
contradictory reports. It has been shown that the specific interaction between M1 and 
glycoproteins does not influence association of M1 with the membrane (Kretzschmar 
et al. 1996, Zhang and Lamb 1996). In the same time, one report has been published, 
which showed that membrane association of the M1 protein is stimulated by the CTs 
of HA and NA (Enami and Enami 1996). In recent studies, a marker for lipid raft 
association, the insolubility of membrane proteins to Triton X-100 (TX-100)-
extraction, was used (Ali et al. 2000). Both glycolipids were associated with lipid rafts 
and resistant to TX-100-extraction. M1, when expressed alone, was soluble and not 
associated with lipid rafts, but when co-expressed with HA and NA, M1 became 
resistant to TX-100, which suggests an interaction between M1 and glycoproteins and 
an association with lipid rafts. This interaction was specific for influenza virus 
glycoproteins because when M1 was co expressed with heterologous proteins it was 
soluble in TX-100 (Ali et al. 2000). 
New RNP complexes are assembled in the nucleus and transported to the cytoplasm 
by M1 and NEP/NS2 proteins. Later M1 and RNPs need to be transported to the 
assembly site, and the mechanism used is not clear. One of the hypotheses suggests 




(Bourmakina and Garcia-Sastre 2005). A study of genetically engineered influenza 
virus, which expressed reduced levels of M1 protein, showed that virus morphology 
and composition were not affected; however, virus assembly and maturation were 
delayed in time. This result supported the first hypothesis and suggested that a 
minimum amount of M1 protein is required for initiation of virus assembly 
(Bourmakina and Garcia-Sastre 2005). Other studies have shown that M1 interacts 
with the CT and TMD of HA and NA and that both glycoproteins support the lipid raft 
association of M1 (Ali et al. 2000, Zhang et al. 2000). Additionally, confocal 
microscopy revealed that in virus-infected cells M1 partially co-localised with HA. In 
presence of an exocytic transport inhibitor, HA was present in perinuclear Golgi region 
and excluded from lipid rafts. Interestingly most of the M1 protein was also associated 
with perinuclear region, supporting co-localisation of M1 and HA (Ali et al. 2000). 
Those results suggest that the M1 protein might associate with the viral glycoproteins 
during exocytic transport, directing M1 to the assembly site, taking RNPs with it. 
However, another model proposes that M1/RNP complexes use the cytoskeleton to 
get to lipid rafts and sites of viral budding (Avalos et al. 1997). It has been shown that 
NP, M1 and M1/RNP complexes interact with cytoskeletal components, mostly actin 
microfilaments, which might direct them to the viral assembly site (Avalos et al. 
1997). An alternative model suggests that RNPs are transported to the assembly site 
individually, independently of the M1 and viral envelope proteins. This hypothesis is 
supported by evidence that NP is located in the apical plasma membrane (Mora et al. 
2002) and that it is associated with lipid rafts in a cholesterol-dependent manner 
(Carrasco et al. 2004). 
The exact details about interactions between viral proteins, their transport to the 
assembly site and order of the assembly remain unknown; however, they are important 









1.4 BUDDING AND MEMBRANE SCISSION 
 
Budding is a complex and multi-stage process that is the final step in the virus life 
cycle. The first stage of this process involves bending of the plasma membrane and 
forming an outward curvature, initiating formation of the bud. The next step involves 
assembly and enveloping of the viral core, with the final stage involving constriction 
of the membrane at the base of the bud leading to membrane scission and release of a 
virus particle. Membrane budding is significant not only for viruses, but also plays an 
important role in biological processes. One of the best known cellular processes 
involving membrane budding is clathrin-mediated endocytosis, in which particles 
from the plasma membrane or outside the cell are transported to the endosomes in 
clathrin coated vesicles. Numerous cellular proteins are involved in clathrin-mediated 
endocytosis including dynamin, epsin and endophillin (McMahon and Boucrot 2011). 
In the first step, formation of the pit is initiated by binding of the cellular proteins to 
regions of the plasma membrane that are enriched in SKRVSKDWLG\OLQRVLWRO 
ELVSKRVSKDWH PIP2) (McMahon and Boucrot 2011). While the pit formation is 
progressing, the particle to be transported is incorporated into it and the coat is 
assembled with several accessory proteins and clathrin. In the last stage dynamin, 
together with accessory proteins, is recruited to the neck of the pit and induces 
constriction of the neck and membrane scission in a guanosine triphosphate (GTP) 
dependent process (Hinshaw and Schmid 1995, McMahon and Boucrot 2011, Faelber 
et al. 2012).  
Another well studied cellular process involving membrane budding is formation of 
multi-vesicular bodies (MVBs), which are used to transport damaged proteins from 
the early endosome to the lysosome where they are destroyed. Damaged proteins are 
ubiquitylated and transported to the endosome membrane, where they bud inside 
forming intralumenal vesicles (ILV).  MVBs then fuse with lysosomes and ILVs and 
its content is destroyed (Wollert et al. 2009b). Numerous cellular proteins in the 
endosomal sorting complex required for transport (ESCRT) machinery regulate 
sorting of ubiquitylated proteins and membrane budding which leads to formation of 
ILVs. ESCRT driven membrane scission is a well-known process and molecular 
details are well described in literature (Carlton and Martin-Serrano 2009, Wollert et 




(HIV), Ebola virus, paramyxovirus PIV-5 and murine leukaemia virus use ESCRT 
machinery to mediate membrane scission and budding. These viruses encode late 
domains within their structural proteins which are sequence motifs that are responsible 
for binding with proteins in ESCRT pathway enabling the virus to use ESCRT 
machinery for membrane scission and production of new virions (Carlton and Martin-
Serrano 2009). Influenza virus has been shown to mediate membrane scission and 
budding independent from ESCRT machinery with an unknown mechanism (Rossman 
et al. 2010b). 
 
1.4.1 Assembly and budding 
Details about initiation of bud formation are not fully understood, however in a VLP 
system both HA (Chen et al. 2007) and NA (Lai et al. 2010) can induce budding from 
cells when expressed alone, as mentioned before (see chapter 1.3.2). These results 
suggest hat HA and NA might be able to induce positive Gaussian curvature (PGC) of 
the membrane and initiate the budding process. Nevertheless HA and NA are not able 
to complete in vivo budding in virus-infected cells, which may be prevented by 
assembly of other viral proteins, interactions of M1 with the CT of glycoproteins and 
recruitment of the vRNPs (reviewed in (Rossman and Lamb 2011)).  
Assembly of the virion is the next step in budding process. Newly synthesised vRNP 
complexes and M1 are transported to the assembly site, followed by recruitment of 
M2 (Rossman and Lamb 2011). During virus budding, M1 interacts with the CT of 
both viral glycoproteins and is recruited to the plasma membrane therefore M1 may 
also be able to alter membrane curvature providing that HA and NA already initiated 
budding event. M1 interacts with the inside layer of the lipid bilayer (Ruigrok et al. 
2001), which could cause bending of the plasma membrane generating PGC and 
progressing viral bud formation (Rossman and Lamb 2011). It is probable that HA, 
NA and M1 cooperate to alter membrane curvature and progress virion assembly and 
budding. 
M1 is the most abundant protein in the virion and has additional functions during the 
virus budding process. Interactions between M1 proteins lead to development of the 




the host proteins from the budding site (Ruigrok et al. 2001). It has been shown that 
size and shape of the viral particles depends on M1. Filamentous virion formation was 
genetically linked with the M1 protein (Bourmakina and Garcia-Sastre 2003, Elleman 
and Barclay 2004). Recent work has shown that not only M1, but also M2, and 
interactions between both proteins, determines production of filamentous virions 
(Zebedee and Lamb 1988, Zebedee and Lamb 1989, Iwatsuki-Horimoto et al. 2006, 
McCown and Pekosz 2006, Rossman et al. 2010a). It has been shown that mutation in 
the M2 amphipathic helix or truncation of M2 to 70 amino acids caused a loss of viral 
filaments (McCown and Pekosz 2006, Rossman et al. 2010a). It is possible that the 
region between 70-77 amino acids in the CT of M2 is responsible for binding to M1 
and for vRNP integration into virions (McCown and Pekosz 2005, McCown and 
Pekosz 2006).  
In the later stages of virion assembly the M2 protein is incorporated into the budding 
site. When expressed alone the M2 protein is not associated with lipid rafts however, 
when expressed with other viral proteins it co-localises with lipid rafts (Rossman et 
al. 2010a). It is possible that M2 interacts with M1 or HA and results in direction of 
the M2 protein to the lipid rafts and incorporation into virions (McCown and Pekosz 
2006). An additional study has shown that the amphipathic helix of M2 is able to alter 
membrane curvature in a cholesterol dependent manner (Rossman et al. 2010b). In 
low cholesterol levels, less than 17 mol %, M2 induces negative Gaussian curvature 
(NGC) and in high cholesterol levels it has an opposite effect as the M2 AH may not 
insert as deeply into the membrane (Rossman et al. 2010b, Schmidt et al. 2013). Viral 
budding site is enriched in cholesterol therefore incorporation of the M2 protein into 
the site at this stage may prevent strong elicitation of NGC, stabilizing budding site 









1.4.2 Membrane scission 
The final step in virus budding is membrane scission at the neck of the budding virion. 
A model of influenza virus budding and release suggests that the M2 protein might be 
responsible for membrane scission (Rossman et al. 2010b). During budding, M2 
localises to the boundary between lipid raft and bulk plasma. Lipid raft domains are 
used to form new virions and progression of that process lead to non-raft localisation 
of M2 in the neck of budding virion. In this low cholesterol environment, the M2 
protein¶V amphipathic helix may be inserted deeper into the membrane and cause 
alterations in its curvature. Induction of NGC in the neck of budding virion may 
constrict the membrane to a level that will allow spontaneous membrane scission to 
occur, leading to formation of a new influenza virus particle (Rossman et al. 2010b). 
These studies also showed that mutation in the amphipathic helix of M2 blocks 
membrane scission and release of the virus. Mutant virions were not able to complete 
budding and displayed a ³EHDGVRQDVWULQJ´PRUSKRORJ\, with many virions in process 
of budding but unable to be released due to impaired scission (Rossman et al. 2010b). 
Recent studies, using solid-state nuclear magnetic resonance (NMR) spectroscopy 
confirmed that M2 amphipathic helix alters membrane curvature (Wang et al. 2012). 
It was also shown that the M2 AH binds to lipid domains with high curvatures and 
that this binding can cause lipid head group disruptions (Wang et al. 2012). 
Additionally, research using small angle X-ray scattering has shown that M2 is able 
to generate NGC in lipid membranes (Schmidt et al. 2013). Consistent with previous 
results, reduction in the hydrophobicity of the AH by amino acid substitution resulted 
LQ DQ LQKLELWLRQ 0¶V DELOLW\ WR DOWHU PHPEUDQH FXUYDWXUH (Schmidt et al. 2013). 
Although the M2 AH was necessary and sufficient to generate NGC, the presence of 
the M2 TMD enhanced the M2 AH-induction of NGC, suggesting that the TMD may 
affect AH activity, facilitating membrane curvature changes (Schmidt et al. 2013). It 
has been shown, that mutation of the CT of the M2 protein causes massive reduction 
LQ LQIHFWLRXV YLUXV WLWHU DQG GHFUHDVH LQ EXGGLQJ HIILFLHQF\ EXW LW GRHVQ¶W FDXVH
complete inhibition of virus release (McCown and Pekosz 2005, McCown and Pekosz 
2006). This suggests that other cellular factors, may be involved in the budding process 
or may function as redundant scission factors (Martyna and Rossman 2014). It has 
been shown that influenza virus requires a number of host factors, such as adenosine 




Nayak 2001, Hui and Nayak 2002). Another study showed that cellular GTP-binding 
protein, Rab11 together with Rab11-family interacting protein 3 supports formation 
of filamentous particles. Additionally, the Rab11 protein might be involved in final 
budding steps of spherical particles (Bruce et al. 2010). Further studies are required to 
determine the molecular mechanism of membrane scission and exact role of the M2 
AH and cellular factors in it.  
 
1.4.3 Model of influenza budding   
An overall influenza assembly and budding model suggest that several virus proteins 
mediate the process, rather than a single one. HA and NA are transported to the lipid 
rafts, where they concentrate (Fig. 1.4-1 A). This molecular crowding may cause 
alteration of membrane curvature and initiation of the budding event. M1 may then be 
recruited to the site by interacting with the cytoplasmic tails of HA and NA (Fig. 1.4-
1 A). Membrane bound M1 can polymerise and form the inner structure of the virion 
(Fig. 1.4-1 B), excluding host proteins from the budding site. Additionally, M1 may 
alter membrane curvature to progress the budding event; however, recruitment of 
vRNPs and M2 by M1 may block completion of budding process (Fig. 1.4-1 A and 
B). Recruitment of M2 to the budding site, which is a cholesterol rich environment, 
can cause stabilisation of the site and allow for proper assembly of the virion. In the 
later stages of budding M2 can be localised to the neck of the budding virion, in the 
boundary between lipid rafts and the bulk plasma membrane phase, which is a low 
cholesterol environment. Insertion of the amphipathic helix in to the membrane may 
cause NGC and in this localisation may cause membrane scission (Fig. 1.4-1 C). 
Despite many years of research, many aspects of Influenza A virus assembly and 
budding are not known. The order of viral protein assembly, interactions between them 
and their role in proper assembly of the virion as well as their influence on initiation 
and progression of viral budding are not fully understood. It has been proposed that 
membrane curvature may be altered in two ways: by disrupting the line tension 
between the two lipid phases or disruptions in the packing of the lipid membrane 
(Rossman et al. 2010b). However, the exact molecular mechanism of the M2 
amphipathic helix mediated membrane scission, the interaction with the membrane 











Figure 1. 4 - 1 Model of influenza virus budding. A) The initiation of virus budding caused by 
clustering of HA (red) and NA (orange) in lipid raft domains. M1 (purple) binds to the cytoplasmic 
tails of HA and NA and serves as a docking site for the vRNPs (yellow). B) Elongation of the 
budding virion caused by polymerization of the M1 protein. M2 (blue) is recruited to the periphery 
of the budding virus though interactions with M1. C) Membrane scission caused by the insertion 
of the M2 amphipathic helix at the lipid phase boundary, altering membrane curvature at the neck 












1.5 AIMS OF THE PROJECT 
 
The main aim of this research project was to investigate molecular mechanisms of 
membrane scission, which is the last stage of influenza virus assembly and budding, 
mediated by the M2 protein, starting by determining the structure of the M2 AH in 
different environments and its interactions with membranes. The studies were to 
investigate how different properties of the membrane affect functions of the M2 AH 
and the changes to the lipid membranes introduced by the M2 AH. Budding mediated 
by the M2 AH both in vitro and in vivo was then investigated. This will allow for better 









































Peptides were synthesized by GenScript (NJ, USA) or Biomatik (DE, USA) at 95% 
purity, with trifluoroacetic acid (TFA) removed. Peptide sequences, introduced 
mutations and modifications such as N-terminal acylation and C-terminal amidation 
where indicated are listed in Table 2.1-1. All peptides were dissolved in MiliQ water 
to form a 1 mM stock concentration and stored at -20 ?C. Fluorescent M2 AH peptide, 
based on the A/Udorn/72 strain, incorporates fluorescein isothiocyanate (FITC) 





































Purpose of the mutation 
 
To avoid oxidation of the 
cysteine 
 
To avoid oxidation of the 
cysteine 
To avoid oxidation of the 
cysteine 
 
Weakening of the 
hydrophobic face of the 
helix 
Disruption of the 
cholesterol recognition 
amino acid consensus 
(CRAC) domain 



















































(47-62 of A/Udorn/72) 
 
M2 AH 
(46-62 of A/Udorn/72) 
 
M2 AH FITC 
(47-62 of A/Udorn/72) 
 
M2 AH 
(47-62 of A/England/09) 
M2 AH 
(45-62 of A/England/09) 
 
M2 AH F47A F48A 
(45-62 of A/England/09) 
M2 AH CRAC 
(45-62 of A/England/09) 
M2 AH 5 PM 





















Enhancement of the polar 
face of the helix 
Weakening of the polar 
face of the helix 
Weakening on the helix 
interface 
Disruption of the helix 
phase 













































M2 AH L46K C50K Y57K 
(45-62 of A/England/09) 
M2 AH K49A K56A 
K60A 
(45-62 of A/England/09) 
M2 AH R54A R61A 
(45-62 of A/England/09) 
M2 AH +A 
(45-62 of A/England/09) 
M2 AH +AA 











Lipids used in this studies were purchased from Avanti Polar Lipids (AL, USA) or 
Sigma-Aldrich (MO, USA). All lipids were dissolved in chloroform and stored at -
20 ?C under an overlay of argon gas to prevent oxidation. Full details are shown in 

















































































































































































































2.1.3 Cells, plasmids, viruses and antibodies 
Madin-Darby canine kidney (MDCK) cells and human embryonic kidney 293T (HEK 
293T) cells used in this study were as described previously (Chen et al. 2008). Cells 
were grown in T-75 cm2 flasks with vented caps (Sarstedt, Germany) at 37 ?C in 5% 
CO2 in 'XOEHFFR¶V0RGLILHG(DJOH0HGLXPDMEM) (Gibco) with 10% fetal bovine 
serum (FBS) (Gibco) and 1% Penicillin-Streptomycin (Sigma-Aldrich). Subculturing 
of cells was performed by removing the growth medium from the confluent flask of 
cells and washing with 5 ml of phosphate buffered saline (PBS). The buffer was 
subsequently removed and replaced with 3 ml of TrypLE Express (Gibco), followed 
by incubation for 10-20 min at 37 ?C in 5% CO2 until all cells had detached from the 
flask. 7 ml of DMEM was then added to the flask and the sample was then transferred 
to a sterile 15 ml falcon tube (Sarstedt, Germany) and centrifuged for 10 min at 1000 
revolutions per minute (rpm) in a Heraeus Megafuge 40R (Thermo Scientific) to pellet 
the cells. After centrifugation, the supernatant was removed and the cells were 
resuspended in 10 ml of DMEM and seeded in new flask at the desired concentration. 
Two pCAGGS plasmids (map shown in appendix 6.1) encoding either wild type M2 
protein from Influenza A/Udorn/72 strain or M2 5PM protein which has 5 point 
mutations in AH were used (as described in chapter 2.1.1) (Rossman et al. 2010a). 
The Influenza A/Udorn/72-ǻM2 recombinant virus (Jackson and Lamb 2008, 
Rossman et al. 2010a) and anti M2 monoclonal antibody, 14C2 (Zebedee and Lamb, 












Oligonucleotides were synthesised by Eurofins Genomics (Ebersberg, Germany) with 
features shown in Table 2.1-3. All oligonucleotides were designed to bind to the M 
gene segment of the Influenza A/Udorn/72 strain, either to the untranslated region 

















55.3 7153 Forward UTR in 
the front 




50.9 6812 Reverse UTR in 





55.3 6150 Forward Middle 
position 
(413-432) 
in the M 
gene 
 














2.2.1.1 Small Unilamellar Vesicles (SUVs) 
SUVs were made by sonication of Multilamellar Vesicles (MLVs). To form MLVs, a 
lipid solution containing 12.5 ȝPROHs of lipids (Avanti and Sigma-Aldrich) was made 
using indicated lipid compositions at the required molar ratio. The solution was dried 
under a stream of argon gas followed by drying in a desiccator in a vacuum for 1 h to 
remove residual chloroform. Lipid films were then dissolved in 500 ȝORISRWDVVLXP
buffer (10 mM K2HPO4, 50 mM K2SO4, 5m M MOPS, pH 7.4) and hydrated for 30 
min at a temperature above the phase transition temperature for each particular lipid 
mix (37 ?C for standard mixes, 65 ?C for phase separated vesicles and 80 ?C for mixes 
containing DSPE) with vortex mixing every 5 min. MLVs were then sonicated by 
water bath (Fisherbrand, FB15046) or by probe sonication (Soniprep 150, MSE) to 
form SUVs. For water bath sonication samples were sonicated at 10 min intervals, 
until solution changed from milky to nearly clear, usually up to 30 min. For probe 
sonication samples were placed on ice and were sonicated at an amplitude of 10-12 
microns for 10-15 cycles consisting of 1 min sonication followed by 30 s cooling break 
each. SUVs were stored at 4 ?C for up to 24 h. 
 
2.2.1.2 Large Unilamellar Vesicles (LUVs) 
LUVs were made by extrusion of the MLVs, which were made as described above. 
MLVs were freeze-thawed 15 times using dry ice, in an ethanol bath, and water bath 
set to the hydration temperature for the lipid mix. LUVs were extruded (Avanti Mini-
Extruder, Avanti Polar Lipids) 26 times with different size filter membranes 
(Nuclepore Track-Etched Membranes, Whatman) at hydration temperature. LUVs 
were stored at 4 ?C for up to a week. Standard LUVs used throughout this study were 
composed of phosphatidylcholine (PC), phosphatidylglycerol (PG) and cholesterol 






2.2.1.3 Giant Unilamellar Vesicles (GUVs) 
GUVs were made by electroformation, as previously described in the literature 
(Veatch 2007, Manley and Gordon 2008). A 1 mg/ml lipid solution (Avanti and 
Sigma-Aldrich) was made using indicated lipid compositions at the required molar 
ratio and spread onto the conductive side of two indium tin oxide coated slides (15-
ȍVTVXUIDFHUHVLVWLYLW\6LJPD-Aldrich) at 1 ȝOFP2 (6.4 ȝODW cm2). Lipids were 
then dried in a desiccator in a vacuum for 1 h. Lipid coated slides were sandwiched 
together using FastWell 9 mm spacer (Grace Bio-Labs reagent barriers, Sigma-
Aldrich) and 70 ȝO RI K\GUDWLRQ EXIIHU  0 VXFURVH  mM HEPES, pH 7.2). 
Chamber was then connected to the function generator (Gw Instek SFG-1013 DDS 
function generator) using copper tape and lipids were electroformed by applying 10 
Hz sine wave at 1 V for 4 h. After electroformation GUVs were recovered from the 
chamber using wide-boar pipette tip and used within 4 h. 
 
 
2.2.1.4 Dynamic Light Scattering (DLS) 
Vesicle size was measured using Zetasizer (nano series, Malvern Instruments 
Worldwide). 4 ȝl of vesicles were mixed with 32 ȝl of water, measurements were done 
in micro cuvettes (ZEN0040, Malvern Instruments Worldwide) at 25 ?C. 
 
2.2.2 Nuclear Magnetic Resonance (NMR) Spectroscopy 
NMR spectroscopy experiments were performed as previously described (Lawrence 
et al. 2014) in collaboration with Dr Mark Howard and Dr Michelle Rowe from 
University of Kent. Peptide structural studies were conducted using samples that had 
total volume of 330 ʅl and contained 500 ʅM of the 16 amino acid long M2 AH 
peptide based on the A/Udorn/72 strain and, where indicated, 10 ʅM of standard LUVs 
in water with 10% of deuterium oxide. Samples were placed in 3 mm glass tubes 
(Shigemi) and data was collected using a 14.1 T (600 MHz 1H) Bruker Avance III 
NMR spectrometer with QCI-F cryoprobe at 25ͼC. Total correlation spectroscopy 
(TOCSY) and Nuclear Overhouser effect spectroscopy (NOESY) data sets were 




Analysis (Vranken et al. 2005). Structural ensembles were calculated using CNS 
(Brunger et al. 1998). 1H chemical shifts and through-space structural assignments 
were acquired from TOCSY and NOESY data sets. Dihedral angles were estimated 
using DANGLE (Cheung et al. 2010), which is a built-in module in CCPN Analysis. 
Hydrogen bonds were estimated using the software MOLMOL (Koradi et al. 1996) by 
analysing the calculated structure and distance between oxygen and nitrogen-bound 
hydrogen atoms and were added for the pairs of atoms that were less than 3 Å apart. 
The final ensemble was energy minimised in a water environment using YASARA 
software (available from http://www.yasara.org). The precision and quality of the 
calculated structures was checked by series of statistical analyses, including 
Ramachandran analysis, using PROCHECK (Laskowski et al. 1993) software.  
Saturation-transfer difference (STD) NMR studies were performed using 500 ʅM of 
the 16 amino acid long M2 AH peptide based on the A/Udorn/72 strain and, where 
indicated, 10 ʅM of standard LUVs in water with 10% of deuterium oxide. The 
experiment was performed with 3-9-19 WATERGATE and Gaussian STD excitation 
pulses of 20 ms duration and a ȖB1 of 140 Hz that were applied for 2 s at -3 ppm and 
-30 ppm for saturation and control respectively. 1H T1 relaxation time constants were 
obtained using an inversion-recovery sequence, including 3-9-19 WATERGATE. To 
obtain T1 inversion-recovery 180 ?-ʏ-90 ?delays in 0.1 s steps between 0.2 and 0.1 s 
were used. Quantitative STD NMR amplification factors were obtained from 1H T1 
values using previously described GEM-CRL method. Intensities for STD and T1 
relaxation experiments were obtained using Spectrus Processor (ACD Laboratories).  
 
2.2.3 Peptide binding assay 
Various concentrations of peptide and lipids were tested to determine which one gives 
the best signal, as described in chapter 3.2.2, and the procedure described below is 
based on the best conditions determined in the optimization process. 100 ȝM of M2 
AH FITC labelled peptide was mixed with 2.5 mM of indicated lipids and water to a 
final volume of 50 ȝl. Controls were made with 100 ȝM of M2 AH FITC labelled 
peptide and water. Samples were incubated for 1 h at room temperature in the dark. 
After incubation samples were filter washed twice: 450 ȝl of water was added before 




and centrifuged at 14000 rpm in a bench top centrifuge (Eppendorf, rotor FA-45-18-
11) until 100 ȝl of the sample was remaining in the filter. 50 ȝl of the samples or blank 
(water and vesicles buffer) were transferred to a 96-well plate (black walls and clear 
bottom) and the fluorescence was checked on a fluorescence plate reader (FLUOstar 
Omega, BMG LABTECH) with the excitation filter at 492 nm and emission filter at 
520 nm. All data was blank corrected before processing. 
 
2.2.4 Circular Dichroism (CD) Spectroscopy 
Various concentrations of peptide and lipids were tested to determine the optimal 
peptide:lipid ratio, as described in chapter 3.2.3.1, and procedure described below is 
based on the best conditions determined in the optimization process. 250 ȝ0 RI
indicated peptide and 5 mM of lipids, where indicated, were mixed with water to final 
volume of 300 ȝO %ODQNUHDGLQgs were taken using water or vesicles in water, for 
peptide in solution and peptide with lipids respectively. Where indicated 30% of 2,2,2-
trifluoroethanol (TFE) was added to the samples and blanks, keeping total volume the 
same. All measurements were performed in quadruplicates on a JASCO 
spectropolarimeter (JAS.CO; J-715) using a 1 mm path length glass cuvette (Starna 
Scientific) at 25ͼC. Respective blank measurements were subtracted from all samples 
and percentage of the helix was estimated using K2D3 online bioinformatics tool 
(Louis-Jeune et al. 2012) found on KWWSNGRJLFFD 
 
2.2.5 Immunofluorescence microscopy 
HEK 293T cells were grown on glass cover slips and transfected with 2.5 ʅg of M2-
pCAGGS plasmid using TransIT-293 transfection reagent (Mirus). After 47 h post 
transfection 1 ȝ0RI fluorescently labelledPIP2 was added to the cells and incubated 
for 1 h at 37ͼC in 5% CO2. After 48 h post transfection cells were washed with PBS, 
fixed in 10% formalin:PBS for 10 min and treated with blocking solution (DMEM 
with 10% FBS) for 20 min. Cells were then stained for M2 using monoclonal 14C2 
antibody at a 1:400 dilution for 1 h, as primary antibody without permeabilisation, 
followed by four washes with PBS. Alexa 680, donkey anti-mouse antibody was used 




Coverslips with cells were then mounted on the slides using 12 ʅl of Prolong Gold 
(Invitrogen) and left in the dark for 12 h to set. Slides were imaged on a Leica confocal 
microscope (SP2) using a 63x oil objective with a 488 nm argon laser and a 633 nm 
helium-neon laser at 25% power, with a 496-525 emission filter for fluorescently 
labelled PIP2 and a 685-730 emission filter for M2 protein. 
 
2.2.6 Molecular Dynamics Simulations 
Molecular Dynamic Simulations were used to study the interaction between the M2 
AH peptide and a buckled membrane. Coarse-grained simulations and the analysis 
protocol for simulating curvature sensing by single peptides was performed as 
previously described (Gómez-Llobregat et al. 2016) by  collaborators, Dr -RUGL
*yPH]/OREUHJDWDQG'U0DUWLQ/LQGpQ at Stockholm University using the Swedish 
National Infrastructure for Computing at the National Supercomputer Centre. 
 
2.2.6.1 Simulation parameters 
Coarse-grained simulations were performed using GROMACS 4.6.1 (Pronk et al. 
2013) and the MARTINI force-field (version 2.P) with polarizable water (Kawaoka 
and Neumann 2012, Kikuchi et al. 2012, Neumann et al. 2012), and a relative dielectric 
constant of 2.5 (Kawaoka and Neumann 2012). Standard parameters were used for 
lipids POPC and POPG (Nidom et al. 2012, Victor et al. 2012) and for peptides 
(Murakami et al. 2012). The M2AH peptide structure was obtained from PDB 2L0J 
(Sharma et al. 2010), and was coarse-grained with the martinize script provided by the 
MARTINI developers. Constant temperature was maintained with the velocity 
rescaling thermostat (Kawai et al. 2012) with a 1.0 ps time constant, and pressure was 
controlled with the Berendsen barostat (Shi et al. 2012) using a time constant of 12 ps 
and a compressibility of 3 x10-4 bar-1. Peptide (when present), lipids and solvent were 
coupled separately to the temperature bath. Coulomb interactions were modelled with 
the particle mesh Ewald method (Noda et al. 2012) setting the real-space cut to 1.4 nm 
and the Fourier grid spacing to 0.12 nm. Lennard-Jones interactions were shifted to 






2.2.6.2 Lipid bilayer equilibration 
First two coarse-grained symmetric lipid bilayers twice as large than wide (Lx = 2Ly) 
were built, consisting of 1024 lipids, one with a 4:1 molar ratio of POPC:POPG and 
another with POPC-RQO\7KHV\VWHPVZHUHVROYDWHGZLWK§FRDUVH-grained 
water beads and neutralised with sodium and chloride ion beads. The bilayer systems 
were then equilibrated for 25 ns in an NPT ensemble at 300 K and 1 bar, with pressure 
coupling applied semi-isotropically. 
 
2.2.6.3 Membrane buckling and peptide addition 
After equilibration, both systems were laterally compressed in the x direction by a 
factor Ȗ= (L-LX)/L = 0.2, where L is the linear size of the flat system in the x direction, 
and LX the size of the simulation box in the x direction. This was done by scaling all 
x-coordinates, and the system size LX, by a factor 1-Ȗ = 0.8 at the end of the 
equilibration run, yielding LX = 21.03 and 20.93 nm for the mixed and pure membrane 
patches, respectively. After rescaling, the compressibilities were set to 0 in the x and 
y directions to keep the system size constant in those directions for subsequent 
simulations. Pressure coupling was then applied anisotropically in the z direction only. 
An energy minimisation and a short equilibration run (25 ns) was then performed to 
let the bilayer buckle. Next the M2 AH peptide was added to each system. The peptide 
was initially placed 3 nm above the membrane surface, but quickly attached to the 
membrane-water interface. After the binding event, the system was equilibrated for 
another 5 ʅs before starting a production run of 35 ʅs, where the data was collected 
every 5 ns. 
 
2.2.6.4 Membrane alignment and peptide tracking 
The buckled membrane profile diffuses during the simulation, but curvature sensing 
by the M2AH peptide is reflected in its distribution relative to the buckled shape, and 
the buckled configurations must therefore be aligned in order to extract useful 
information. Previous protocol (Gómez-Llobregat et al. 2016) was used to fit the xz 
profile of the membrane by the ground state of the Helfrich model with periodic 




(Shinya et al. 2012, Hu et al. 2013). This shape depends only on the dimensionless 
buckling parameter Ȗ, where Ȗ = 0 is the flat state. Thus, if one period of the buckling 
profile for LX = 1 is given by a parameter curve x = s + [ (s, Ȗ), z = ] (s, Ȗ), 0 < s < 1, 
the general case LX FDQEHREWDLQHGE\VKLIWLQJDQGVFDOLQJ)RUIDVWHYDOXDWLRQ
[(s, Ȗ) and ] (s, Ȗ) were expanded in truncated Fourier series in s, and created look-up 
tables for Fourier coefficients versus Ȗ. The arc-length coordinate s was scaled to have 
period one independent of the overall system size, and defined such that the curve z(x) 
has a maximum at s = 0.5, minima at s = 0, 1, and inflection points at s = 0.5 ± 0.25. 
The buckled shapes were aligned by fitting the bilayer in each frame to the buckling 
profile and aligning the inflection points. Specifically, the buckling profile was fit to 
the innermost tail beads of all lipids in each frame using least-squares in the x and z 
directions, i.e., minimising 
 ෍൫ݔ଴ ൅ ܮ௫൫ݏ ൅ ߦሺݏ௜ǡ ߛሻ൯ െ ݔ௜൯ଶ ൅ ሺݖ଴ ൅ ܮ௫ߞሺݏ௜ ǡ ߛሻ െ ݖ௜ሻଶ 
 
with respect to Ȗ, the translations x0, z0, and the projected arc-length coordinates si of 
each bead (xi, zi are bead positions). The arclength position s of the peptide was 
computed by projecting the peptide centre of mass onto the buckled profile fitted to 
the membrane midplane in every frame (Fig. 3.3-19 B). The in-SODQHRULHQWDWLRQȖZDV
computed by fitting a line through the backbone particles of the alpha-helical part of 
the peptide and projecting this line to the tangent plane defined by the tangent vector 
W DQG WKH\XQLWYHFWRU WDNLQJȖ WREHWKHDQJOH EHWZHHQ WKHSURMHFWHG OLQHDQG WKH
tangent vector, in the tangent plane. Variations in the buckling parameter VWG>Ȗ@§
0.005) reflect small shape and area fluctuations, that was neglected by using the 
DYHUDJHEXFNOLQJSDUDPHWHUYDOXHVIRUFXUYDWXUHDQDO\VLV>Ȗ@ DQG>Ȗ@ 
for the POPC:POPG and pure POPC systems, respectively. The local curvature, shown 
in Figure 3.3-19 D LV WKHQJLYHQE\&V í>Ȗ@/x G%?GVZKHUH%?LV WKHWDQJHQW
angle in Figure 3.3-19 B (also computed using average compression factors). 
Molecular graphics were generated using Visual Molecular Dynamics (VMD) (Langel 






2.2.7 Laurdan assay for membrane order 
Various peptide concentrations, lipids:dye ratios and total volumes of the samples 
were tested to determine the best conditions for this type of assay, as described in 
chapter 3.4.2.1, and the final protocol is outlined below. 2.5 mM of indicated lipids 
were mixed with Laurdan dye (life technologies) at 1:100 dye:lipid ratio and 200 ȝM 
of indicated peptide, the volume was made up to 50 ȝl with water. Control samples 
were made in the same way, without adding peptide. Samples were then transferred to 
a 96-well plate (white walls and bottom) and the fluorescence was checked on a 
fluorescence spectrophotometer (Cary Eclipse, VARIAN) with the excitation filter set 
at 355 nm and emission filters at 440 and 490 nm. *HQHUDOLVHGSRODULVDWLRQ (GP) value 
was calculated using equation: GP= (I440 ± I490)/ (I440 + I490) (Parasassi et al. 1990, 
Sanchez et al. 2007).  
 
2.2.8 Differential Scanning Calorimetry (DSC) 
MLVs were made as described before (chapter 2.2.1.1) using 13 mmoles of DSPC 
lipid and 1 mM HEPES buffer (pH 7.2) to reconstitute lipid films containing, where 
indicated, 650 ʅM of the M2 AH peptide, giving a 10 mg/ml lipid solution and a 
peptide : lipid ratio of 1:20. MLVs were formed following 30 min of hydration at 60ͼC 
with regular vortexing. Samples were then analyzed on a Phox 200PC DSC (Netzsch, 
Germany) using sealed aluminum crucibles under nitrogen gas.  All runs were 
corrected to a baseline run using empty crucibles. Samples were scanned from 35ͼC ± 
75ͼC at a rate of 10 K/min with 2 min isothermal holds at the end of each run.  All 
samples were scanned four times, with the first scan discarded. Subsequent scans were 
compared to ensure consistency in the identified lipid Tm. After each sample run, 
crucibles were weighed to ensure no weight loss, and thus no sample loss, had 
occurred. Netzsch Proteus Analysis software was used to graph the first differential of 
the data and to identify Tm peaks through the automatic peak calling function near the 







2.2.9 Transmission Electron Microscopy (TEM) 
5 mM of standard LUVs were incubated with increasing concentrations of the M2 AH 
peptide for 1 h at room temperature and stained with uranyl acetate before imaging. 
Samples were imaged on a JEOL 1230 (Tokyo, Japan) electron microscope using a 
Gatan digital camera (CA, USA). Post image processing was limited to cropping and 
equal adjustment of image levels. 
 
2.2.10 GUV budding system 
GUVs composed of PC, PG and fluorescently labelled cholesterol (TopFluor, Avanti) 
at 4:1:0.05 molar ratio were formed as described in chapter 2.2.1.3. 5 ʅl of GUVs were 
diluted 1:100 in resuspension buffer (0.1 M glucose, 1 mM HEPES, pH 7.2) and 
placed in the well of the Nunc Lab-Tek II chamber slides (Thermo Fisher Scientific, 
Rochester, NY) that had been blocked with 1% Bovine serum albumin (BSA) for 1 h 
before use followed by three washes with PBS. 0.5 mg/ml of Lucifer Yellow (Sigma) 
and, where indicated, 10 mM of indicated M2 AH peptide was added to the GUVs 
resuspension. The content of each well was gently mixed by pipette tip and incubated 
for 45 min in the dark prior to imaging on a Leica confocal microscope (SP2) using a 
63x oil objective with a 488 nm argon laser at 25% power, a 496-525 nm emission 
filter for TopFluor and a 530-580 nm emission filter for both TopFluor and Lucifer 
Yellow. Quantification of the budding effect was performed by determining the 
percentage of GUVs that were containing at least one Lucifer Yellow positive 
intralamellar vesicle (ILV) and the percentage of GUVs that leaked and were filled 
with Lucifer Yellow. For each sample total number of at least 200 vesicles 10 ʅm and 










2.2.11 GUV microinjection system 
GUVs composed of PC, PG and fluorescently labelled cholesterol (TopFluor, Avanti) 
at 4:1:0.05 molar ratio were formed as described in chapter 2.2.1.3 using adjusted 
hydration buffer (0.2 M sucrose, 1 mM HEPES, 0.2 mM EDTA, pH 7.4). 5 ʅl of GUVs 
were diluted 1:100 in resuspension buffer (0.1 M KCL, 1 mM HEPES, 0.2 mM EDTA, 
pH 7.4) and placed in the FluoroDish with glass bottom (World Precision Instruments) 
that had been blocked with 1% BSA for 5 min before use, followed by three washes 
with PBS. A solution of 1 mM 16 amino acid long M2 AH peptide based on the Udorn 
strain was loaded into the ICSI-Plus non-spiked injection needle (Research 
Instruments) that had been blocked with 1% BSA for 1.5 h before use followed by 
three washes with PBS using MicroFil syringe needle for filling micropipettes (World 
Precision Instruments). The peptide was injected next to the GUVs using the Tritech 
Research Microinjector System (Narishige Group, Intracel) and an automated pipette 
holder (Sensapex) whilst imaging on a Lumascope 620 (Etaluma) using 40x Olympus 
objective with blue LED light a 473-491 excitation filter and a 502-561 emission filter 
(channel 2). 
  
2.2.12 Supported bilayers with excess membrane reservoir 
(SUPER) templates system  
SUPER templates experiments were done in collaboration with Dr Saipraveen 
Srinivasan from University of Texas. Samples were prepared as previously described 
(Neumann and Schmid 2013), using SUVs composed of DOPC, DOPS, PIP2 and 
RhPE at 79:15:5:1 molar ratio prepared as described in chapter 2.2.1.2 using MilliQ 
water instead of hydration buffer. 200 ʅM SUVs were mixed with 2.5 ʅm silicon 
microspheres (Corpuscular) in potassium buffer (150 mM KCl buffer, 20 mM HEPES, 
pH 7.5) to total volume of 100 ʅl. After 30 min incubation at room temperature 
templates were washed by addition of 1 ml of potassium buffer followed by 
centrifugation at 260 g for 2 min in bench top centrifuge (eppendorff) and discarding 
1ml from the supernatant. Washes were repeated 4 times in total and after the final 




then treated with 0.5 ȝ0$PSKLSK\VLQ,, where indicated, and incubated for 30 min 
in the presence or absence of 25 ȝ00$+RU the 5 point mutant M2 AH peptide. 
Samples were then centrifuged at 260 g for 2 min in bench top centrifuge. The 
supernatant was removed and observed for released vesicles via fluorescence 
measurements in a plate reader set to look at Rhodamine fluorescence following 
treatment with 0.1% Triton-X and compared to the total lipid present in the remaining 




HEK 293T cells were grown in 6 well plates and transfected, where indicated, with 
2.5 ʅg of M2-pCAGGS plasmid, M25PM-pCAGGS plasmid and an empty pCAGGS 
plasmid using TransIT-293 transfection reagent (Mirus). At 48 h post transfection the 
media were harvested by pouring into a 15 ml Falcon tube and centrifuging at 3000 
rpm for 10 min in bench top centrifuge (eppendorff). Both cell lysates and supernatant 
from the centrifuged samples were prepared according to the protocol contained in 
Bolt Bis-Tris Plus Mini Gel Electrophoresis system (Life Technologies) with an 
optional reducing agent present and modified with an increased temperature to 90 ?C 
instead of 70 ?C at the sample preparation step. The precast polyacrylamide gel 
compatible with this system was loaded with up to 20 ʅl of each sample per well and 
with one well containing 10 ʅl of SeeBlue Plus2 Pre-Stained Protein Standard (Novex, 
Life Technologies). The gel was run at 165 V for 35 min using an EC570-90 Power 
Supply (ThermoEC). Proteins were then transferred from the gel to a polyvinylidene 
difluoride (PVDF) membrane using an iBlot Dry Blotting System (Life Technologies) 
with an iBlot Gel Transfer Device (Life Technologies) set to programme 3. 
Immunoblotting of the membrane was done with 14C2 as the primary antibody and an 
anti-mouse secondary antibody using a Western Breeze chromogenic 






2.2.14 Repeated virus passaging  
2.2.14.1 Virus growth 
MDCK cells were grown in T-75 cm2 flasks and infected with Influenza A/Udorn/72-
ǻM2 recombinant virus by removing the growth media and adding 3 ml of DMEM 
containing virus at 0.01 multiplicity of infection (MOI). Cells were incubated for 2 h 
at 37 ?C, 5% CO2 and shaking every 15 min to prevent from drying. After incubation 
the media was replaced with 15 ml of DMEM with 1% N-acetyl trypsin (NAT) and 
cells were incubated until cytopathic effects, such as changed morphology and dead 
cells in the media, were observed. The virus was then harvested by pouring the media 
into a 15 ml sterile tube and centrifuging for 20 min at 1000 rpm in a Heraeus 
Megafuge 40R (Thermo Scientific). The virus contained in the supernatant was then 
transferred into a new sterile 15 ml tube and stored at -20 ?C for further analysis and 
subsequent passages. 
 
2.2.14.2 Plaque assay 
Virus titer was checked after each passage by plaque assays. MDCK cells were grown 
in 6 well plates until 100% confluency. Series of dilutions of harvested virus, 10-2 to 
10-7, were prepared in DMEM with 1% BSA. The media was aspirated from the cells 
followed by a wash with 2 ml PBS and addition of 400 ʅl of diluted virus into each 
well. Cells were incubated for 2 h at 37 ?C, 5% CO2 and shaking every 15 min to 
prevent from drying. After incubation, the media was removed from the wells and 2 
ml of replacement media (50% volume of 2% agarose at 50 ?C and 50% volume of 2X 
DMEM, 2X Penicillin-Streptomycin and 2 ʅg/ml of NAT at 37 ?C) was added. Plates 
were left for 5 min at room temperature to allow agarose overlay to set up and then 
inverted and incubated at 37 ?C, 5% CO2 for about 3 days, until plaques appeared. 
Plaque assay was performed in duplicates and virus titer (in plaque forming units 
(PFU) per ml) was calculated using equation: 






2.2.14.3 RNA extraction and reverse transcription 
Viral RNA was extracted from samples using QIAamp Viral RNA Mini Kit (Qiagen) 
and maximum volume of the sample. Concentration of viral RNA after extraction was 
measured by NanoDrop 2000 (Thermo Scientific).  Reverse Transcriptase Polymerase 
Chain Reaction (RT-PCR) were performed using One-Step RT-PCR Kit (Qiagen) in 
3Prime PCR machine (Techne) with 0.6 ʅM of each primer: M_UTR_F and 
M_UTR_R (described in chapter 2.1.4) and 2 ʅg of template RNA. Cycling conditions 
were set up according to the protocol with 40 cycles in 3-step PCR, each cycle 
consisting of 3 steps: denaturation, 1 min at 94 ?C; annealing, 1 min at 47 ?C and 
extension, 1 min at 72 ?C. After RT-PCR all samples were run on agarose gel to select 
correct synthesis product prior to purification. A 1.2% agarose (Melford, UK) gel was 
made in 1xTBE buffer (Tris-Base, Boric acid and 0.5M, pH 8 EDTA) with 1,5 ʅl of 
ethidium bromide (Sigma) in an electrophoresis unit (Fisher Scientific) and left for 20 
min at room temperature to set. The gel was then covered with 1xTBE buffer and 10 
ʅl of a 1 kb HyperLadder (Bioline), was loaded into the wells along with RT-PCR 
samples mixed with 5 ʅl of gel loading buffer (0.25% bromophenol blue and 40% 
sucrose in water). The gel was run at 100 V for 1 h using an EC570-90 Power Supply 
(ThermoEC) and was viewed in a BenchTop UV transluminator (UVP). Bands of the 
correct size were cut out from the gel with a sterile blade and DNA was extracted using 
a Gel Extraction Kit (Thermo Scientific). DNA concentration in each sample was 
measured on NanoDrop.  
 
2.2.14.4 Sequencing 
Aliquots of DNA at 1 ng/ʅl per 100 base pairs of the PCR product (10 ng/ʅl total) and 
three primers: M_UTR_F, M_UTR_R and M_F2 at 3.2 pmol/ʅl were prepared in 






























3.1 STRUCTURE OF THE M2 AMPHIPATHIC HELIX 
 
3.1.1 Introduction 
The M2 protein from the Influenza A virus is 97 amino acids long, which in its native 
form is a homotetramer and contains three domains: the ecto domain (residues 1-24),  
the transmembrane domain (residues 25-43) and the cytoplasmic tail (residues 44-97) 
(Lamb et al. 1985, Zebedee et al. 1985, Pinto et al. 1992), as shown in Figure 1.2-2. 
To date the full high resolution structure of the M2 protein has not been solved, 
however, the structure of the TMD, which functions as an ion channel, has been 
intensively studied.  The structure of the TMD between residues 22-46 has been solved 
by X ray crystallography (Stouffer et al. 2008) and the N-terminal of the cytoplasmic 
tail, up to residue 60, has been solved together with the TMD and few residues from 
the ecto domain (from residue 18) by NMR (Schnell and Chou 2008), which suggests 
formation of an amphipathic helix on the beginning of CT, between residues 51-59. It 
has been shown that this AH plays an important role in virus assembly and budding, 
especially in membrane scission. Therefore the structure of the 16 amino acid long M2 
AH, which corresponds to residues 47-62 of the full length M2 protein, based on 
A/Udorn/72 strain, has been solved in solution and in presence of standard LUVs using 
NMR. To determine which part of the helix is responsible for interactions with 
membranes Saturation-transfer difference (STD) NMR experiments have been 
performed. STD NMR is a technique that allows for detection of a small molecule 
binding to a larger receptor and detection of the molecular regions of the ligand that 










3.1.2 M2 AH formation upon membrane binding 
The structure of the M2 AH in solution and in the presence of standard LUVs 
(composed of POPC, POPG and Ch at 4:1:0.05 molar ratio, 100 nm) was resolved 
using 1H 2D NMR, mainly nuclear Overhouser effect (NOE) through-space contacts. 
The peptide used in this study was a 16 amino acid long M2 AH based on the 
A/Udorn/72 strain and corresponds to residues 47-62 on the full length M2 protein. 1H 
chemical shift assignments in parts per million (ppm) for the peptide in solution and 
in presence of  LUVs were obtained from 2D NMR TOCSY and NOESY experiments 
and are shown in Table 3.1-1 and Table 3.1-2 respectively. 
 
 
Residue HN HĮ Hȕ HȖ Hį Hİ 
1 Phe - 4.41 2.86    
2 Phe 8.03 4.49 2.91  3.05    
3 Lys 7.98 4.17 1.73 1.29 1.61  
4 Ser 8.09 4.34 3.76    
5 Ile 7.92 4.08 1.74  0.73  
6 Tyr 8.04 4.45 2.80  2.91    
7 Arg 7.91 4.11 1.50 1.30 3.02 7.04 
8 Phe 7.88 4.44 2.88  2.95    
9 Phe 7.94 4.51 2.89  2.99  7.12  
10 Glu 8.14 4.12 1.82  1.90 2.17   
11 His 8.41 4.59 3.11  3.24    
12 Gly 8.32 3.88     
13 Leu 8.01 4.28 1.53  1.53  
14 Lys 8.3 4.25 1.68  1.74 1.35 1.60 2.91 
15 Arg 8.37 4.27 1.69  1.79 1.56 3.12 7.11 
16 Gly 8.39 3.86     







Table 3. 1 - 2 Chemical shifts (ppm) of the M2 AH peptide in presence of standard LUVs. 
 
 
1H NMR spectra for the M2 AH in solution and in presence of LUVs were also 
obtained from TOCSY and NOESY experiments with fingerprint regions of each 
spectra shown in Figures 3.1-1 to 3.1-4 respectively. Peaks in each spectra were 
assigned and the structure of the peptide in each environment was resolved mainly 
using NOE through-space contacts. TOCSY spectra for the M2 AH peptide in solution 
and in the presence of LUVs appear similar (Fig. 3.1-1 and 3.1-3 respectively) 
however, the NOESY spectra show more peaks in presence of LUVs than for a peptide 
in solution  (Fig. 3.1-2 and 3.1-4 respectively) suggesting a higher amount of internal 
interactions in presence of LUVs and hence more structured peptide.  
 
 
Residue HN HĮ Hȕ HȖ Hį Hİ 
1 Phe - 4.41 2.86  7.09 7.16 
2 Phe 8.04 4.49 2.90  3.04  7.16 7.27 
3 Lys 7.98 4.17 1.73 1.29 1.61 2.92 
4 Ser 8.09 4.34 3.77    
5 Ile 7.92 4.08 1.74 1.15 1.00 0.73  
6 Tyr 8.04 4.45 2.90  2.79  6.99 7.08 
7 Arg 7.91 4.11 1.5 1.30 3.02 7.04 
8 Phe 7.88 4.44 2.88  2.96  7.12 7.26 
9 Phe 7.95 4.5 2.89  2.99  7.13 7.26 
10 Glu 8.14 4.12 1.81  1.89 2.16   
11 His 8.41 4.6 3.11  3.26  7.23  
12 Gly 8.33 3.88     
13 Leu 8.01 4.28 1.53  0.83  
14 Lys 8.29 4.24 1.74  1.69 1.35 1.61 2.91 
15 Arg 8.37 4.27 1.69  1.79 1.55 3.12 7.12 



















Figure 3. 1 - 3 TOCSY NMR spectra of the fingerprint region for M2 AH peptide in presence of 











The observed NOE contacts and statistics of the calculated structures for peptide in 
solution and in the presence of LUVs are shown in Table 3.1-3. When the M2 AH 
peptide was in solution, the number of observed NOE contacts - both inter and intra-
residue - was drastically reduced compared to the same peptide in the presence of 
LUVs which suggests that peptide is unstructured in solution and becomes structured 
upon binding with membranes. Due to the lack of interactions for the peptide in 
solution no dihedral restraints were used to calculate this structure. The structure 
statistics for the peptide in both environments show that NOE and dihedral angle 
violations (where present) are on a very low level which suggests that each structure 
was optimal. Ramachandran analysis for 20 structure ensembles shows nearly 90% of 
each structure to be in most favoured region and additionally allowed region which is 
expected from a good quality model. Additionally Ramachandran plot for the peptide 
in the presence of LUVs show concentration of data points in the region corresponding 
WRDQĮ-helix conformation (see appendix 6.2). Root mean squared deviation (rmsd) 
values for 20 structure ensembles calculated over residues 4-16 of each model were 
around two times higher for peptide in solution than for the peptide in presence of 
LUVs which suggest that there is more variability in the model for peptide in the 
solution and it might be a result of reduced number of observed NOE contacts and 














 In solution In presence of 
LUVs 
NMR distance and dihedral constrains   
Distance constraints   
Total NOE 38 218 
Intra-residue 3 55 
Inter-residue 35 163 
Sequential (|i - j| = 1) 35 91 
Medium-range (|i - j| < 4) 35 160 
Long-range (|i - j| > 4) 0 3 
Dihedral restraints 0 18 
Lennard-Jones Energy (kJ mol-1) -231± 23 -300 ± 20  
Structure statistics   
Violations   
NOE violations >0.2 Å 0 0 ± 0.00375 
Dihedral angle violations >2.0 Å - 0 ± 0.18234 
Ramachandran (%)   
Most favoured region 52.7 67.3 
Additionally allowed region 33.1 25.8 
Generously allowed region 9.6 3.1 
Disallowed region 4.6 3.8 
Average pairwise r.m.s. deviation (Å)*   
Heavy 5.140 2.610 
Backbone 3.171 1.570 
* Pairwise r.m.s. deviation was calculated over residues 4-16 
Table 3. 1 - 3 NMR and structure statistics for 20 structure ensembles of the M2 AH peptide in 
solution and in presence of standard LUVs. 
 
 
Models of the M2 AH peptide in solution and in the presence of LUVs were composed 
of 20 structure ensembles fitted over the backbone atoms in residues 4-16 and the 
structure closest to the mean of the ensemble was used to made a cartoon 
representation of each structure.  Calculated structures show random coil confirmation 
for the M2 AH peptide in solution (Fig. 3.1-5 A and B) and formaWLRQRIDQĮ-helix 
between residues 4-16 (residues 50-62 of a full length M2 protein) of the peptide in 
the presence of LUVs (Fig. 3.1-5 C and D). This confirms that the M2 AH is formed 








Figure 3. 1 - 5 Structures of the M2 AH peptide in solution (A and B) and in presence of standard 
LUVs (C and D). 20 structure ensembles fitted over backbone atoms in residues 4-16 are shown 
in A and C. Cartoon representations of the structure closest to the mean of the ensemble are shown 
in B and D.  
 
NOE contacts, hydrogen bond donors, dihedral restraints and secondary structure 
showing limitations of helix formation according to Ramachandran analysis of 20 
structure ensembles for the M2 AH peptide in solution and in the presence of LUVs 
are shown in Figure 3.1-6 and 3.1-7 respectively. As expected, there are not many 
NOE contacts when peptide is in a solution however, there are many HĮ-HN, HN-HN 
and Hȕ-HN i-i+1 NOEs observed when LUVs are present. Additionally, when the M2 
AH peptide is in the presence of LUVs, some HĮ-HN i-i+3 NOEs have been observed 
which are characteristic for an Į-helix formation. However, secondary structure for 
the M2 AH peptide in the SUHVHQFHRI/89VGRHVQ¶WVKRZIRUPDWLRQRIDFRQWLQXRXV










Figure 3. 1 - 6 NOE contacts, chemical shift difference, hydrogen bond donors and dihedral 
restrains for M2 AH peptide in solution. The secondary structure indicates the limits of helix 











Figure 3. 1 - 7 NOE contacts, chemical shift difference, hydrogen bond donors and dihedral 
restrains for M2 AH peptide in presence of standard LUVs. The secondary structure indicates the 







3.1.3 M2 AH membrane interactions 
One-dimensional (1D) STD NMR was performed by Dr Mark Howard from 
University of Kent and was used to determine the interaction between the M2 AH and 
the lipid membrane. STD control and difference spectra for the M2 AH in solution and 
with LUVs present are shown in Figure 3.1-8 and 3.1-9 respectively. When the peptide 
is in solution there are no interactions present and therefore no peaks are visible in the 
difference spectrum (Fig. 3.1-8). However, when the peptide is in the presence of 
LUVs, there are interactions between the peptide and the lipids in the membrane and 
therefore there are peaks visible in the STD difference spectrum, with some of the 
peaks identified as some of the amino acids present in the AH, based on the chemical 
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Figure 3. 1 - 9 1D 1H STD NMR for M2 AH peptide in presence of LUVs showing control spectrum (A) and STD difference spectrum for the M2 AH peptide in 




Quantitative STD values were calculated by modifying STD values according to the 
T1 relaxation rate, both of which were obtained through correlation of signal intensity 
to the nuclei of specific residues from the peptide (data not shown). These values were 
then converted to a percentage of the maximum transfer value, which was observed 





Residue Assignment Integral [abs] % of max 
8Phe HH1/2 1239392 34.6 
9Phe HH1/2 3587120 100.0 
11His HG1/2 1764799 49.2 
2Phe HG1/2 1054350 29.4 
8/9 Phe HG1/2 2082138 58.0 
6Tyr HH1/2 979446 27.3 
6Tyr HG1/2 865698 24.1 
12Gly HD2/3 733069 20.4 
Phe HD 1581385 44.1 
13Leu HG1 864895 24.1 
13Leu HG2 837269 23.3 
5Ile HG 1879250 52.4 
 
Table 3. 1 - 4 Quantitative STD values and percentage of the maximum transfer value for selected 










The percentage of the maximum STD transfer values from Table 3.1-4 were mapped 
on the calculated structure closest to the mean of the ensemble for the M2 AH peptide 
in the presence of LUVs, highlighting residues across the face of the helix responsible 
for interaction with the membrane based on their significance (Fig. 3.1-10).  The most 
important residues involved in interactions with the membranes are phenylalanine at 
residues 9 and 8 and isoleucine at residue 5 (residues 55, 54 and 51 in the full length 
M2 protein respectively) with phenylalanine at residue 2, histidine at residue 11 and 
glycine at residue 12 (residues 48, 57 and 58 in the full length M2 protein respectively) 
also being involved in the interaction but to a lesser degree. All of these residues, 
except the histidine, are in the hydrophobic face of the helix suggesting that the M2 
AH interacts with lipids using hydrophobic interactions, which confirms previous 






















Figure 3. 1 - 10 Calculated structure closest to the mean of the ensemble for the M2 AH peptide 
in presence of LUVs with residues across the face of the helix responsible for interaction with the 
membrane coloured based on a percentage of the maximum STD transfer. All images were 
generated in YASARA program, side view (A), top view- side view rotated 90ͼ through horizontal 
plane (B) and bottom view- top view rotated through 180ͼ (C). 
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In conclusion, NMR spectroscopy has been used to investigate the structure of the M2 
AH. Calculated models based on the 1H 2D NMR experiment show that peptide in 
solution is in random coil conformation however, when liposomes are present the 
SHSWLGH EHFRPHV KHOLFDO ZLWK DQ Į-helix being formed between residues 4 and 16 
(residues 50-62 in a full length M2 protein) (Fig. 3.1-5). To further investigate the 
interactions between the M2 AH and the lipid membrane, a 1D STD NMR experiment 
was performed. Results show that the phenylalanines at residues 9 and 8 and isoleucine 
at residue 5 are mostly responsible for the interactions with the membrane, with 
phenylalanine at residue 2, histidine at residue 11 and glycine at residue 12 being 
involved to a lesser degree (Fig. 3.1-10). This shows that residues 48, 51, 54, 55, 57 
and 58 are important for the peptide to be able to bind to lipids and with the majority 
of them being in the hydrophobic face of the helix, it suggests that the helix interacts 




















NMR experiments have shown that the M2 AH is formed upon binding with 
membranes (see chapter 3.1.2) and that the hydrophobic face of the helix is responsible 
for interaction with lipids (see chapter 3.1.3). To investigate how efficiently the M2 
AH can bind to lipid membranes a binding assay has been developed. Further 
investigation of the formation of the M2 AH in different environments, how well this 
is conserved between influenza virus strains and how different mutations affect this 
process, has been done using circular dichroism spectroscopy to determine the 
secondary structures of these peptides.  
 
3.2.2 Binding to lipid membranes 
The NMR has shown that the M2 AH is formed upon binding with lipid membranes 
(see chapter 3.1.2) therefore, an assay to quantify binding ability of the M2 AH with 
liposomes has been created. In this assay, fluorescently labelled M2 AH peptide was 
incubated with liposomes- SUVs, LUVs or GUVs. Unbound peptide was removed by 
filter washes and the fluorescence of each sample was checked by a plate reader. To 
determine the optimal concentration of the peptide, samples with a constant 
concentration of standard LUVs (2.5 mM) and a varied concentration of peptide (0-
100 ʅM) were tested, with it being determined that 100 ʅM of peptide gave the best 






Figure 3. 2 ± 1 Fluorescence readings for samples with 2.5 mM of standard LUVs incubated with 
increasing concentration of fluorescently labelled M2 AH peptide. 
 
100 ʅM of peptide was then used with varied amount of lipids, to further optimise 
assay conditions. Results showed that 2.5 mM of lipids gives the best signal out of the 
concentrations tested, with higher concentrations being out of detection range (Fig. 
3.2-2). Therefore 100 ʅM of peptide and 2.5 mM of lipids were chosen as optimal 
concentrations for this type of assay and used during all further experiments. 
 
Figure 3. 2 - 2 Fluorescence readings for samples with 100 ȝ0RIIOXRUHVFHQWO\ODEHOOHG M2 AH 















































Each experiment, peptide with liposomes or a control sample (containing peptide 
without liposomes), was measured in triplicate. Average Fold Binding was calculated 
from Fold Binding values, calculated by dividing fluorescent readings of a peptide 
with liposomes sample by an average value for the control samples. Control samples 
would contain residual peptide that has not been removed by the washes and from any 
background fluorescence that has been detected by the plate reader. The fluorescence 
signal from M2 AH peptide bound to standard LUVs was over 5 fold greater than the 
background, with standard error of 1.3, which shows that M2 AH peptide has bound 
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Table 3. 2 - 1 Fluorescence readings for samples with 100 ȝ0IOXRUHVFHQWO\ ODEHOOHG0 $+
peptide incubated with 2.5 mM standard LUVs and control samples without LUVs present. Fold 
Binding values were obtained by dividing fluorescence readings for samples with peptide and 







3.2.3 Alpha helix stabilisation upon binding 
 
3.2.3.1 Detection of secondary structure 
To confirm NMR observations, the secondary structure of the M2 AH peptide in a 
lipid environment was determined by circular dichroism (CD) spectroscopy. CD is the 
difference in absorption of left-handed circularly polarised light and right-handed 
circularly polarised light over a range of wavelengths (Greenfiled 2006). Structured 
molecules give characteristic spectra, for example, an Į-helix gives troughs at around 
222 nm and 208 nm whereDVȕ-sheets give a trough at around 218 nm (Fig. 3.2-3). 
Based on the spectra, theSHUFHQWDJHRIHDFKVWUXFWXUHLQWKHPROHFXOHZDVHVWLPDWHG














Initial experiments have been performed using a range of different peptide and lipid 
concentrations to determine the optimal peptide:lipid ratio that would give the best 
signal. Throughout these experiments, a 16 amino acid long M2 AH peptide based on 
the A/Udorn/72 strain and standard LUVs have been used. When 100 ʅM of the M2 
AH peptide was used the CD spectra showed two troughs at around 223 and 208 nm 
which suggests formation of an Į-helix (Fig. 3.2-4 A). Increasing the lipid 
concentration, from 200 ʅM to 5 mM, resulted in increase of the troughs depth and 





Figure 3. 2 - 4 CD spectra for 100 ȝ00$+SHSWLGHZLWKLQFUHDVLQJFRQFHQWUDWLRQRIVWDQGDUG
LUVs (A) and estimated SHUFHQWDJHRIDQĮKHOL[SUHVHQWLQHDFKVDPSOH calculated based on the 













































When 250 ʅM of the M2 AH peptide was used with the same range of lipid 
concentrations, the CD spectra only resembled an Į-helix in the presence of the two 
highest lipid concentrations (2 and 5 mM). In the lowest concentration of lipid (200 
ʅM), the spectra showed a peak at around 218 nm, suggesting a random coil formation 
(Fig. 3.2-5 A). Increasing the peptide concentration caused an increase in the troughs 
depth (Fig. 3.2-5 A) when compared with the 100 ʅM dataset (Fig. 3.2-4 A), and an 
increase in the estimated helix percentage values, which now ranged from 4.65 up to 




Figure 3. 2 - 5 CD spectra for 250 ȝ00$+SHSWLGHZLWKLQFUHDVLQJFRQFHQWUDWLRQRIVWDQGDUG
/89V$DQGHVWLPDWHGSHUFHQWDJHRIDQĮKHOL[SUHVHQWLQHDFKVDPSOHFDOFXODWHGEDVHGRQWKH














































When the peptide concentration was increased to 500 ʅM, the CD spectra showed 
similar trends as seen with 250 ʅM: In low lipid concentrations (up to 200 ʅM) the 
spectra resembled a random coil conformation and with high lipid concentrations (2 
mM and above) the spectra resembled an Į-helix conformation (Fig. 3.2-6 A). The 
estimated helix percentage also showed a similar trend, with stable and high levels of 





Figure 3. 2 - 6 CD spectra for 500 ȝ00$+SHSWLGHZLWKLQFUHDVLQJFRQFHQWUDWLRQRIVWDQGDUG
/89V$DQGHVWLPDWHGSHUFHQWDJHRIDQĮKHOL[SUHVHQWLQHDFKVDPSOHFDOFXODWHGEDVHGRQWKH
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These results confirm that the M2 AH is formed upon addition of lipids and its 
formation is lipid and peptide concentration dependant. The estimated helix 
percentage increased when the lipid concentration increased, with the total value being 
dependent on the peptide concentration (Fig. 3.2-4 B and Fig. 3.2-5 B). However, 
when a certain threshold was reached, 5 mM and 2 mM of lipids with 250 ʅM and 500 
ʅM of peptide respectively, helix percentage was staying at similar, high level (Fig. 
3.2-5 B and Fig. 3.2-6 B). It was concluded that 5 mM of lipids and 250 ʅM of peptide 
would be the optimal concentrations for this type of assay and therefore were used 
during all experiments (unless otherwise stated).  
 
3.2.3.2 Structural changes in different environments 
NMR experiments have shown that an amphipathic helix is formed between residues 
4 and 16 of the M2 AH peptide in a lipid environment and the peptide remains 
unstructured in solution (see chapter 3.1.2). To confirm these observations, a M2 AH 
peptide structure (16 amino acid long based on A/Udorn/72 strain) has been 
determined in a detergent-free solution, in presence of 30%  2,2,2-trifluoroethanol 
(TFE, an agent that drives formation of secondary structures (Povey et al. 2007)), and 
in presence of standard LUVs. Results showed that the peptide in solution is a random 
coil but when liposomes are present the peptide becomes nearly 90% helical. A similar 
effect was observed with the addition of 30% TFE in the absence of liposomes (Fig. 
3.2-7 A and B). In the presence of TFE, the M2 AH shows classical AH formation, 
whereas in presence of liposomes the signal is slightly distorted but retains the key 
minimum at 222 nm for the structure to be predicted using bioinformatics program. 
This confirms that the M2 AH peptide is becoming stabilised and a helix is being 






Figure 3. 2 - 7 CD spectra for 500 ȝ016 amino acid long M2 AH peptide based on A/Udorn/72 
strain in solution, with 30% TFE and with 12.5 mM standard LUVs present (A) and estimated 
SHUFHQWDJH RI DQ Į KHOL[ SUHVHQW LQ HDFK VDPSOH FDOFXODWHG EDVHG RQ WKH VSHFWUD XVLQJ .'
bioinformatics tool on http://k2d3.ogic.ca/ website (B). 
 
 
The M2 protein is highly conserved among influenza virus strains, with only three 
amino acids different in the M2 AH between the most widely used laboratory strain, 
A/Udorn/72 and the recent pandemic influenza strain, A/England/09 (Fig. 3.2-8).  Two 
of those amino acids, at positions 54 and 57, are residues that have been identified by 



















































A. A/Udorn/72 strain M2 AH: 
R L F F K C I Y R F F E H G L K R G 
45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 
 
B. A/England/09 strain M2 AH: 
R L F F K C I Y R R F K Y G L K R G 
45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 
 
Figure 3. 2 - 8 Comparison of the M2 AH sequence between A/Udorn/72 (A) and A/England/09 
strain (B). Differences are highlighted in red and numbers indicated position of each residue in 




The CD spectra for the peptide based on A/England/09 strain has shown two troughs 
when in presence of standard LUVs, with about 89% of the helix present, or a peak 
when peptide was in solution, resembling random coil confirmation and only about 
5% of the helix present (Fig. 3.2-9 A and B). Similar results have been observed for 
the M2 AH peptide based on the A/Udorn/72 strain (Fig. 3.2-7 A and B) which 
suggests that formation of the M2 AH upon binding with membranes is conserved 
among different influenza virus strains, despite some differences in the region that has 










Figure 3. 2 - 9 CD spectra for 250 ȝ0DPLQRDFLGORQJ0$+SHSWLGHEDVHGRQA/England/09 
strain in solution and with 5 P0VWDQGDUG/89VSUHVHQW$DQGHVWLPDWHGSHUFHQWDJHRIDQĮ
helix present in each sample calculated based on the spectra using K2D3 bioinformatics tool on 
http://k2d3.ogic.ca/ website (B). 
 
 
To investigate structure and function of the M2 AH two different length peptides, 16 
and 17 amino acids based on laboratory A/Udorn/72 strain, were initially used, 
however, further analysis showed that the 16 amino acid long peptide is more soluble, 
with both peptides behaving in similar ways when bound to liposomes or in solution 
(Fig. 3.2-7 A and Fig. 3.2-10 A) and both give a similar helix percentage by CD (Fig. 
3.2-7 B and Fig. 3.2-10 B). Therefore 16 amino acid long M2 AH peptide, based on 













































Figure 3. 2 - 10 CD spectra for 250 ȝ0DPLQRDFLGORQJ0$+SHSWLGHEDVHGRQA/Udorn/72 
strain in solution, with 30% TFE and with 5 mM standard LUVs present (A) and estimated 
SHUFHQWDJH RI DQ Į KHOL[ SUHVHQW LQ HDFK VDPSOH FDOFXODWHG EDVHG RQ WKH VSHFWUD XVLQJ .'
bioinformatics tool on http://k2d3.ogic.ca/ website (B). 
 
 
3.2.3.3 A/England/09 and AH mutants 
A peptide based on the pandemic A/England/09 strain and covering first 18 amino 
acids of the M2 CT (residues 45-62 of the full M2 protein) was made to test differences 
between strains and different mutations have been introduced to the peptide to 
investigate how they affect peptide structure and function. Both hydrophobic and polar 
faces of the helix have been mutated in order to make them stronger or weaker by 
replacing residues with lysine (K), which is a charged amino acid or alanine (A), which 
is a non-polar amino acid respectively. 5 point mutations, F47A F48A I51A Y52A 
F55A have been introduced to the hydrophobic face of the helix to inhibit its functions, 
these mutations have been shown previously to impair viral growth (Rossman et al. 











































by replacing two hydrophobic residues with alanine, F47A and F48A which are part 
of the 5 point mutant. The M2 AH contains a cholesterol recognition amino acid 
consensus (CRAC) domain (Schroeder et al. 2005, Schroeder 2010) which was also 
disrupted by substitution of the amino acids in the domain with alanine (Y52A R53A). 
The polar face of the helix was enhanced by substituting three hydrophobic residues 
that are present in there, L46 C50 Y57, with lysine which will make the polar face 
completely charged. This face was also weakened by replacing three lysine residues, 
K49 K56 K60 with alanine, which will reduce the overall charge of the polar face. A 
R54A R61A double mutation was introduced into the M2 AH peptide to weaken the 
helix at its interface. Additionally the M2 AH was disrupted by addition of either one 
or two extra alanine residues on the N-terminus to alter the phase of helical rotation. 
The majority of the peptides in solution behaved similarly as a wild type M2 AH, with 
CD spectra resembling a random coil (Fig. 3.2-11 A) and the helix percentage being 
below 10% (Fig. 3.2-11 B). However, three mutations ± F47A F48A, CRAC mutation 
and addition of one alanine in the N-terminus showed slightly increased helix 
percentage, up to 20% (Fig. 3.2-11 B), which suggests that these mutations allowed 
the peptide to start changing its conformation, but formation of the helix was not 
successful. Interestingly addition of two alanine residues in the N-terminus resulted in 
formation of a helix in solution, with over 95% of the estimated helix percentage 






Figure 3. 2 ± 11 CD spectra for 250 ȝ0  DPLQR DFLG ORQJ 0 $+ SHSWLGH EDVHG RQ
A/England/09 strain and its mutants (as described in chapter 2.1.1) in solution (A) and estimated 
SHUFHQWDJH RI DQ Į KHOL[ SUHVHQW LQ HDFK VDPSOH FDOFXODWHG EDVHG RQ WKH VSHFWUD XVLQJ .'
bioinformatics tool on http://k2d3.ogic.ca/ website (B). 
 
 
In the presence of standard LUVs, most of the peptides show two deep troughs that 
resemble spectra for an Į-helix and over 94% of the helix present (Fig. 3.2-12 A and 
B), with very deep troughs (about two fold increase in depth) for the R54A R61A 
double mutant. This suggests that those mutations do not affect the peptide¶V ability to 
IRUPDQĮ-helix in a lipid environment. As expected, introduction of a 5 point mutation 
in the hydrophobic face of the helix resulted in huge reduction of the troughs depth 
and, as a result, in the helix percentage (Fig. 3.2-12 A and B), which confirms that the 
growth impairment mutant is not able to form a helix. The F47A F48A mutation, 

























M2 AH F47A F48A CRAC mutation
5P helix mutation L46K C50K Y57K K49A K56A K60A
























depth, with the helix percentage dropping from over 94% to around 78% (Fig. 3.2-12 
A and B). Interestingly, a similar result has been observed with the L46K C50K Y57K 
mutant, which had mutations in the polar face of the helix designed to complete the 
polar face with charged residues. This suggests that it is not only the hydrophobic face, 
but also the polar face of the helix which may be important for its formation, especially 
the few hydrophobic residues that are present in the polar face.  
 
 
Figure 3. 2 - 12 CD spectra for 250 ȝ0DPLQRDFLGORQJ0$+SHSWLGHEDVHGRQA/England/09 
strain and its mutants (as described in chapter 2.1.1) with 5 mM standard LUVs (A) and estimated 
SHUFHQWDJH RI DQ Į KHOL[ SUHVHQW LQ HDFK VDPSOH FDOFXODWHG EDVHG RQ WKH VSHFWUD XVLQJ .'




























M2 AH F47A F48A CRAC mutation
5P helix mutation L46K C50K Y57K K49A K56A K60A























NMR experiments have shown that the M2 AH is formed upon binding with liposomes 
and when the peptide is in solution it is unstructured (see chapter 3.1.2). To quantify 
the binding ability of the M2 AH, an assay has been created in which fluorescently 
labelled peptide is incubated with liposomes, unbound peptide is removed by filter 
washes and fluorescence is measured on a fluorescence plate reader. Initial 
experiments have shown that the optimal concentrations for this type of assay are 100 
ʅM of peptide and 2.5 mM of lipids (Fig. 3.2-1 and 3.2-2). The M2 AH bound to 
standard LUVs give 5 fold greater signal than the controls, which shows the peptide 
bound well to the liposomes (Table 3.2.2).   
 
To further investigate the structure of the M2 AH and the effect of different 
environments on it, CD spectroscopy has been used. Initial experiments have been 
performed with a range of different lipid and peptide concentrations showing that an 
Į±helix is being formed in presence of liposomes and that it is lipid and peptide 
concentration dependent. At lower lipid and peptide concentrations, 250 ʅM and 100 
ʅM respectively, the estimated helix percentage was low but it was rising with an 
increase in concentrations until a certain threshold was reached, 5 mM and 2 mM of 
lipids with 250 ʅM and 500 ʅM of peptide respectively, after which high level of 
estimated helix percentage, above 90%, was maintained (see chapter 3.2.3.1). 
Therefore 5 mM lipid concentration and 250 ʅM peptide concentration were chosen 
as optimal concentrations for this type of assay. 
 
Further CD experiments confirmed that the M2 AH peptide is unstructured in solution 
and DQĮ±helix is being formed in presence of liposomes or TFE (Fig. 3.2-7). Similar 
results have also been observed with 17 amino acid long M2 AH peptide based on the 
A/Udorn/72 strain and with the M2 AH peptide based on recent pandemic strain, 
A/England/09 (Fig. 3.2-10 and Fig. 3.2-9 respectively). Interestingly these two 
influenza virus strains differ in the M2 AH sequence by only three amino acids at 
positions 54, 56 and 57 (Fig. Fig. 3.2-8) with regard to full length M2 protein. Residues 




with the lipid membranes by STD NMR (Fig. 3.1-10) and therefore are important for 
formation of the helix. This shows that formation of the M2 AH upon binding with 
liposomes is conserved among influenza virus strains and that these changes in 
sequence between those two strains do not inhibit helix formation or binding with 
membranes, even if they are present in a region that has been shown to be responsible 
for binding with membranes. This suggests that either the changes are not significant 
enough to fully disrupt helix formation, they affect the strength of interaction (which 
was not possible to determine in these assays), or other residues in the helix become 
involved to compensate for the changes. 
 
A series of different mutations were introduced to different parts of the M2 AH, as 
described in chapter 2.1.1, and were then tested by CD spectroscopy to investigate 
how they affect formation of the helix. The majority of mutations did not affect 
SHSWLGH¶VEHKDYLRXULQVROXWLRQVKRZLQJYHU\ORZOHYHOVRIHVWLPDWHGKHOL[SHUFHQWDJH 
(below 10%) (Fig. 3.2-11) however, three of the mutations: F47A F48A, CRAC 
mutation and addition of one alanine in the N-terminus showed slightly increased the 
helix percentage which suggests that they allowed the peptide to start changing its 
conformation, but formation of the helix could not be completed. Interestingly one 
mutation, addition of two alanine residues in the N-terminus of the peptide allowed 
for formation of an Į±helix in solution (Fig. 3.2-11).  
In the presence of LUVs, the majority of mutations did not affect the SHSWLGH¶V
behaviour, showing formation of the helix (Fig. 3.2-12). As expected, the introduction 
of the 5 point mutation into the peptide, which causes growth impairment in the virus 
(Rossman et al. 2010a, Rossman et al. 2010b), caused a huge reduction in the 
estimated helix percentage (Fig. 3.2-12). Two mutations caused slight reduction in 
estimated helix percentage: F47A F48A, which is also a part of a 5 point mutant, and 
L46K C50K Y57K, which is a mutation that enhances and completes the polar face of 
the helix (Fig. 3.2-12). The latter of these suggests that it is not only the hydrophobic 
face, but also polar face of the helix that may be important for helix formation, 





These results correspond well to the STD NMR data (see chapter 3.1.3) which shows 
that residues in hydrophobic face of the helix at positions 48, 51, 54, 55, 58 and the 
hydrophobic residue in the polar face at residue 57 are responsible for binding with 
lipid membranes. Therefore if an amino acid in one of these positions has been 
replaced with a non-polar alanine residue (as in case of F47A F48A) or the polar lysine 
residue (as with the L46K C50K Y57K mutants) helix formation was slightly reduced. 
When three of the amino acids were replaced with alanine, as in case of 5 point mutant 




















3.3 EFFECTS OF THE LIPID ENVIRONMENT ON M2 
AMPHIPATHIC HELIX ± MEMBRANE BINDING 
 
3.3.1 Introduction 
It has been shown that the M2 AH is formed upon binding with liposomes with the 
hydrophobic face of the helix mainly being responsible for binding (see chapters 3.1.2; 
3.1.3; 3.2.2 and 3.2.3). However, these interactions were investigated in presence of a 
standard lipid membrane. Different compositions of the membrane may influence the 
formation and binding of the M2 AH.  The M2 AH is composed of polar and 
hydrophobic faces. The polar face of the helix contains charged amino acids, of which 
many are cationic, and therefore these residues may interact with anionic lipids present 
in the membrane.  
Some lipids, such as cholesterol in higher concentrations and sphingomyelin have 
been shown to inhibit the M2 AH (Rossman et al. 2010b), but the mechanism of action 
behind this inhibition is unknown. PIP2 has been shown to play a role in the transport 
of viral proteins and assembly of HIV (Carlson and Hurley 2012) and HIV budding 
occurs at defined lipid raft domains similar to Influenza A virus, which suggests that 
it may also play a role in influenza virus assembly. However, lipid composition of the 
membrane is not the only factor that can affect the M2 AH formation and binding, the 
presence of different domains or defects and curvature of the membrane may also 
affect the M2 AH formation and binding.  
The influenza virus buds off from lipid raft domains, which are liquid ordered phases 
located on the liquid disordered phase plasma membrane, with the M2 protein 
localised just outside of the lipid rafts (Takeda et al. 2003, Leser and Lamb 2005, Chen 
et al. 2007). Therefore line tension, which is an interfacial energy at the edge between 
liquid ordered and disordered phase may have an effect on the M2 AH. In the final 
stages of viral budding the M2 protein is localised to the neck of newly formed virion 
(Rossman et al. 2010b), which is a region of high positive membrane curvature thus 
M2 AH may preferentially bind to membranes with high positive membrane curvature. 
Defects present in the membrane, which are spacing in one leaflet of the membrane 




insertion of the AH into the membrane. To investigate how different lipids and 
different membrane properties affect the M2 AH formation and binding with 
membranes, different size liposomes have been made composed of variety of lipids 





3.3.2 Charge interactions 
 
3.3.2.1 Different anionic lipids 
M2 AH has a lot of cationic residues on the polar face (Fig. 1.2-3) and so the different 
types of charged lipids may have an effect on the protein. To investigate this, the M2 
AH peptide has been tested in the presence of standard LUVs in which PG has been 
replaced with different types of anionic lipids. Both phosphatidylserine (PS) and 
phosphatidic acid (PA) are anionic lipids and phosphatidylethanolamine (PE) is 
zwitterionic and has a cone shape (Li et al. 2015). In presence of PG, PS and PA 
VSHFWUDUHVHPEOHGVSHFWUDFKDUDFWHULVWLFIRUDQĮ-helix with high helix percentage, at 
around 90% (Fig. 3.3-1 A and B). That suggests that type of anionic lipid present in 
the membrane does not influence formation of the M2 AH. However, when PG was 
replaced by PE, the troughs depth and helix percentage significantly dropped (to about 
60%) suggesting that PE disrupts the membrane because of its shape and this inhibited 












Figure 3. 3 - 1 CD spectra for 250 ȝ00$+SHSWLGHZLWK mM of standard LUVs (PC:PG:Ch 
at 4:1:0.05 molar ratio) and LUVs containing different types of anionic lipids (PS and PA) or 
zwitterionic lipid (PE) instead of PG, at the same molar ratio (A) and estimated percentage of an 
ĮKHOL[SUesent in each sample calculated based on the spectra using K2D3 bioinformatics tool on 
http://k2d3.ogic.ca/ website (B). 
 
 
The binding assay confirmed good binding of the M2 AH peptide to the membranes 
composed of PC, PG and Ch (Fig. 3.3-2). Surprisingly when PG was replaced by PS 
or PA average fold binding doubled (Fig. 3.3-2), which might suggest that although 
the type of anionic lipid does not influence formation of the M2 AH, as shown by CD 
(Fig. 3.3-1 A and B), it may enhance its ability to bind to the membranes. When PG 
was replaced by PE, average fold binding has been significantly reduced (Fig. 3.3-2), 














































Figure 3. 3 - 2 Average Fold Binding values for samples with 100 ȝ0RIIOXRUHVFHQWO\ODEHOOHG
M2 AH peptide incubated with 2.5 mM of standard LUVs (PC:PG:Ch) and LUVs containing 
different types of anionic lipids (PS and PA) or zwitterionic lipid (PE) instead of PG. 
 
 
To further investigate the role of anionic lipids in the M2 AH formation and binding 
with lipid membranes, a range of different PS concentrations have been tested. When 
used as a replacement for another anionic lipid (PG) so far, PS was at 1 molar ratio in 
LUVs which corresponds to 20 molar %. In this concentration range PS was used at 
few lower concentrations - 1,5,10 molar % and one higher - 40 molar %.  All 
concentrations tested showed similar CD spectra, which suggest formation of an Į-
helix, but trough depth has been slightly reduced for 1% and 10% of PS present (Fig. 
3.3-3 A). The helix percentage for 1% and 10% PS membranes was also reduced, by 
approximately 10% and 20% respectively (Fig. 3.3-3 B) however, higher percentage 
of PS in the membrane, 20% (Fig. 3.3-1 B) and 40% (Fig. 3.3-3 B) show very high 
helix percentage, above 87%. These results suggest that, although in low PS 
concentrations (between 1-10%) formation of the M2 AH is varied and may be 






































Figure 3. 3 - 3 CD spectra for 250 ȝ00$+SHSWLGHZLWK mM of 100 nm LUVs composed of 
3&36&KZLWKLQFUHDVLQJFRQFHQWUDWLRQRI36SUHVHQW$DQGHVWLPDWHGSHUFHQWDJHRIDQĮKHOL[
present in each sample calculated based on the spectra using K2D3 bioinformatics tool on 




Binding assays with a range of different PS concentrations in the membrane showed 
reduced binding in case of 1% PS, and increased binding activity for higher PS 
concentrations (Fig. 3.3-4), when compared with standard LUVs (Table 3.2-1). 
Despite high variability in the measurements, which leads to high standard error values 
(especially in case of 10% PS membranes), average fold binding is significantly 
increased with PS concentration above 5% (Fig. 3.3-4), which suggest that higher 















































Figure 3. 3 - 4 Average Fold Binding values for samples with 100 ȝ0RIIOXRUHVFHQWO\ODEHOOHG
M2 AH peptide incubated with 2.5 mM of 100 nm LUVs composed of PC:PS:Ch with an 




3.3.2.2 Absence of anionic lipids 
To investigate if there are interactions between the cationic face of the helix and 
anionic lipids in the membrane, which influences formation of the M2 AH and its 
ability to bind to lipid membranes, LUVs with and without anionic lipids have been 
used. In the presence of standard LUVs, the M2 AH peptide gave a spectra resembling 
an Į-helix formation, with a deep trough at around 222 nm and helix percentage above 
94% (Fig. 3.3-5 A and B). When PG was removed and only PC and Ch were present 
in the membrane, the trough depth in the CD spectra was significantly reduced and 
helix percentage dropped to approximately 77% (Fig. 3.3-5 A and B). These results 
suggest that anionic lipids support formation of the M2 AH but are not essential as 



























Figure 3. 3 - 5 CD spectra for 250 ȝ00$+SHSWLGHZLWK mM of standard LUVs and LUVs 
ZLWKRXWDQLRQLF OLSLG 3* SUHVHQW $DQGHVWLPDWHG SHUFHQWDJH RIDQĮ KHOL[SUHVHQW LQHDFK
sample calculated based on the spectra using K2D3 bioinformatics tool on http://k2d3.ogic.ca/ 
website (B). 
 
Surprisingly, analysis of peptide binding showed an increased binding activity to the 
membranes without anionic lipids present (Fig. 3.3-6). This suggests that, although 
anionic lipids may support formation of the helix, WKH\DUHQRWVXSSRUWLQJWKHSHSWLGH¶V
ability to bind to membranes. Similar experiments have been performed using LUVs 
made in 1 mM HEPES buffer instead of potassium buffer, showing a similar trend, 
with an increase in overall binding activity in both cases, which suggests that HEPES 
buffer may increase peptide binding to the membranes, but does not influence 














































Figure 3. 3 - 6 Average Fold Binding values for samples with 100 ȝ0RIIOXRUHVFHQWO\ODEHOOHG






Figure 3. 3 - 7 Average Fold Binding values for samples with 100 ȝ0RIIOXRUHVFHQWO\ODEHOOHG
M2 AH peptide incubated with 2.5 mM of LUVs and LUVs without anionic lipid (PG) present 













































3.3.2.3 Ionic strength  
To further investigate if charge interactions affects the M2 AH interaction with 
membranes, binding assays were performed using standard LUVs made in 1mM 
HEPES with an increasing ionic strength in the buffer which was accomplished with 
the addition of increasing concentrations of sodium chloride instead of water, which 
was used before. With low ionic strength (32 mM) in the buffer the average fold 
binding drops slightly, followed by a slight increase with an increase in the ionic 
strength in the buffer (32-482 mM), after which average fold binding value is dropping 
again for the highest ionic strength concentration to a level observed with 0 mM 
concentration (Fig. 3.3-8). This suggests that, although there are slight changes in the 
SHSWLGH¶VDELOLW\WRELQGWRWKHPHPEUDQHZLWKDFKDQJLQJEXIIHULRQLFVWUHQJWKWKHUH
are no drastic changes associated with a particular concentration. All samples showed 
at least a two fold increase in peptide binding compared to when potassium buffer was 
used to make LUVs (Fig. 3.3-6), but this is a characteristic specific for this type of 
LUVs (Fig. 3.3-7), not an effect caused by increasing ionic strength in the buffer. Ionic 
strength of the buffer does not influence the interaction between the M2 AH and the 
lipid membrane due to charged interactions. This is because increase in ionic strength 
of the buffer will saturate the AH charge interactions and prevent charge interactions 
with the membrane, so if charge interactions are involved in binding loss of signal 















Figure 3. 3 - 8 Average Fold Binding values for samples with 100 ȝ0RIIOXRUHVFHQWO\ODEHOOHG
M2 AH peptide incubated with 2.5 mM of LUVs made in 1 mM HEPES with an increasing ionic 
strength in the buffer. 
 
3.3.3 Effects of cholesterol  
Cholesterol and VSKLQJRPH\HOLQ KDYH EHHQ VKRZQ WR LQKLELW WKH EXGGLQJ DFWLYLW\
FDXVHGE\WKH0SURWHLQ+LJKOHYHOVRIFKROHVWHUROPRODUDQGDERYHLQKLELW
WKH0$+ PHGLDWHGEXGGLQJEXWZKHQFKROHVWHURO LVDWDSK\VLRORJLFDOO\ UHOHYDQW
OHYHODERXWPRODURUEHORZWKH0$+LQGXFHVEXGGLQJLQ/89V5RVVPDQHW
DOE To investigate the role of cholesterol in the M2 AH formation and binding 
with the membrane, a range of LUVs with different concentrations of cholesterol have 
been used. Standard LUVs are normally formed with PC, PG and Ch mix at 4:1:0.05 
molar ratio, which corresponds to 1 molar % for cholesterol. In this range 5, 10, 20, 
30 and 40 molar % of cholesterol have been used reducing molar % of PC respectively 
and keeping molar % of PG at a constant level to form LUVs. Surprisingly, all samples 
showed similar CD spectra, which resembles spectra characteristic for an Į-helix, with 
only slight reduction in trough depth in the highest cholesterol concentration (Fig. 3.3-
9 A). Helix percentages were on a high and stable level, around 90% for all samples, 
for all concentrations with exception of the highest cholesterol concentration (40%), 
when helix percentage dropped by 5% (Fig. 3.3-9 B)., suggesting that the level of 

























Figure 3. 3 - 9 CD spectra for 250 ȝ0 0 $+ SHSWLGH ZLWK  mM of standard LUVs with 
LQFUHDVLQJFRQFHQWUDWLRQRIFKROHVWHUROSUHVHQW$DQGHVWLPDWHGSHUFHQWDJHRIDQĮKHOL[SUHVHQW
in each sample calculated based on the spectra using K2D3 bioinformatics tool on 
http://k2d3.ogic.ca/ website (B). 
 
 
Binding assays showed a similar level of binding with 5 molar % of cholesterol present 
in the membrane as with the standard LUVs, which are composed of 1 molar % of 
cholesterol (Fig. 3.3-10). Increasing the cholesterol concentration, up to 10 molar % 
caused an increase in binding activity, however, further increase in cholesterol 
concentration, above 20 molar %, caused constant decrease in binding activity (Fig. 
3.3-10). In the presence of the highest cholesterol concentration, 40 molar %, the 
average fold binding dropped below the level observed for 5 molar % (Fig. 3.3-10). 
This suggests that although the low cholesterol concentrations, 5 and 10 molar %, may 
support the M2 AH peptide binding to membranes, higher cholesterol concentrations, 

























5% Ch LUVs 10% Ch LUVs 20% Ch LUVs 30% Ch LUVs 40% Ch LUVs


















Figure 3. 3 - 10 Average Fold Binding values for samples with 100 ȝ0RIIOXRUHVFHQWO\ODEHOOHG




3.3.4 Effects of PIP2 
7KH OLSLGFRPSRVLWLRQRI WKH PHPEUDQHFDQDIIHFW WKHEXGGLQJRI YLUXVHV IURP WKH
FHOOV3,3LVRQHRIWKHOLSLGVWKDWLVSUHVHQW LQWKHSODVPDPHPEUDQHDQGKDVEHHQ
VKRZQWRSOD\DUROHLQFOXVWHULQJRIWKH*DJSURWHLQWKDWLQLWLDWHVDVVHPEO\RIWKH+,9




)OXRUHVFHQWO\ ODEHOOHG 3,3 ZDV DOVR LQFXEDWHG ZLWK WKH FHOOV DQG UHPRYHG EHIRUH
IL[DWLRQDQGPRXQWLQJRQWKHVOLGHV$VVKRZQLQ)LJXUH0DQG3,3UDUHO\







































Figure 3. 3 - 11 Confocal images of HEK 293T cells transfected with 2.5 ȝJRISODVPLGH[SUHVVLQJ
M2 protein, stained with fluorescently labelled PIP2 and fixed after 47 h and 48 h post transfection 
respectively, followed by immunostaining with 14C2 antibody. A- PIP2, B- M2, C- HEK 293T 






DQG%7KHELQGLQJDVVD\ DOVRVKRZHGVLPLODU OHYHOVRIELQGLQJ IRUDOO WKUHH3,3
FRQFHQWUDWLRQVXVHG)LJZLWKDYHUDJHIROGELQGLQJRQO\VOLJKWO\KLJKHUWKDQ
YDOXHVREWDLQHGZLWK VWDQGDUG/89V (Table 3.2-1). These results suggest that PIP2 
may support formation of the M2 AH and it is binding with the membranes but it is 
not essential as the peptide structure and functions are not affected when PIP2 is 






Figure 3. 3 - 12 CD spectra for 250 ȝ0 0 $+ SHSWLGH ZLWK  mM of standard LUVs with 
increasing concentration of PIP2 incorporated into the membrane (A) and estimated percentage of 
DQĮKHOL[SUHVHQWLQHDFKVDPSOHFDOFXODWHGEDVHGRQWKHVSHFWUDXVLQJ.'ELRLQIRUPDWLFVWRRO
on http://k2d3.ogic.ca/ website (B). 
 
 
Figure 3. 3 - 13 Average Fold Binding values for samples with 100 ȝ0RIIOXRUHVFHQWO\ODEHOOHG
M2 AH peptide incubated with 2.5 mM of standard LUVs with increasing concentration of PIP2 


































































3.3.5 Effects of lipid domain line tension  
Influenza virus buds off from lipid raft domains, but the M2 protein is localised just 
outside of the lipid rafts, on the boundary between  liquid ordered and disordered 
phases (Takeda et al. 2003, Leser and Lamb 2005, Chen et al. 2007), therefore changes 
in the line tension between domains may have an effect on the M2 AH binding, 
interaction and insertion into the membranes. To test how line tension in the membrane 
affects M2 AH, a range of phase separated LUVs in which part of the vesicle is in a 
lipid ordered phase and  part in a lipid disorder phase, with increasing line tension in 
the boundary on the phases interface have been used. A series of different PC types, 
with a decreasing length of the acyl chain, have been used to modify thickness of the 
lipid disordered phase, which leads to increasing height mismatch between the two 
phases, and hence an increase in the line tension between domains, as shown 
previously (Garcia-Saez et al. 2007). LUVs have been formed in the temperature 
above the phase transition temperature respective for each lipid mix and composed of 
40 molar % of sphingomyelin, 20 molar % of cholesterol and 40 molar % of different 
PC types, shown in Table 3.3-1, where dierucoyl-phosphocholine (DEPC) has the 
longest acyl chain and hence the smallest line tension and dimyristoleoyl-
phosphocholine (DMPC) has the shortest acyl chain and the highest line tension in the 
series. 
 
PC type (in increasing 
line tension order) 




















Table 3. 3 - 1 Characteristics of different PC types with decreasing length of acyl chain that have 





trough (Fig. 3.3-14 A)7KHVHFRQGFKDUDFWHULVWLFĮ-helix trough is not visible due to 
an early voltage cut off, after which data is not available. The trough depth has been 
significantly reduced for first four PC types in the series (DEPC, DeisPC, DOPC and 
DPPC) and small reduction has been observed for DMPC, which has the shortest acyl 
chain (Fig. 3.3-14 A).  The helix percentage appears to be significantly reduced when 
the PC with long acyl chains was used, with only 3.3% for DEPC and 29.49% for 
DeisPC (Fig. 3.3-14 B). However, as the acyl chain got shorter, the percentage 
increased, with DMPC reaching 64.89% (Fig. 3.3-14 B). These results show that the 
shorter the acyl chain in the PC lipid, and hence the higher the line tension in the 




Figure 3. 3 - 14 CD spectra for 250 ȝ00$+SHSWLGHZLWK mM of 100 nm LUVs composed 
of sphingomyelin, cholesterol and series of different PC types (at 2:1:2 ratio) with decreasing 
length of acyl chain which results in increase of the line tension, where DEPC has the longest acyl 
chain and '03& WKH VKRUWHVW $ (VWLPDWHG SHUFHQWDJH RI DQ Į KHOL[ SUHVHQW LQ HDFK VDPSOH












































CD showed significant reduction in trough depth and helix percentage for all samples, 
with the highest values for DMPC LUVs not reaching levels observed with standard 
LUVs (Fig. 3.2-7). Binding assays also showed a reduction in binding activity 
compared with standard LUVs (Table 3.2-1), which might be caused by the 
composition of phase separated LUVs- high levels of sphingomyelin and cholesterol 
and no anionic lipids, such as PG present. For most of the samples, average fold 
binding was reduced but on similar stable level, between 2 and 3 (Fig. 3.3-15). 
Surprisingly the highest binding activity was detected in presence of DeisPC, where 
average fold binding come to a level observed with standard LUVs (Fig. 3.3-15). 
These results suggest that although line tension in the domains influence formation of 
the M2 AH it does not influence its ability to bind to the membrane, as in majority of 
samples average fold binding is on similar level. The increase in binding in presence 
of DeisPC may suggest that this lipid supports M2 AH binding with membranes but 





Figure 3. 3 - 15 Average Fold Binding values for samples with 100 ȝ0RIIOXRUHVFHQWO\ODEHOOHG
M2 AH peptide incubated with 2.5 mM of 100 nm LUVs composed of sphingomyelin, cholesterol 
and series of different PC types (at 2:1:2 ratio) with decreasing length of acyl chain which results 


































3.3.6 Effects of membrane curvature  
 
3.3.6.1 Standard membranes 
During virus budding, the M2 protein localises to the neck of the budding virion 
(Rossman et al. 2010b), which in its narrowest point is a region of high positive 
membrane curvature. To test how positive curvature of the membrane influences the 
structure and function of the peptide, a series of different size liposomes were made 
either by sonication (SUVs), by the extrusion through different filter sizes (LUVs), or 
by electroformation (GUVs). Vesicle sizes were checked using Dynamic Light 
Scattering (DLS). For 100 nm LUVs, the size distribution showed a single peak (Fig. 
3.3-16) and based on that data, the average vesicle size was 102.6 nm (Table 3.3-2). 
The whole range of different size vesicles size distribution data is shown in appendix 
6.3 A and average vesicle sizes are summarised in Table 3.3-2. These averages show 
that LUV sizes vary from the filter pore size however, they were within the advertised 
limits, and gave a range of different size liposomes between 58.88 nm and 350.4 nm 




Figure 3. 3 - 16 Graph showing size distribution by intensity for 100 nm LUVs composed of 












actual size  
(average size 
measured on DLS) 
SUVs 58.88 d.nm 
30 nm LUVs 89.19 d.nm 
50 nm LUVs 77.7 d.nm 
100 nm LUVs 102.6 d.nm 
200 nm LUVs 150.4 d.nm 
1000 nm LUVs 350.4 d.nm 
 
Table 3. 3 - 2 Designed and actual average size of the PC:PG:Ch vesicles in the size range 





The CD spectra showed troughs of varied depth for range of SUVs and LUVs, 
however, when GUVs were present the spectra changed, with all three concentrations 
tested showing a small peak, (Fig. 3.3-17 A), similar to what was observed for a 
peptide in solution (Fig. 3.2-7).  The helix percentage was at a very high level, around 
90% for all range of small vesicles, which have more positive membrane curvature 
(with an exception of 89 nm LUVs, where helix percentage dropped to around 60%) 
which dropped significantly, to around 5%, when large vesicles has been present, 
which correspondingly have less positive membrane curvature (Fig. 3.3-17 B). Those 
results suggest that M2 AH is formed in wide range of positively curved membranes 





Figure 3. 3 - 17 CD spectra for 250 ȝ00$+SHSWLGHZLWK mM of different size SUV, LUVs 
DQGLQFUHDVLQJFRQFHQWUDWLRQRI*89VFRPSRVHGRI3&3*&K$(VWLPDWHGSHUFHQWDJHRIDQĮ
helix present in each sample calculated based on the spectra using K2D3 bioinformatics tool on 




Binding assays showed similar levels of binding for vesicles sized 103 nm in diameter 
and above and increasing binding activity with decrease of the vesicle size below 103 
nm, with the highest value observed for the smallest 59 nm SUVs (Fig. 3.3-18). These 
results confirm that the M2 AH can work in a wide range of positively curved 
membranes but preferentially binds to membranes with high positive membrane 

























59 nm SUVs 77 nm LUVs 89 nm LUVs
103 nm LUVs 150 nm LUVs 350 nm LUVs






















Figure 3. 3 - 18 Average Fold Binding values for samples with 100 ȝ0RIIOXRUHVFHQWO\ODEHOOHG





To further investigate how membrane curvature influences the M2 AH and to 
determine specific localisation of the M2 AH in the lipid bilayer molecular dynamic 
(MD) simulation was performed ± performed by collaborators, Dr -RUGL *yPH]
/OREUHJDW DQG 'U 0DUWLQ /LQGpQ IURP WKH &HQWHU IRU %LRPHPEUDQH 5HVHDUFK DW
6WRFNKROP 8QLYHUVLW\ 0' VLPXODWLRQ ZDV GRQH RQ D EXFNOHG OLSLG ELOD\HU ZLWK
UHJLRQVRISRVLWLYHQHJDWLYHDQGQHXWUDOFXUYDWXUHFRPSRVHGRI3&DQG3* OLSLGV
7KH VLPXODWLRQ VKRZHG WKDW WKH 0$+ LV PRVWO\ DVVRFLDWHG ZLWK KLJK OHYHOV RI
SRVLWLYH PHPEUDQH FXUYDWXUH )LJ$DQG%ZLWK PD[LPXP ELQGLQJ WRWKH
PHPEUDQHVFRUUHVSRQGLQJWRDQPYHVLFOH)LJ%DQG&KRZHYHULWLVQRW
UHVWULFWHGWRKLJKO\FXUYHGPHPEUDQHVEHLQJDEOHWRZRUNLQZLGHUDQJHRISRVLWLYH













































Figure 3. 3 - 19 Representative top-view (A) and side-view (B) snapshots of the Molecular 
Dynamics simulation of the M2 AH on lipid bilayers composed of PC and PG, buckled in the Lx 
dimension. The system size is Lx = 20.88 nm and Ly =13.05 nm. Lipid headgroups are shown in 
pink, acyl chains in grey, lipid tail ends as orange spheres and the M2 AH in red.  Indicated vectors 
represent the RULHQWDWLRQRIWKH0$+SHSWLGHRQWKHELOD\HUșLVWKHDQJOHEHWZHHQWKHFHQWUH
line of the helix (arrow pointing towards the C-terminal end) and the XZ plane. The side view also 
shows the tangent angle (?, the Euler buckling profile (red line) fitted to the bilayer mid-plane and 
S values representing the different curvatures in one repeat of the buckled bilayer, with S=0.5 
being the most positively curved point of the membrane. Molecular graphics generated with VMD. 
Localisation of the M2 AH to regions of different curvature during the simulation, shown as a 





3.3.6.2 Absence of anionic lipids  
To further investigate how positive membrane curvature influences the M2 AH 
structure and function, a range of different SUV and LUV sizes were made which only 
contained the lipid PC, to remove any effect of charge-charge interactions that might 
obscure any subtle curvature sensing. Vesicle sizes have been checked by DLS, 
showing the size distribution (see appendix 6.3 B) and average vesicle size for each 
sample (Table 3.3-3). Once again the average sizes of LUVs varied from the filter pore 
size, and were slightly higher than corresponding standard LUVs (Table 3.3-2), giving 
a wider range of vesicle sizes and suggesting that the lipid mix may predispose to the 
formation of slightly bigger LUVs which may be a result of, for example, an 









 (average size 
measured on DLS) 
sonicated SUVs 34.52 d.nm 
sonicated SUVs 85.56 d.nm 
50 nm LUVs 101.9 d.nm 
100 nm LUVs 136.5 d.nm 
200 nm LUVs 153.6 d.nm 
1000 nm LUVs 3135 d.nm 
 









CD showed a similar trend as with the standard vesicles range, with a varied trough 
depth for SUVs and LUVs and peaks for both GUVs concentrations suggesting a 
random coil confirmation (Fig. 3.3-20 A).  Roughly 70% of the peptide becomes 
helical in the presence of vesicles ranging between 102-3135 nm and the percentage 
increasing with the decrease of the vesicle size to about 85% and 90% in case of 86 
nm and 35 nm SUVs respectively, which have a much more curved membrane (Fig. 
3.3-20 B). However, when vesicles are increasing in size (GUVs) and membrane is 
less curved, peptide helicity again drops to a level similar to peptide in the solution 
(Fig. 3.3-20 B). These results confirms that the M2 AH peptide is associated with 
highly curved membranes, such as SUVs or those at the neck of budding virion but 




Figure 3. 3 - 20 CD spectra for 250 ȝ00$+SHSWLGHZLWK mM of different size SUV, LUVs 
aQGLQFUHDVLQJFRQFHQWUDWLRQRI*89VFRPSRVHGRI3&&K$(VWLPDWHGSHUFHQWDJHRIDQĮKHOL[
present in each sample calculated based on the spectra using K2D3 bioinformatics tool on 
























35 nm SUVs 86 nm SUVs 102 nm LUVs
137 nm LUVs 154 nm LUVs 3135 nm LUVs






















Binding assays have shown a huge increase in average fold binding in the presence of 
35 nm SUVs and slight increase in the presence of 86 nm SUVs, with similar level of 
average fold binding for vesicles sized 102 nm and above (Fig. 3.3-21). These results 
show a similar trend as seen with standard vesicles (Fig. 3.3-18) and corresponds well 





Figure 3. 3 - 21 Average Fold Binding values for samples with 100 ȝ0RIIOXRUHVFHQWO\ODEHOOHG
M2 AH peptide incubated with 2.5 mM of different size SUV, LUVs and GUVs composed of 
PC:Ch. 
 
Overall, these results indicate that M2 AH is mainly associated with highly curved 
membranes, such as those present in the neck of a budding virion. However, it can 
also work in a wide range of positively curved membranes, such as LUVs but when 
membranes become less curved, such as GUVs, the M2 AH formation and binding to 
the membranes is significantly reduced. Presence of anionic lipids in the vesicles and 
possible charge-charge interactions do not influence the ability of the M2 AH to sense 









































3.3.7 Sensing of lipid defects in the membrane 
Some peptides and AHs can sense membrane curvature directly and others by sensing 
lipid packing defects in the membrane, which are gaps in the headgroup region of the  
bilayer formed in membranes with high positive membrane curvature (Drin et al. 2007, 
Drin and Antonny 2010).  To investigate if the M2 AH senses membrane curvature by 
sensing lipid packing defects in the membrane two PE types has been used to form 
liposomes- dioleoyl-phosphoethanolamine and distearoyl- phosphoethanolamine 
(DOPE and DSPE respectively).  
DOPE contains mono-unsaturated lipid tails and it is a cone shaped lipid which, due 
to its shape, affects lipid packing in the curved bilayer and causes formation of many 
lipid packing defects. On the other hand, DSPE contains fully saturated lipid tails and 
it is a cylindrical lipid which results in tighter lipid packing in the membrane and 
causes fewer defects in the membrane than DOPE (Nath et al. 2014). CD showed 
similar spectra for both DOPE and DSPE containing LUVs, with a slightly deeper 
trough in presence of DOPE (Fig. 3.3-22 A). The helix percentage was also increased 
(about 10%) in presence of DOPE, reaching nearly 80% (Fig. 3.3-22 B). This shows 





















Figure 3. 3 - 22 CD spectra for 250 ȝ00$+SHSWLGHZLWKP M of 100 nm LUVs composed 
RI3&DQG'23(RU'63(DWUDWLR$(VWLPDWHGSHUFHQWDJHRIDQĮKHOL[SUHVHQW LQHDFK
















































Binding assays have shown a huge increase in binding activity when DOPE (causing 
more packing defects than DSPE) was present compared with when DSPE (causing 
fewer packing defects than DOPE) was present in the membrane (Fig. 3.3-23). These 
results shows that the M2 AH forms better and binds tighter to a membrane with 
packing defects present, which suggest that the M2 AH senses membrane curvature 







Figure 3. 3 - 23 Average Fold Binding values for samples with 100 ȝ0RIIOXRUHVFHQWO\ODEHOOHG


































The M2 AH is formed upon binding with lipid membranes (see chapters 3.1.2 and 
3.2.3) and the hydrophobic face of the helix is the one that interacts and binds with 
lipid membranes as shown by NMR and STD NMR (see chapter 3.1.3). However, 
membrane properties such as lipid composition, presence of defects, changes to the 
line tension between different domains and curvature of the membrane may affect 
formation and binding of the M2 AH. Cationic residues that are present in the polar 
face of the helix may, for example, interact with anionic lipids present in the 
membrane. Interaction between different types of anionic lipids and the M2 AH and 
effect on helix formation and binding were investigated by using LUVs in which 
anionic lipid, PG was replaced with different anionic lipids, PS and PA or zwitterionic 
PE. 
 
CD experiments have shown that the type of anionic lipid present in the membrane 
does not influence the M2 AH formation but when PG was replaced with PE helix 
formation was reduced by about 30%, suggesting that PE disrupted the membrane, 
probably due to its shape, which influenced formation of the helix (Fig. 3.3-1). 
Interestingly binding assays showed a two fold increase in binding activity when PG 
was replaced with PA or PS, which suggests that although different types of anionic 
lipids do not influence formation of the M2 AH they might influence binding affinity 
of the helix (Fig. 3.3-2). Presence of PE in the membrane instead of PG caused a 
reduction of the average fold binding, which suggests that PE does not support 
formation of the M2 AH and its binding with the membranes (Fig. 3.3-2). To further 
investigate how anionic lipids affect the M2 AH formation and binding, LUVs with a 
range of different concentrations of PS have been used.  
Previously different anionic lipids have been used as a replacement of PG at 
concentration of 20 molar %, in this range 1, 5, 10 and 40 molar % concentrations of 
PS have been tested. Interestingly CD showed that formation of the M2 AH was 
slightly reduced with 1 and 10 molar % of PS present and was on a high level, around 
87% for 5 and 40 molar % of PS present (Fig. 3.3-3), which was similar to what had 
been observed previously with 20 molar % of anionic lipid in the membrane (Fig. 3.3-
1). This suggests that formation of the M2 AH is varied when lower levels of PS are 




membranes (20 and 40 molar %) supports the formation of the helix. Binding assays 
also showed that higher concentrations of PS in the membrane, above 5 molar %, 
increase the ability of the peptide to bind (Fig. 3.3-4).  
Anionic lipids have been removed from the membrane to test if their presence is 
necessary for the M2 AH to be formed and binding with the membranes. CD has 
showed a reduction in estimated helix percentage by about 20% when anionic lipids 
were removed from the membrane (Fig. 3.3-5), which suggests that anionic lipids 
support helix formation but are not necessary as helix formation was not completely 
inhibited. Surprisingly binding assays showed an increase in fold binding when 
anionic lipids were removed from the membrane (Fig. 3.3-6), suggesting that although 
anionic lipids support helix formation they do not support helix binding with the 
membranes.  
To further investigate binding properties of the M2 AH and influence of charge 
interactions on them binding assays have been performed in the presence of an 
increasing ionic strength in the buffer using sodium chloride. Average fold binding 
decreased with a low ionic strength buffer (32 mM) compared to 0 mM buffer but after 
that it was slightly increasing with an increase in the ionic strength but with the highest 
concentration it dropped to the level observed with 0 mM (Fig. 3.3-8). Additionally 
values for all samples were about two fold greater than in presence of water. This 
shows that there are slight changes in peptide binding due to changes of the ionic 
strength of the buffer, but there are no drastic changes observed that are associated 
with any particular concentration. This suggest that ionic strength of the buffer may 
strengthen the binding between helix and the membrane but does not influence it due 
to charged interactions. 
Cholesterol has been shown to inhibit M2 AH mediated budding in LUVs in a dose 
dependent manner, with budding observed with up to 17 molar % of cholesterol 
present in the membrane (Rossman et al. 2010b). Therefore LUVs with a range of 
different molar % of cholesterol (5-40%) have been used to investigate how 
cholesterol levels in the membrane affect the M2 AH formation and binding. 
Surprisingly, CD have shown high levels of estimated helix percentage (around 90%) 
for all cholesterol concentrations tested,  with just 5% drop when the highest 




On the other hand binding assays showed a similar level of binding with membranes 
containing low cholesterol levels (5 molar %) as with standard LUVs (containing 1 
molar % of cholesterol) which slightly increased with increase when the cholesterol 
level was raised to 10 molar % (Fig. 3.3-10). Further increases in cholesterol levels in 
the membrane (20 molar % and above) caused a reduction in binding (Fig. 3.3-10), 
which correlates with previous findings showing inhibition of the M2 AH induced 
budding when higher concentrations of cholesterol are present in the membrane 
(Rossman et al. 2010b).  These results suggest that although the cholesterol 
concentration in the membrane may not affect formation of the M2 AH it does affect 
ability of the M2 AH to bind with the membranes. 
 
Some lipids have been shown to play an important role in assembly of other viruses, 
such as PIP2 which is involved in assembly of the HIV virus (Carlson and Hurley 
2012). Immunofluorescence microscopy has shown that PIP2 and M2 do not co-
localise in cells but often are proximal to each other (Fig. 3.3-11). Furthermore, 
different concentrations of PIP2 have been incorporated in to the LUVs to test how 
PIP2 affects formation and binding of the M2 AH. CD spectroscopy has shown high 
levels of estimated helix percentage, about 90% for all concentrations tested (Fig. 3.3-
12) with binding assays also showing similar levels of binding across all 
concentrations, with average fold binding value being slightly higher than for standard 
LUVs (Fig. 3.3-13 and Table 3.2-1). Those results suggest that PIP2 might play a role 
in the M2 AH mediated budding due to their close localisation in the cells. It might 
also enhance formation of the M2 AH and binding of the AH with membranes but it 
is not necessary and the full mechanism is not known.  
 
The lipid composition of the membrane can affect structure and function of the M2 
AH, but other membrane properties such as curvature, presence of different domains 
or defects may also play a role. A range of phase separated LUVs in which the 
thickness of the lipid disordered phase has been modified, by using different PC types 
with decreasing acyl chain length, leading to an increase in the line tension between 
domains, as described before (Garcia-Saez et al. 2007), have been used to test how 




has shown that the estimated helix percentage increases with an increase in the line 
tension (Fig. 3.3-14), but it does not reach the levels observed with standard LUVs 
(Fig. 3.2-7). Surprisingly binding assays have shown a reduced yet similar level of 
binding for majority of the samples, with exception of LUVs composed of DeisPC 
(second in the series) in which binding was nearly two fold higher than for the rest 
(Fig. 3.3-15) and reached the levels observed with standard LUVs (Table 3.2-1). 
Overall, the reduction in both the estimated helix percentage and average fold binding 
levels may be caused by a different lipid composition of the LUVs used, with results 
suggesting that the line tension plays a role in the formation of the M2 AH, but it does 
not influence AH binding with the membranes.  
In the final stages of budding, the M2 protein is localised to the neck of budding virion 
which is region of high positive membrane curvature (Rossman et al. 2010b). 
Therefore the effect of positive membrane curvature on the M2 AH structure and 
function was investigated using a range of SUVs, LUVs and GUVs composed of 
standard lipids (PC, PG and Ch) and increasing in diameter, which was confirmed by 
DLS (Table 3.3-2).  The estimated helix percentage was on a high level, around 90%, 
for the majority of SUVs and LUVs (with exception of 89 nm LUVs when helix 
percentage dropped by about 30%), but in the presence of GUVs it dropped to about 
5% (Fig. 3.3-17). Binding assays showed the highest binding levels for the smallest 
vesicles, with the value decreasing as the vesicles increased in size (Fig. 3.3-18). This 
suggests that the M2 AH can work in wide range of positively curved membranes but 
it preferentially binds with membranes of high positive membrane curvature and when 
the membrane is less curved, as seen with GUVs, formation and binding of the M2 
AH is inhibited.  
To further investigate how membrane curvature affect the M2 AH, MD simulations 
were performed RQDEXFNOHGOLSLGELOD\HU5HVXOWVFRQILUPHGSUHYLRXVREVHUYDWLRQV
VKRZLQJWKDWWKH0$+LVPRVWO\DVVRFLDWHGZLWKSRVLWLYHO\FXUYHGPHPEUDQHVZLWK
PD[LPXP ELQGLQJ RFFXUULQJ DW UHJLRQV FRUUHVSRQGLQJ WR D  QP YHVLFOH ZLWK QR
DVVRFLDWLRQREVHUYHG LQQHJDWLYHO\FXUYHGUHJLRQVRI WKHPHPEUDQH(Fig. 3.3-19)$
UDQJHRIGLIIHUHQWVL]HSUVs, LUVs and GUVs composed of PC only were also used 
to test how positive membrane curvature affects the M2 AH, without any anionic lipids 
present in the membrane and therefore no potential charge-charge interactions that 




estimated helix percentage in presence of the smallest vesicles, which was slightly 
decreasing as the vesicles became larger, before a huge drop in presence of the biggest 
vesicles, GUVs (Fig. 3.3-20). Binding assays showed very strong binding between the 
M2 AH and the smallest vesicles (35 nm SUVs), which was significantly reduced with 
an increase of vesicle size (Fig. 3.3-21). This confirms that the M2 AH preferentially 
binds with high positive curvature membranes but can also work with wide range of 
positively curved membranes. 
 
Membranes with high positive curvature can be detected by peptides or AHs either by 
directly sensing membrane curvature or by sensing lipid packing defects associated 
with high curvature. LUVs composed of two different PE types, DOPE and DSPE, 
which due their shape form either a lot of defects or just a few defects in the membrane 
respectively (Nath et al. 2014), have been used to investigate if the M2 AH senses 
membrane curvature by sensing lipid packing defects in the membrane. CD 
spectroscopy showed a slight difference in helix formation between two lipid types, 
with about 10% more helix in presence of the membrane containing DOPE (Fig. 3.3-
22). Binding assays showed very strong binding when DOPE was present in the 
membrane, about 6 fold greater than when DSPE was present (Fig. 3.3-23). These 
results suggest that the M2 AH forms and binds better to the membranes when a lot of 
packing defects are present,  suggesting that this is how the M2 AH detects membranes 















The M2 AH is formed upon binding with lipid membranes (see chapters 3.1.2 and 
3.2.3) and therefore the lipid composition of the membrane and its properties, such as 
curvature or presence of defects, affects the M2 AH structure and its ability to bind 
with membranes (see chapter 3.3). From the other side, insertion of the peptide into 
the bilayer may cause changes to the membrane. M2 has lipid order binding 
preferences and is located at a lipid phase boundary therefore an assay has been 
developed to detect changes to membrane fluidity and ordering of the lipids in the 
membrane cause by insertion of the M2 AH. In this assay Laurdan dye and the M2 
AH peptides based on two different strains and its mutations have been used to detect 
if the M2 AH causes changes to membrane fluidity and how different mutations affect 
this. Changes in membrane fluidity and lipid ordering also result in changes of the 
lipids transition temperature so to further investigate changes in the bilayer caused by 
the M2 AH lipids transition temperature were analysed by differential scanning 
calorimetry. The M2 AH has been shown to play a role in final stage of influenza virus 
budding where it is located to the neck of budding virion, which is a region of high 
positive membrane curvature (Rossman et al. 2010b), in this environment the M2 AH 
may enhance positive membrane curvature, causing membrane scission and leading to 
the release of the new virion to the environment. Therefore the ability of the M2 AH 
to induce positive membrane curvature has been tested upon binding to LUVs using 










3.4.2 Ordering of lipids in the membrane 
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200 ʅM peptide concentration and 1:100 lipid: dye ratio were chosen as optimal 
concentrations for this type of assay and used during all subsequent experiments, 









Figure 3. 4 - 1 Change in Laurdan GP value with 100 ȝ0RIWKH0$+DQG mM of standard 





Figure 3. 4 - 2 Change in Laurdan GP value with increasing concentrations of M2 AH peptide 
























































Different total sample volumes; 50, 100 and 200 ʅl have also been tested, showing 
similar levels of increase in Laurdan GP (see appendix 6.4), which suggests that the 
sample volume does not influence results. To test if the M2 AH peptide itself does not 
increase the Laurdan GP control, experiments have been performed with Laurdan dye 
in presence and absence of the peptide. Results showed a small decrease in Laurdan 
GP when the peptide was present, independently from the volume of the sample tested 
(Fig. 3.4-3). That shows that the M2 AH peptide itself is not able to cause an increase 
in Laurdan GP and previously observed increase was due to changes in the membrane 





Figure 3. 4 - 3 Change in Laurdan GP value with 100 ʅM of M2 AH peptide and 25 ʅM of the 

































3.4.2.2 A/England/09 and AH mutants 
The M2 AH is mostly conserved among different influenza virus strains, with only 3 
different residues between A/Udorn/72 strain, which is mostly used laboratory strain, 
and the most recent pandemic A/England/09 strain, (Fig. 3.2-8). CD has shown similar 
results for wild type peptides based on both strains (Fig. 3.2-7 and 3.2-9), however, 
certain mutations, especially in the hydrophobic face of the helix, can cause a 
UHGXFWLRQLQWKHKHOL[¶VVWUXFWXUHDQGfunction (Fig. 3.2-11 and 3.2-12 ). To investigate 
if strain differences and mutations in the helix influence its ability to increase lipid 
ordering in the membrane the M2 AH peptide based on A/England/09 strain and two 
of its mutants, R54A R61A and the 5 point mutant, that based on the CD results (Fig. 
3.2-11 and 3.2-12), cause increase and decrease in helix formation respectively, 
compared to wild type A/England/09 have been used.  
Surprisingly, wild type A/England/09 M2 AH causes only slight increase in Laurdan 
GP (Fig. 3.4-4) which, when compared, is only half the magnitude seen by the peptide 
based on the A/Udorn/72 strain (Fig. 3.4-2). On the other hand, the M2 AH peptide 
with the 5 point mutations in the helix is not able to increase Laurdan GP and causes 
small decrease (Fig. 3.4-4). Interestingly the double mutation, R54A R61A, causes 
more than a twofold greater increase in Laurdan GP than the wild type A/England/09 
peptide (Fig. 3.4-4). These results suggest that although the M2 AH sequence is 
conserved among the strains and small differences in its sequence do not influence 
formation of the helix, as shown by CD (Fig. 3.2-7 and 3.2-9), they affect functions of 
the helix and its ability to increase lipid ordering in the membrane. However, 
mutations on the helix interface, R54A R61A, seem to compensate for the strain 
differences bringing the change in Laurdan GP to the levels observed with the wild 
type peptide based on the A/Udorn/72 strain (Fig. 3.4-2). Introducing a 5 point 
mutation into the helix not only affects the structure of the helix (Fig. 3.2-12) and virus 
growth, but also its function, which suggest that hydrophobic face of the helix plays 










Figure 3. 4 - 4 Change in Laurdan GP value with 100 ʅM of M2 AH peptide based on Eng/09 




3.4.2.3 Different membrane compositions 
To investigate how the membrane composition affects the ability of M2 AH to order 
lipids, SUVs and LUVs composed of different lipids have been used. When anionic 
lipids have been removed and LUVs were composed of PC and Ch only, the M2 AH 
peptide caused an increase in Laurdan GP (Fig. 3.4-5), and it was on a similar level to 
when standard LUVs were used (Fig. 3.4-2). Interestingly, when SUVs were used 
instead of LUVs, increase in Laurdan GP was reduced (Fig. 3.4-5). Those results 
suggest that anionic lipids do not affect the M2 AH ability to order lipids in the 
membrane and that although high positive membrane curvature supports helix 
formation (Fig. 3.3-17 and 3.3-20) and binding to the membrane (Fig. 3.3-18 and 3.3-


































Figure 3. 4 - 5 Change in Laurdan GP value with 100 ȝ0RI0$+SHSWLGHDQG mM of SUVs 




To test the effect of cholesterol on the M2 AH ability to order lipids in the membrane, 
a series of LUVs with an increasing cholesterol percentage have been used, as 
described in chapter 3.3.3. Unfortunately the measurements contained a high degree 
of variation, which  has led to high standard errors especially in case of 5 and 30 molar 
% of cholesterol samples. Despite that, the increase in Laurdan GP appears to decrease 
with the rising levels of cholesterol level in the membrane, with negative values 
observed for the highest cholesterol concentration tested (Fig. 3.4-6). This suggests 
that having high levels of cholesterol present in the membranes not only affects the 
































Figure 3. 4 - 6 Change in Laurdan GP value with 100 ȝ0RI0$+SHSWLGHDQG mM of 




A series of phase separated LUVs composed of different PC types, with decreasing 
length of acyl chains and hence increased line tension, as described in chapter 3.3.5, 
have been used to test how line tension influences the M2 AH ability to order lipids in 
the membrane. A small increase in Laurdan GP has been observed when DEPC LUVs 
were present, where the line tension in the domains was the smallest from the series 
(Fig. 3.4-7). This increase in Laurdan GP was then seen to be increasing as the line 
tension increased, with the highest increase seen in the presence of DMPC LUVs, 
where the line tension in the domains were the highest from the series (Fig. 3.4-7). 
Those results show that line tension influence the M2 AH ability to order lipids in the 









































Figure 3. 4 - 7 Change in Laurdan GP value with 100 ȝ0RI0$+SHSWLGHDQG mM of 100 
nm LUVs composed of sphingomyelin, cholesterol and series of different PC types (at 2:1:2 ratio) 
with decreasing length of acyl chain which results in increase of the line tension, where DEPC has 




It has been show that the M2 AH senses membrane curvature by sensing membrane 
packing defects in the bilayer, see chapter 3.3.7. Therefore, LUVs with different levels 
of packing defects present in the membrane have been used to test if membrane 
packing defects influence the M2 AH ability to order lipids. In presence of both, DSPE 
and DOPE, the M2 AH caused an increase in Laurdan GP at similar level (Fig. 3.4-8), 
which suggests that lipid packing defects do not play a role in the M2 AH ordering of 












































Figure 3. 4 - 8 Change in Laurdan GP value with 100 ȝ0RI0$+SHSWLGHDQG mM of 100 




3.4.3 Alteration of membrane phase-transition temperatures 
M2 AH is associated with highly curved membranes (see chapter 3.3.6) and increases 
lipid ordering in the membrane, as showed above (chapter 3.4.2.1).  Increase in lipid 
order in the membrane decreases its fluidity which in turn increases lipid transition 
temperature. To further investigate the M2 AH effect on the lipid order, membrane 
phase transition temperatures were analysed by differential scanning calorimetry 
(DSC). In this experiment multilamellar vesicles (MLVs), composed of DSPC were 
used and when the M2 AH peptide was added to the MLVs lipid transition temperature 
of the membrane increased (Fig. 3.4-9). This shows that M2 AH increases lipid 
































Figure 3. 4 - 9 DSC curves of DSPC MLVs (black), DSPC MLVs reconstituted with M2 AH at a 




3.4.4 Induction of positive membrane curvature  
As shown before (see chapter 3.3.6), the M2 AH associates with membranes of high 
positive membrane curvature. To test if M2 AH can also induce membrane curvature, 
standard LUVs were incubated with varied concentrations of the M2 AH peptide and 
changes in the liposomes morphology have been observed by TEM ± work done in 
collaboration with Matthew D. Badham, School of Biosciences, University of Kent. 
TEM analysis showed that at higher concentrations (125 ʅM), M2 AH causes 
formation of tubes and blebs on the LUVs surface indicated by red arrows, which are 
not present at lower concentrations (12.5 ʅM) and in control samples (Fig. 3.4-10). 
Those results suggest, that M2 AH binds to positively curved membranes, inserts to 






Figure 3. 4 - 10 TEM images of 5 mM of standard LUVs incubated for 1 h with increasing 
concentrations of the M2 AH peptide and negative stained. Arrows indicate membrane blebs and 






Properties of the lipid membrane, such as composition, curvature or presence of the 
defects can affect formation and binding of the M2 AH, however, insertion of the helix 
into the membrane can also cause changes in the bilayer. To detect changes in the 
membrane fluidity caused by changes to the lipid ordering in the membrane by the M2 
AH an assay has been developed in which changes to the lipid phase are detected by 
Laurdan dye (Parasassi et al. 1990, Sanchez et al. 2007). Initial experiments have been 
performed using standard LUVs with a range of different peptide concentrations and 
lipid: dye ratios, showing the M2 AH increases ordering of the lipids in the membrane 
in dose dependent manner and that optimal peptide concentration for this assay is 200 
ʅM with 1:100 lipid: dye ratio (Fig. 3.4-1 and 3.4-2). Peptides based on the 
A/England/09 and two of its mutants, R54A R61A and 5 point mutant which increase 
or decrease helix formation based on the CD results respectively, have also been tested 
to check if the ability to increase lipid ordering in the membrane is conserved among 




Results showed that peptide based on A/England/09 strain can increase ordering of 
lipids in the membrane (Fig. 3.4-4), but not as much as peptide based on A/Udorn/72 
strain (Fig. 3.4-2), which suggest that although differences between strains do not 
influence formation of the M2 AH (Fig. 3.2-7 and 3.2-9) they affect peptide ability to 
change membrane fluidity. As expected, the introduction of 5 point mutations into the 
helix, which affects helix formation (Fig. 3.2-12) and cause growth impairment in the 
virus, also inhibited the M2 AH ability to increase lipid ordering (Fig. 3.4-4). 
Surprisingly double mutant on the helix interface, R54A R61A caused increase in lipid 
ordering (Fig. 3.4-4) to the levels observed for peptide based on A/Udorn/72 strain 
(Fig. 3.4-2) which suggests that these mutations compensate for the differences 
EHWZHHQ VWUDLQV ZKLFK DSSHDU WR UHGXFH WKH 0 $+¶V DEility to order lipids in the 
membrane. Liposomes composed of different lipids have been used to investigate how 
the composition of the membrane affects the M2 AH ability to increase lipid ordering. 
When anionic lipids have been removed, and LUVs were composed of PC and Ch 
only, the M2 AH increased lipid ordering to a level that was similar to what has been 
observed for standard LUVs (Fig. 3.4-5 and 3.4-2 respectively), which suggests that 
anionic lipids and charge-charge interactions do not affect the M2 AH ability to change 
membrane fluidity. Surprisingly, when SUVs composed of PC and Ch have been used 
instead of LUVs, the increase in lipid ordering was significantly reduced (Fig. 3.4-5). 
Cholesterol has been shown previously to inhibit the M2 AH mediated budding in a 
dose dependent manner (Rossman et al. 2010b) and to reduce binding with 
membranes. Therefore a range of LUVs with increasing concentrations of cholesterol 
have been used to investigate the effect of cholesterol on the M2 AH ability to increase 
lipid ordering. There was a high degree of variability in the samples, but overall results 
suggest the increase in cholesterol concentration in the membrane reduces the M2 AH 
ability to increase lipid ordering (Fig. 3.4-6).  
To investigate how line tension affects changes in the membrane fluidity induced by 
the M2 AH range of LUVs with increasing line tension between domains, as described 
in chapter 3.3.5 have been used. Results showed that an increase in the line tension 
increases lipid ordering of the membrane by the M2 AH (Fig. 3.4-7). Membrane 
curvature is sensed by the M2 AH by sensing lipid defects in the membrane. LUVs 
composed of DOPE and DSPE with a varied amount of lipid packing defects, as 




the M2 AH ability to increase lipid ordering in the membrane. Results showed similar 
increase in lipid ordering in presence of both types of LUVs (Fig. 3.4-8), which 
suggests that presence of lipid packing defects in the membrane do not affect the M2 
AH ability to change membrane fluidity.  
To further investigate changes to the membrane induced by the M2 AH lipids 
transition temperature was analysed by DSC. An increase in lipid ordering decreases 
fluidity of the membrane, resulting in an increase in the lipid transition temperature. 
Results showed that the addition of the M2 AH into the membrane increases lipid 
transition temperature (Fig. 3.4-9), which confirms that insertion of the M2 AH in to 
the lipid membranes increases lipid ordering and changes membrane fluidity.  
The M2 AH plays a role in membrane scission, which is the last stage of influenza 
virus budding. It has been shown to associate with membranes of high positive 
curvature and localises to the neck of budding virion (Rossman et al. 2010b) where 
might induce positive membrane curvature leading to scission. To test if the M2 AH 
induces positive membrane curvature, the peptide has been incubated with LUVs and 
morphological changes to the vesicles have been observed by TEM. At higher 
concentrations the M2 AH forms tubes and blebs on LUVs surface (Fig. 3.4-10) which 













3.5 M2 AMPHIPATHIC HELIX MEDIATED BUDDING IN 
VITRO 
 
3.5.1 Introduction  
The M2 AH is being formed upon binding with membranes (see chapters 3.1.2 and 
3.2.3), it preferentially binds with membranes with high positive membrane curvature 
(see chapter 3.3.6) and can induce positive membrane curvature in LUVs (see chapter 
3.4.4). It has been shown that the M2 AH plays an important role in influenza virus 
budding, and when mutated budding is inhibited (Rossman et al. 2010b), but the full 
details still remain unknown. The ability of the M2 AH to induce budding was 
therefore investigated using a system involving GUVs. This system is very difficult to 
work with, and so a single-vesicle imaging system has been developed using 
microinjectors for further and more detailed investigation of budding mediated by the 
M2 AH. Additionally supported bilayers with excess membrane reservoir (SUPER) 
templates system has been used to study membrane scission induced by the M2 AH. 
 
 
3.5.2 GUV budding 
M2 AH is associated with membranes with high positive membrane curvature (see 
chapter 3.3.6) and can induce positive membrane curvature in LUVs (see chapter 
3.4.4). To investigate if M2 AH can cause budding a model imitating biological 
membranes, the GUVs system, has been used. In this system, fluorescently labelled 
GUVs were diluted in buffer followed by addition of the M2 AH peptide and an 
aqueous dye (lucifer yellow, shown in red). After incubation morphological changes 
in the GUVs have been observed by confocal microscopy. :KHQWKHSHSWLGHGLGQRW
FDXVHDQ\HIIHFWRQ*89V WKH\DSSHDUHGEODFN LQVLGHZLWKFRORXUHG ULPDQGZKHQ
*89V KDG VPDOO LQWHUQDO YHVLFOHV ZLWK UHG LQVLGH EXW WKH PDLQ *89 KDYLQJ EODFN
LQVLGH LW LQGLFDWHGEXGGLQJDFWLYLW\:KHQ*89VDSSHDUHGFRPSOHWHO\ UHG LQVLGH LW
LQGLFDWHGOHDNLQJRIWKHDTXHRXVG\HLQWRWKHYHVLFOHVZKLFKPLJKWVXJJHVWWKDWWKH
0$+SHSWLGHLVDEOHWRLQLWLDWHIRUPDWLRQRIDSRUHRUEUHDNDJHLQWKHELOD\HUOHDGLQJ




on A/England/09 strain and all its mutants DVGHVFULEHGLQFKDSWHUin the system 
using a mix of lipids: PC, PG and fluorescently labelled cholesterol (at 4:1:0.05 ratio) 
to form vesicles. Examples of cRQIRFDOLPDJHVRI*89VWUHDWHGZLWKGLIIHUHQWSHSWLGHV
DUHVKRZQLQ)LJXUH 
 
Figure 3. 5 - 1 &RQIRFDO LPDJHV RI *89¶V FRPSRVHG RI 3& 3* DQG IOXRUHVFHQWO\ ODEHOOHG
cholesterol, at 4:1:0.05 ratio, incubated with 10 ȝ0RI(QJ0$+DQGLWVPXWDQWVZLWK0.5 
mg/ml of an aqueous dye present in the buffer. Top panel shows detection of the signal from the 
*89¶VDQGERWWRPSDQHOVKRZVVLJQDOIURPERWK*89¶VDQGDTXHRXVG\H 
 




OHDNLQJ ZKHUHDV RWKHUV VXFK DV )$ )$ ZHDNHQHG K\GURSKRELF IDFH /.
&.<.VWURQJHUSRODUIDFHRU&5$&PXWDQWFDXVHDVOLJKWLQFUHDVHLQEXGGLQJ
DFWLYLW\)LJ6XUSULVLQJO\WKHZLOGW\SH0$+IRU$(QJODQGVWUDLQGRHV
QRW FDXVH WKH H[SHFWHG UREXVW EXGGLQJ which may be related to its reduced AH 
formation or its reduced lipid ordering )LJ&RQWURO VDPSOHV KDYH VKRZQ D









Figure 3. 5 - 2 Budding activity induced by Eng/09 M2 AH and its mutants in *89¶VFRPSRVHG
RI3&3*DQGIOXRUHVFHQWO\ODEHOOHGFKROHVWHURODWUDWLR'DWDDQDO\VHGE\6WXGHQW¶VW-














































Figure 3. 5 - 3 Budding activity induced by M2 AH based on Udorn strain in *89¶VFRPSRVHG
RI3&3*DQGIOXRUHVFHQWO\ODEHOOHGFKROHVWHURODWUDWLR'DWDDQDO\VHGE\6WXGHQW¶VW-




The GUVs system is highly variable and difficult to work with, with a lot of diversity 
and forming errors in the GUV population which amongst small vesicles shows the 
same morphology as budding or leaking effect caused by the peptide, which leads to  
high values in control samples and is not seen in larger vesicles. In samples with 
peptide present, a significant effect cannot be quantified with larger vesicles, possibly 
due to the lower positive membrane curvature preventing activity from the helix (see 



























3.5.3 GUV microinjections 
As discussed before (see above), the GUVs system is highly variable, time consuming 
(especially data analysis and microscope image counting) and the M2 AH induced 
budding might not be efficient enough to be quantified in it. To overcome these 
problems, a single vesicle imaging system has been developed. In this system the 
unlabelled M2 AH peptide has been injected using a microinjection needle into the 
fluorescently labelled GUVs diluted in buffer. Changes in GUVs morphology have 
been observed in real time after injection on a fluorescence microscope. The M2 AH 
peptide, based on A/Udorn/72 strain, has been used due to the higher budding activity 
observed in the GUVs system compared to the A/England/09 strain based peptide (Fig. 
3.5-2 and 3.5-3) with GUVs composed of PC, PG and fluorescently labelled 
cholesterol (at 4:1:0.05 ratio). Injection of the M2 AH peptide pushed nearby vesicles 
aside, forming a zone of clearance around the needle (Fig. 3.5-4 B). Small vesicles 
and blebs have been formed on the GUVs membranes placed around the needle (on 
the edge of the clearance zone) 30 seconds after injection, indicated by red arrows on 
Figure 3.5-4 D. A lot of very small vesicles or lipid puncta have also been formed in 
the buffer 30 seconds after injection, indicated by blue arrows on Figure 3.5-4 D, 
which could be some of the small vesicles that have budded off from GUVs 
membranes or been degraded GUVs by the M2 AH peptide. Both effects have been 
maintained during the experiment, up to 10 minutes after injection (Fig. 3.5-4 D-H). 
Those results suggest that the M2 AH is able to induce membrane curvature, form 
small vesicles on the membrane and mediate budding. The M2 AH facilitated budding 
is a rapid process, taking 15-30 seconds, but effects can be observed for a long time, 




























Figure 3. 5 - 4 Fluorescent microscopy images of GUVs composed of PC, PG and fluorescently 
labelled cholesterol at 4:1:0.05 ratio injected with M2 AH peptide. A - pre-injection, B - injection, 
C - 15 s post-injection , D - 30 s post-injection , E - 1 min post-injection, F - 2 min post-injection, 
G - 5 min post-injection and H - 10 min post-injection. Red arrows indicate small vesicles/blebs 
formed on the GUVs membrane after injection of the peptide and blue arrows indicate formation 










3.5.4 SUPER templates and membrane scission 
To investigate and quantify membrane scission mediated by the M2 AH supported 
bilayers with excess membrane reservoir (SUPER) templates system has been used. 
In this system SUPER templates were formed by incubating SUVs with silica beads 
following washes to remove residual lipids. SUPER templates were then tubulated by 
addition of Amphiphysin I and incubated with the M2 AH peptide after which 
membrane scission activity was assessed by detection of released fluorescent lipid 
from the templates. Addition of Amphiphysin I to the templates caused a scaffolding 
reaction and led to formation of membrane tubes that undergo a background level of 
spontaneous membrane extraction which is unrelated to scission (Fig. 3.5-5). The M2 
AH caused significant lipid release from the templates whereas the 5 point mutant 
peptide was not able to cause release of lipids, with only background levels being 
observed (Fig. 3.5-5). Interestingly the M2 AH peptide did not cause lipid release in 
the absence of Amphiphysin I mediated scaffolding (Fig. 3.5-5). These results show 
that the M2 AH mediates membrane scission but it acts only on specially scaffolded 
or pre-constricted lipid domains and the introduction of 5 point mutations into the 






















Figure 3. 5 ± 5 Percentage of fluorescent lipids released from DOPC:DOPS:PIP2:RhoPE-
containing SUPER templates at molar ratio of 79:15:5:1 (RhoPE released into the supernatant as 
% of total RhoPE fluorescence of SUPER templates, shown as mean ± SD for three independent 
repeats performed in duplicate), tubulated with the addition of 0.5 ȝ0 $PSKLSK\VLQ , ZKHUH
indicated. Membrane scission was observed in the presence or absence of 25 ȝ0M2 AH and 5 





























The M2 AH has been previously shown to play a role in influenza virus budding 
(Rossman et al. 2010b) by mediating membrane scission. It is associated with 
membranes of high positive membrane curvature and induces positive membrane 
curvature in LUVs. Therefore the M2 AH ability to mediate budding has been 
investigated using GUVs system. In this system the M2 AH peptide has been 
incubated with fluorescently labelled GUVs in presence of a second fluorescent dye 
in the buffer followed by quantification of morphological changes observed in LUVs. 
Wild type M2 AH peptide, based on A/England/09 strain, has been tested in this 
system together with different helix mutants, as described in chapter 2.1.1 and two 
types of effects have been observed in GUVs populations: budding, when small 
internal vesicles filled with buffer dye were present in the main vesicles which did not 
have buffer dye present inside and leaking, when the interior of the main vesicles was 
filled with buffer dye. Increased budding activity has been observed with )$)$
/. &. <. DQG &5$& PXWDQWV ZKHUHDV WKH SRLQW PXWDQW 5$ 5$
GRXEOHPXWDQWDQGPXWDQWVZLWKGLVUXSWHGKHOL[SKDVHFDXVHGLQFUHDVHGOHDNLQJ)LJ
6XUSULVLQJO\WKHZLOGW\SH0$+EDVHGRQ$(QJODQGVWUDLQGLGQRWVKRZ
WKH H[SHFWHG UREXVW EXGGLQJ )LJ which may be related to its reduced AH 



















LV LQMHFWHG ULJKW QH[W WR WKH IOXRUHVFHQWO\ ODEHOOHG *89V XVLQJ D PLFURLQMHFWRU DQG








7KH 683(5 WHPSODWHV V\VWHP KDV EHHQ XVHG WR LQYHVWLJDWH PHPEUDQH VFLVVLRQ
PHGLDWHG E\ WKH 0$+ ,Q WKLV V\VWHP 683(5 WHPSODWHV ZKLFK DUH IRUPHG E\
LQFXEDWLRQRI/89VZLWKVLOLFDEHDGVZHUHtubulated by addition of Amphiphysin I 
and incubated with the M2 AH peptide. Results showed that the M2 AH but not the 5 
point mutant M2 AH cause significant release of lipids from the templates )LJ
. Interestingly that effect is only observed if SUPER templates are tubulated with 
Amphiphysin I )LJ. These results show that the M2 AH mediates membrane 
scission but it acts only on specially scaffolded or pre-constricted lipid domains and 












3.6 M2 AMPHIPATHIC HELIX MEDIATED BUDDING IN VIVO 
 
3.6.1 Introduction 
Using LUVs and GUVs, which imitate biological membranes, it has been shown that 
the M2 AH can induce positive membrane curvature and mediates budding (see 
chapters 3.4.4 and 3.5). However, both those systems are artificial and therefore there 
are no cellular factors involved which might play an important role in virus budding. 
Previously it has been shown that the Rab11 protein might be involved in formation 
of filamentous virions (Bruce et al. 2010), but knowledge about other cellular proteins 
involved in influenza virus budding is limited. To investigate if M2 also induces 
budding, in vivo supernatant from cells transfected with M2 protein and its 5 point 
mutant version have been analysed by immunoblotting. An influenza virus with 5 
point mutations in the M2 AH have also been repeatedly passaged in cells and the 
sequence of the M segment of the genome has been analysed to identify any acquired 
reverse mutations that restored virus properties.  
 
 
3.6.2 Virus-like particles (VLP) release 
It has been shown that the M2 AH induces positive membrane curvature in LUVs (Fig. 
3.4-10), forms small vesicles and mediates budding in GUVs (Fig. 3.5-5). Further 
investigation of the M2 AH mediated budding has been performed in vivo. HEK 293T 
cells have been transfected with plasmids expressing either a wild type M2 or a M2 
with 5 point mutants in the AH (which cause growth impairment in virus), and after 
48 h of incubation the presence of the M2 protein in the cells and the supernatant has 
been detected by immunoblotting using the M2 specific monoclonal antibody, 14C2. 
As expected M2 has been detected in cells transfected with the M2 expressing plasmid, 
with reduced levels of M2 being observed in cells transfected with the 5 point mutant 
M2 expressing plasmids (Fig. 3.6-1). In both cases two bands have been detected, one 
about 15 kDa in size which corresponds to a full length M2 protein (Iwatsuki-
Horimoto et al. 2006) and second, slightly smaller, about 13 kDa in size which is a 
truncated version of the M2 protein that has undergone caspase cleavage processing 





around 28 kDa, which corresponds to the M2 dimer (Fig. 3.6-1) (Iwatsuki-Horimoto 
et al. 2006). Those results suggest that the M2 AH does not only induce positive 
membrane curvature in LUVs (Fig. 3.4-10), lead to the formation of small vesicles on 
the membrane of GUVs and initiate budding in GUVs (Fig. 3.5-5), but also mediates 
budding in transfected cells. 
   
 
 
Figure 3. 6 - 1 Western blot of HEK 293T cells 48 h post-transfection with 2.5 ȝJRISODVPLG
expressing M2 and M2 5 point helix mutant (growth impairment) proteins. Cell lysates (CL) and 
supernatant (S) for transfected cells and control were immunoblotted with specific monoclonal 
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3.6.3 Restoration of viral growth 
NMR showed that the M2 AH is formed in presence of liposomes (see chapter 3.1.2) 
and that it is mainly the hydrophobic face of the helix that is responsible for binding 
with membranes (see chapter 3.1.3). These results have been confirmed by CD 
spectroscopy (see chapters 3.2 and 3.3). To further investigate which parts of the helix 
are important for the M2 AH structure and the effect of the cellular environment on its 
function, the sequence of the viral M gene have been analysed before and after 
repeated passaging. Influenza A virus with 5 point mutants in the M2 protein, which 
previously had been shown to impair virus growth (Rossman et al. 2010a, Rossman et 
al. 2010b) have been repeatedly passaged in the MDCK cells in order to see if any 
compensating mutations emerge. Virus titer was checked after each passage by plaque 
assay and viral RNA have been isolated for two samples: in the early stages of 
passaging (passage 4), when viral titer was very low; and after 10 more passages 
(passage 14), when viral titer was high and on similar levels for a few consecutive 
passages (Table 3.6-1). The M segment of both viruses have been sequenced to detect 
any reversion mutations that may have arisen after repeated passaging that may have 






(detected by plaque assay) 
4 1x104 
5 1.5x105 






Table 3. 6 - 1 Virus titers detected by plaque assays for the Influenza A virus with 5 point mutations 






Sequencing analysis of the M segment showed no change to the viral genome after 4 
passages which, together with a low virus titer, suggests that the virus was not able to 
restore the functions that are lost due to the introduced mutations (Fig. 3.6-2). Two 
point mutations in the M segment at positions 910 and 925, which correspond to the 
region coding for the CT of the M2 protein (residue 66 and 71 of the full length protein 
respectively) arose after 14 passages (Fig. 3.6-3). However, those mutations were only 
detected in one of the two sequencing reactions covering that region of the M gene but 
WKH\GRDIIHFWVHTXHQFHRIWKH0SURWHLQ¶V&7UHVXOWLQJLQ(*DQG6)PXWDWLRQV
(see appendix 6.5). This suggests that virus growth and functions have been restored 
as the titer was very high, without any reverse mutations in the M2 AH, but with 
possible mutations in the further parts of the CT. This suggests that mutations in parts 
of the M2 CT may compensate for the decreased M2 AH functions but other viral 
proteins and cellular factors may also be involved. The molecular mechanism behind 









Figure 3. 6 - 2 Sequence alignment of the M gene of the influenza A/Udorn/72 virus with 5 point 
mutations in the M2 protein (top) aligned with the M gene of that virus after 4 passages (row 2-4) 
in MDCK cells sequenced with three primers: M_UTR_F, M_F2 and M_UTR_R. The same 










Figure 3. 6 - 3 Sequence alignment of the M gene of the influenza A/Udorn/72 virus with 5 point 
mutations in the M2 protein (top) aligned with the M gene of that virus after 14 passages (row 2-
4) in the MDCK cells sequenced with three primers: M_UTR_F, M_F2 and M_UTR_R. The same 








The M2 AH has been shown to: associate with membranes with high positive 
curvature (see chapter 3.3.6), induce positive membrane curvature (see chapter 3.4.4) 
and mediate budding in artificial lipid membranes (see chapter 3.5). Further 
investigation of the M2 AH mediated budding was performed in vivo as it has been 
shown previously that some of cellular proteins may play a role in influenza virus 
budding, such as Rab11 which is involved in formation of filamentous virions (Bruce 
et al. 2010) and therefore the cellular environment may affect the M2 AH ability to 
mediate budding. Supernatant and cell lysates from cells transfected with plasmids 
expressing either the wild type M2 protein or the M2 protein with 5 point mutants in 
the AH, have been analysed by immunoblotting. The M2 protein and its truncated 
version have been detected in both cell lysates, with reduction of band intensity for 
the M2 with 5 PM (Fig. 3.6-1). Interestingly similar bands, but much less intense have 
been detected in the supernatant fractions (Fig. 3.6-1), suggesting that M2 mediates 
budding in vivo, and the introduction of the 5 PM into the AH significantly reduces 
M2 induced budding.    
To further investigate the effect of the cellular environment on the M2 AH, the 
influenza A virus with 5 PM in the AH, which causes growth impairment in the virus 
as described before (Rossman et al. 2010a, Rossman et al. 2010b), has been repeatedly 
passaged in MDCK cells. The sequence of the M segment of the genome has been 
analysed at an early stage of passaging, at passage 4, when viral titer was low, and 
following 10 more passages, when viral titer was high for few consecutive passages, 
to detect any reverse mutations that arose and restored virus growth and functions. 
Sequencing analysis showed no changes in the M segment in the early stages (Fig. 
3.6-2), but after 14 passages sequencing with one of two primers covering the region 
of the M segment coding for the CT of the M2 protein showed 2 point mutations (Fig. 
3.6-3). These point mutations resulted in two single mutations in the sequence of the 
M2 CT, E66G and S71F suggesting that further parts of the CT may compensate for 
loss of function in the M2 AH. Interestingly previous research has shown that 
mutations in residue 71 of the M2 protein showed resistance to the 14C2 antibody, 
moreover one of the identified mutations responsible for this was S71F (Zebedee and 
Lamb 1989). However, cellular factors and other viral proteins may also play a role 








The M2 AH has been shown to form a helix upon binding with membranes (see 
chapters 3.1.2 and 3.2.3), with the hydrophobic face of the helix mainly being 
responsible for lipid binding (see chapter 3.1.3), and it is associated with highly curved 
membranes (see chapter 3.3.6), such as the neck of the budding virion. In this 
environment, the M2 AH can induce positive membrane curvature (see chapter 3.4.4) 
leading to membrane scission, facilitating budding (see chapters 3.5 and 3.6). 
Membrane budding is a multi-step process which is important not only for viruses, but 
also plays a role in many biological processes, such as endocytosis or vesicle 
trafficking involving many different proteins and AHs. Many of those AHs either 
sense or generate membrane curvature in few different ways. Curvature sensing 
proteins or AHs may contain a Bin-Amphiphysin-Rsv (BAR) domain or Amphipathic 
Lipid Packing Sensor (ALPS), which sense membrane curvature either by forming a 
crescent shape and binding to the membrane with the preferred curvature (Peter et al. 
2004) or by insertion into the membrane and sensing curvature by using hydrophobic 
interactions (Drin and Antonny 2010). On the other hand, generation of membrane 
curvature can be induced by insertion of the cationic face of the AH into the 
membrane, as is the case with many antimicrobial peptides (Ford et al. 2002, Peter et 
al. 2004, Boucrot et al. 2012). Many proteins contain both BAR domains and AHs that 
can generate membrane curvature with its polar face, meaning they are able to sense 
and generate membrane curvature however, both those activities are associated with 
different domains.  The M2 AH has been shown to have both features, as it contains 
many hydrophobic residues together with several cationic ones and its able to sense 
and induce membrane curvature therefore it might belong to a novel group of AH 
which binds to membranes with high positive membrane curvature, induce positive 
membrane curvature which in this environment leads to membrane scission. Several 
AHs from cellular proteins have been tested to determine if their mechanism of 





3.7.2 Arf1, CHMP4b, EndophilinA3 and Epsin1 
 
3.7.2.1 Structural changes in different environments 
A range of cellular peptides containing AH that have been shown to play a role in 
vesicle budding and scission have been analysed, with the exact mechanism for the 
scission currently unknown. Peptides with AHs that were close sequence homologues 
with the M2 AH have not been identified however, AHs that have similar features to 
the M2 AH, such as hydrophobicity, hydrophobic moment and net charge have been 
identified in the Arf 1, Endophillin A3, Epsin 1 and CHMP4b proteins, as shown in 
Figure 3.7-1. Arf 1 is involved in COP-vesicle budding (Beck et al. 2011), Endophillin 
A3 plays a role in non-clathrin-mediated-endocytosis (Boucrot et al. 2012) whereas 
Epsin 1 has a role in dynamin-dependent scission which is a part of clathrin-mediated-
endocytosis (Boucrot et al. 2012) and CHMP4b is involved in multi-vesicular body 





Figure 3. 7 ± 1 Biophysical properties and helical wheel plots of M2 AH and the human Arf 1, 
CHMP4b, Endophillin A3 and Epsin 1 AHs were calculated and generated using HeliQuest 
(Gautier et al. 2008) found at http://heliquest.ipmc.cnrs.fr/ and E(z)3D. Positively charged polar 
residues are shown in blue, negatively charged polar residues are in red, polar uncharged residues 





CD spectra showed that in solution the majority of these peptides are unstructured, 
with exception of Epsin 1 which shows the deepest trough, suggesting partial 
IRUPDWLRQ RI DQ Į-helix in solution (Fig. 3.7-2). In presence of standard LUVs 
Endophillin A3 and Epsin 1 peptides showed two big troughs, corresponding to 
IRUPDWLRQRIDQĮ-helix, with over 95% of the helix present (Fig. 3.7-3). Arf 1 peptide 
also showed two troughs, but their depth was significantly reduced compared to 
Endophillin A3 and Epsin 1 peptides, despite that the estimated helix percentage 
showed nearly 95% of the helix present (Fig. 3.7-3). On the other hand CHMP4b 
peptide showed a similar CD spectra in solution and with LUVs, with less than 5% 
helix present for both (Fig. 3.7-2 and 3.7-3). Those results show that three cellular AH  
Endophillin A3, Epsin 1 and Arf 1 behave same as the M2 AH and form helix upon 
binging with liposomes. 
 
 
Figure 3. 7 - 2 CD spectra for 250 ȝ0RIFHOOXODUSHSWLGHV$UI(QGRSKLOOLQ$(SVLQDQG
&+03ELQVROXWLRQ$(VWLPDWHGSHUFHQWDJHRIDQĮKHOL[SUHVHQWLQHDFKVDPSOHFDOFXODWHG


















































Figure 3. 7 - 3 CD spectra for 250 ȝ0RIFHOOXODUSHSWLGHV$UI(QGRSKLOOLQ$(SVLQDQG
CHMP4b with 5 mM of standard LUVs (A(VWLPDWHGSHUFHQWDJHRIDQĮKHOL[SUHVHQWLQHDFK


















































3.7.2.2 Anionic lipids and positive membrane curvature effect on 
cellular AH formation 
To further investigate similarities between the cellular AHs and the M2 AH a range of 
SUVs, LUVs and GUVs of different sizes, composed of PC and Ch have been used to 
test if anionic lipids and positive membrane curvature affect helix formation. Vesicle 
sizes have been checked by DLS, showing size distribution (see appendix 6.3 B) and 
average vesicle size for each sample (Table 3.7-1). Again LUVs average sizes varied 
from the filter pore size, showing higher or lower average size than the filter size for 
50 nm and 1000 nm LUVs respectively (Table 3.7-1). Interestingly, the average GUV 
size was only just above 1000 nm (Table 3.7-1) with the size distribution graph 
showing two distinct peaks, at around 1000 and 5000 nm (see appendix 6.3 B), which 







measured on DLS) 
SUVs 41.69 d.nm 
50 nm 101.9 d.nm 
100 nm 113.7 d.nm 
1000 nm 540 d.nm 
GUVs 1119 d.nm 
 
Table 3. 7 - 1 Designed and actual average size of the PC:Ch vesicles in the size range measured 
on DLS. 
 
The Arf 1 peptide showed troughs for vesicles ranging between 42 and 540 nm and a 
peak when GUVs were present (Fig. 3.7-4). The highest helix percentage - 81.47% 
was in the presence of the smallest vesicles, increasing the vesicle size caused a 
decrease in percentage of helix present, with the lowest value of around 18% in 
presence of GUVs (Fig. 3.7-4). This shows that the smaller the vesicles, and hence the 
higher the positive membrane curvature, the better helix formation. The helix 
percentage for 100 nm LUVs was around 70% (Fig. 3.7-4) and was reduced compared 
to standard LUVs (Fig. 3.7-3), which suggest that anionic lipids support formation of 





Figure 3. 7 - 4 CD spectra for 250 ȝ0RI$UISHSWLGHZLWK mM of different size SUV, LUVs 
and GUVs composed of PC:Ch (A(VWLPDWHGSHUFHQWDJHRIDQĮKHOL[SUHVHQWLQHDFKVDPSOH
calculated based on the spectra using K2D3 bioinformatics tool on http://k2d3.ogic.ca/ website 
(B). 
 
CD spectra for Endophillin A3 showed peaks for vesicles sized 102 nm and above and 
one big trough for the smallest vesicles (Fig. 3.7-5).  The helix percentage in presence 
of 42 nm SUVs was the highest ± 94.54% and when vesicles increased in size to 102 
nm and 114 nm helix percentage dropped significantly, to about 43% and 53% 
respectively (Fig. 3.7-5). Further increases in vesicle size led to a further decrease in 
helix percentage, with only 9.37% of helix formed in presence of GUVs (Fig. 3.7-5). 
Those results suggest that Endophillin A3 AH is formed in highly curved membranes 
and even a small increase in vesicle size, and hence decrease in positive membrane 
curvature, influences the formation of the helix. The absence of anionic lipids in the 
membrane caused significant reduction in helix percentage ± from over 95% to about 
53% (Fig. 3.7-3 B and 3.7-5 B), which suggest that anionic lipids might play some 













































Figure 3. 7 - 5 CD spectra for 250 ȝ0RI(QGRSKLOOLQ$SHSWLGHZLWK mM of different size 
SUV, LUVs and GUVs composed of PC:Ch (A(VWLPDWHGSHUFHQWDJHRIDQĮKHOL[SUHVHQW LQ
each sample calculated based on the spectra using K2D3 bioinformatics tool on 
http://k2d3.ogic.ca/ website (B). 
 
The Epsin 1 peptide showed a deep trough in presence of 42 nm SUVs, with about 
94% of the helix present, and in presence of vesicles 102 nm in size and above, CD 
showed smaller troughs with helix percentage ranging between 63 and 76% (Fig. 3.7-
6).  Increasing the vesicle size, and hence decrease in positive membrane curvature, 
caused only slight reduction in percentage of helix formed, which suggests that Epsin 
1 AH prefers membranes with high positive curvature but can work in wide range of 
positively curved membranes. In the presence of 100 nm LUVs helix percentage was 
about 75% (Fig. 3.7-6), which corresponds to about 20% drop compared with standard 
100 nm LUVs (Fig. 3.7-3). Those results suggest that similar as the M2 AH, Epsin 1 
AH formation is supported by anionic lipids present in the membrane, but they are not 




















































Figure 3. 7 - 6 CD spectra for 250 ȝ0RI(SVLQSHSWLGHZLWK mM of different size SUV, LUVs 
and GUVs composed of PC:Ch (A(VWLPDWHGSHUFHQWDJHRIDQĮKHOL[SUHVHQWLQHDFKVDPSOH



















































The CD spectra for the CHMP4b AH were very wavy with a lot of variability, 
suggesting a random coil confirmation in presence of all vesicles (Fig. 3.7-7 A). 
Estimated helix percentages was also on a very low level, between 1.84 ± 4.88% (Fig. 
3.7-7 B), confirming our earlier observations (Fig. 3.7-3) and show that CHMP4b AH 
is not formed upon binding with membrane and positive membrane curvature and 





Figure 3. 7 - 7 CD spectra for 250 ȝ0RI&+03ESHSWLGHZLWK mM of different size SUV, 
LUVs and GUVs composed of PC:Ch (A(VWLPDWHGSHUFHQWDJHRIDQĮKHOL[SUHVHQW LQHDFK


























42 nm SUVs 114 nm LUVs 540 nm LUVs GUVs
















3.7.2.3 Effect of line tension on cellular AH formation 
The M2 AH is associated with membranes with high positive membrane curvature 
(see chapter 3.3.6) and can sense membrane curvature by sensing lipid packing defects  
that are formed with high curvature and an increased line tension in the membrane 
(see chapter 3.3.7). To test how line tension in the membrane affects cellular AHs, 
peptides have been tested in the presence of two LUVs from the range of phase 
separated LUVs in which the line tension of the domains have been increased by using 
a series of different PC with decreasing length of the acyl chain (see chapter 3.3.5). 
DEPC and DMPC containing LUVs have been used that have the longest and the 
shortest acyl chain and hence the smallest and the highest line tension in the series 
respectively. CD spectra showed small troughs for Arf 1 and Endophillin A3 peptides 
and deeper troughs for the Epsin 1 peptide (Fig. 3.7-8 A).  
In the presence of DMPC LUVs troughs were slightly deeper than in presence of 
DEPC LUVs for all peptides (Fig. 3.7-8 A). An increase in helix percentage in 
presence of LUVs with higher line tension have been observed for all cellular peptides 
tested, however, for Arf 1 and Endophillin A3 helix percentage was low in presence 
of both LUVs types and the increase was not as substantial as for the Epsin 1 peptide 
(Fig. 3.7-8 B). These results show that high line tension in the LUVs domain increases 
formation of Arf 1, Endophillin A3 and Epsin 1 AHs, which suggest that those cellular 
peptides might sense positive membrane curvature by sensing membrane packing 

















   
Figure 3. 7 - 8 CD spectra for 250 ȝ0RIFHOOXODUSHSWLGHV$UI(QGRSKLOOLQ$DQG(SVLQ
with 5 mM of 100 nm LUVs composed of sphingomyelin, cholesterol and either DEPC or DMPC 
(at 2:1:2 ratio) which results in low and high line tension between domains in the membrane  
respectively (A). Estimated SHUFHQWDJHRIDQĮKHOL[SUHVHQWLQHDFKVDPSOHFDOFXODWHGEDVHGRQ




























DEPC LUVs + Arf1 DEPC LUVs + EndophilinA3 DEPC LUVs + Epsin1





















3.7.2.4 Ordering of the lipids in the membrane 
The M2 AH has been shown to increase lipid ordering upon binding with the 
membrane (see chapter 3.4.2), therefore the cellular AHs have been tested if they also 
affect membrane fluidity. Laurdan assays have shown a substantial increase in 
Laurdan GP caused by the Endophillin A3 and Epsin 1 peptides and a slightly smaller, 
but still significant increase caused by Arf 1 (Fig. 3.7-9). On the other hand, CHMP4b 
AH did not cause significant increase in Laurdan GP (Fig. 3.7-9), which indicates that 
it does not change fluidity of the membrane. Those results suggest that Arf 1, 
Endophillin A3 and Epsin 1 AHs work in similar way as the M2 AH and increase lipid 
ordering upon binding with membranes which changes fluidity of the membrane and 





Figure 3. 7 - 9 Change in Laurdan GP value with 100 ȝ0RIFHOOXODUSHSWLGHV$UI(QGRSKLOOLQ































3.7.2.5 Induction of positive membrane curvature 
The M2 AH has been shown to induce positive membrane curvature in LUVs (see 
chapter 3.4.4) therefore the cellular AHs have been tested if they also induce positive 
PHPEUDQHFXUYDWXUHE\LQGXFLQJFKDQJHVWRWKHYHVLFOH¶VPRUSKRORJ\7(0DQDO\VLV
has shown that Arf 1, Endophillin A3 and Epsin 1 AHs cause formation of tubes and 
blebs on the LUVs surface (indicated by red arrows on Fig. 3.7-10), similar to the M2 
AH (Fig. 3.4-10); however, incubation of LUVs with the CHMP4b AH does not cause 
changes to the vesicles morphology. Those results suggest that Arf 1, Endophillin A3 
and Epsin 1 AHs, but not CHMP4b work in similar way as the M2 AH and induce 






Figure 3. 7 - 10 TEM images of 5 mM of standard LUVs incubated for 1 h with 125 ȝ0RIFHOOXODU
peptides: Arf 1, Endophillin A3, Epsin 1 and CHMP4b and negative stained. Arrows indicate 







Membrane budding is an important and complex process that is crucial not only for 
viruses, but also plays a role in many biological process. Many proteins and AHs have 
been identified to be involved in membrane budding by either sensing or generating 
membrane curvature (Peter et al. 2004, Drin and Antonny 2010). The M2 AH contains 
many hydrophobic residues as well as several cationic residues and has been shown to 
be associated with highly curved membranes (see chapter 3.3.6), inducing positive 
membrane curvature (see chapter 3.4.4) and leading to scission (see chapters 3.5 and 
3.6). This suggests that the M2 AH may belong to a novel group of AHs that can sense 
and generate membrane curvature. Four cellular proteins containing AHs; Arf 1, 
Endophillin A3, Epsin 1 and CHMP4b have been identified as having similar features 
as the M2 AH and therefore were tested to detect if their mechanism of membrane 
scission is the same as the M2 AH. CD spectroscopy has shown that all cellular 
peptides are unstructured in solution, with the exception of Epsin 1 which shows 
SDUWLDO IRUPDWLRQ RI DQ Į-helix (Fig. 3.7-2). In presence of liposomes Arf 1, 
Endophillin A3 and Epsin 1 showed high levels of estimated helix percentage, around 
95%, whereas CHMP4b showed similar levels of helix as in solution (Fig. 3.7-3). This 
indicates that Arf 1, Endophillin A3 and Epsin 1 behave similarly to the M2 AH and 
form DQĮ-helix upon binding with membranes, but CHMP4b does not. 
To test if anionic lipids and positive membrane curvature affect the formation of the 
helix of the cellular peptides, a range of SUVs, LUVs and GUVs of different sizes, 
composed of PC and Ch have been used. CD spectroscopy showed that two of the 
cellular AHs, Arf 1 and Endophillin A3, are formed in membranes with high positive 
membrane curvature, with a decrease in positive membrane curvature resulting in a 
reduction of helix formation (Fig. 3.7-4 and 3.7-5), as was also seen with the M2 AH 
(see chapter 3.3.6). Although those AHs prefer highly curved membranes, they can 
work in wide range of positively curved membranes and are inhibited only in presence 
of vesicles with small positive curvature of the membrane, such as GUVs (Fig. 3.7-4 
and 3.7-5). Epsin 1 AH seems to work in similar way, it is associated with high positive 
membrane curvature and an increase in vesicle size decreases helix formation (Fig. 
3.7-6) however, this effect is not as drastic as in case of other AHs, which suggests 
that Epsin 1 AH is not as sensitive to membrane curvature changes as the other AHs. 




changes in the positive curvature of the membrane not affecting its formation (Fig. 
3.7-7). Anionic lipids present in the membrane facilitate formation of the M2 AH but 
are not essential, as the helix percentage is only slightly reduced in presence of LUVs 
without anionic lipids in the membrane compared to standard LUVs with an anionic 
lipid present (see chapter 3.3.2). Similar trends have been observed with the Arf 1 
(Fig. 3.7-4), Endophillin A3 (Fig. 3.7-5) and Epsin 1 AHs (Fig. 3.7-6), but not the 
CHMP4b AH (Fig. 3.7-7), which shows that anionic lipids also facilitate formation of 
those AHs. In case of Endophillin A3 AH reduction in helix percentage was slightly 
higher (just above 50% compared to about 70% for Arf 1 and Epsin 1), which indicates 
that anionic lipids may play a role in structure and formation of this AH (Fig. 3.7-5 
B). In conclusion, three cellular peptides: Arf 1, Endophillin A3 and Epsin 1 showed 
similarities with the M2 AH in terms of membrane curvature preference and 
interactions with anionic lipids.  
It has been shown that the M2 AH senses membrane curvature by sensing lipid 
packing defects that are formed in the membranes with high curvature (see chapter 
3.3.7) and that the line tension between the membrane domains affects the helix 
formation (see chapter 3.3.5). Phase separated LUVs composed of two types of PC 
with longer or shorter acyl chain, which result in low and high line tension between 
domains respectively (part of the LUVs range with an increasing line tension described 
in chapter 3.3.5)(Garcia-Saez et al. 2007), have been used to test if the line tension 
affects the formation of the cellular AHs. Results showed a slight increase in helix 
formation with an increase in line tension between domains for Arf 1 and Endophillin 
A3 and a significantly higher increase in helix formation for Epsin 1, with the overall 
levels of helix percentage much higher for that peptide (Fig. 3.7-8). These results 
suggest that, as with the M2 AH, an increase in line tension between domains increases 
formation of Arf 1, Endophillin A3 and Epsin 1 AHs. 
The M2 AH has been shown to increase lipid ordering in the membrane upon binding 
(see chapter 3.4.2), so cellular peptides have been tested using the Laurdan assay to 
see if they also increase lipid ordering upon binding.  Endophillin A3 and Epsin 1 
caused significant increase in Laurdan GP (Fig. 3.7-9), similar to levels observed with 
wild type M2 AH (Fig. 3.4-2). Arf 1 also induced increase in Laurdan GP however, to 
slightly lesser degree than the wild type M2 AH (Fig. 3.7-9). CHMP4b did not induce 




Endophillin A3 and Epsin 1 AHs increase lipid ordering upon binding with 
membranes, as the M2 AH but CHMP4b does not. The M2 AH has also been shown 
to induce positive membrane curvature in LUVs (see chapter 3.4.4), therefore cellular 
peptides have been tested if they are able to induce similar effect. TEM analysis have 
shown that when incubated with LUVs, three cellular AHs: Arf 1, Endophillin A3 and 
Epsin 1 cause formation of tubes and blebs on the surface (Fig. 3.7-10). On the other 
KDQGFKDQJHVWRWKHYHVLFOH¶VPRUSKRORJ\ZHUHQRWREVHUYHGLQFDVHRICHMP4b AH 
(Fig. 3.7-10). This shows that Arf 1, Endophillin A3 and Epsin 1 AHs induce positive 
membrane curvature, similar as the M2 AH but CHMP4b does not 
All of these results suggest that three out of the four cellular AHs tested: Arf 1, 
Endophillin A3 and Epsin 1 appear to work in a similar manner to the M2 AH and 
therefore belong to a novel group of AHs. Those AHs are being formed upon binding 
with membranes (with exception of Epsin 1 which is partially formed in solution) and 
are associated with membranes with a high level of positive curvature, but can work 
in wide range of positively curved membranes. Anionic lipids present in the membrane 
facilitate formation of those AHs but are not essential and increase in line tension in 
the domains increases formation of the AHs. Insertion of these AHs into the membrane 


































4.1 STRUCTURE OF THE M2 AH 
 
The main aim of this project was to investigate molecular mechanism of membrane 
scission mediated by the M2 protein, which is the last stage of virus life cycle. The 
first step was to determine the structure of the M2 AH, which is formed at the 
beginning of the M2 SURWHLQ¶V CT section and has been shown previously to play a 
role in virus assembly and budding. It has been hypothesised that this helix may 
mediate membrane scission, allowing for release of the new virion into the 
environment. The high resolution structure of the full length M2 protein has not been 
solved up to date, however, the TMD, together with small parts of the ecto domain 
and CT, has been determined by both x-ray crystallography and NMR (Schnell and 
Chou 2008, Stouffer et al. 2008). The NMR studies showed that M2, which in its 
native form is a homotetramer in the presence of micelles, forms a pore with its TMD 
(residues 25-46) that acts as a pH-gated proton channel. After the channel a flexible 
loop is formed between residues 47-50 and its followed by formation of an 
amphipathic helix between residues 51-59 which is situated nearly perpendicular to 
the ion channel (Schnell and Chou 2008).  
In this study the structure of the M2 AH, between residues 47-62 of the full length M2 
protein, based on A/Udorn/72 strain has been solved in different environments using 
1H 2D NMR. In presence of standard LUVs (100 nm composed of PC, PG and 
cholesterol at 4:1:0.05 molar ratio) an Į-helix was formed between residues 4 and 16 
(residues 50-62 of the full length protein) (Fig. 3.1-5), which corresponds well to the 
previous NMR research performed in micelles (Schnell and Chou 2008). Interestingly, 
when the M2 AH peptide was in solution, with no LUVs present, it showed a random 
coil confirmation (Fig. 3.1-5). This suggests that the M2 AH is formed upon binding 
with lipid membranes. To further investigate binding between the M2 AH and a lipid 
membrane, and to determine which part of the helix is responsible for binding, a 1D 
STD NMR experiment was performed. The results showed that the residues Phe9, 
Phe8 and Ile5 (residues 55, 54 and 51 respectively) are the main residues involved in 
binding with membranes, with Phe2, His11 and Gly12 (residues 48, 57 and 58 
respectively) being involved to a lesser degree (Fig. 3.1-10). The residues involved 




interactions, as most of the residues responsible for binding are in the hydrophobic 
face of the helix, confirming earlier suggestions (Rossman et al. 2010b). In conclusion, 
it has been shown that the M2 AH is formed upon binding with membranes and it 
interacts with lipid membranes through hydrophobic interactions, however, future 
work is needed to investigate the structure of the full length CT as it is probable that 
other important structural motifs are present in the further parts of the protein. 
Determining the structure of the full length M2 protein in the presence of a lipid 
membrane would also be important as presence of a full length protein could influence 




















4.2 MECHANISM OF ACTION 
 
4.2.1 Membrane binding 
The NMR experiments showed that the M2 AH is formed upon binding with 
membranes (Fig. 3.1-5), therefore the interactions between the M2 AH and 
membranes have been investigated further. Good binding between the M2 AH and the 
standard lipid membranes have been shown with a peptide binding assay (Table 3.2-
1). Further investigation using CD spectroscopy, has shown that the M2 AH is formed 
and stabilised upon binding with a membrane and remains unstructured in the solution 
(Fig. 3.2-7), which confirms previous observations by NMR (Fig. 3.1-5).  
Similar trends have been observed with a slightly longer peptide (17 amino acids) 
based on the same strain (Fig. 3.2-10) and a 16 amino acid peptide based on the 
A/England/09 strain (Fig. 3.2-9), which differs from the A/Udorn/72 based peptide by 
only three amino acids (F54R, E56K and H57Y in regards to full length M2 protein) 
(Fig. 3.2-8). Interestingly, STD NMR has shown that residues at two of those 
positions, 54 and 57 are responsible for binding of the M2 AH with lipid membranes 
(Fig. 3.1-10) and therefore are important for helix formation. Differences in the 
sequence between strains do not affect formation of the helix, even if the changes are 
in the region shown to be responsible for binding with membranes. It is possible that 
the changes in sequence are not significant enough to affect formation of the M2 AH.  
Even though the charge and hydrophobicity are changed between those two strains, 
with hydrophobic, negatively charged and positively charged residues being replaced 
with two positively charged and hydrophobic respectively, the overall shape and 
length of the amino acids do not change drastically therefore function of the M2 AH 
is not affected. It is also possible that different residues are responsible for binding 
with the membranes for A/England/09 strain than for A/Udorn/72 and therefore 
changes in the region shown to be responsible for binding with membranes for 
A/Udorn/72 does not influence formation of the M2 AH based on A/England/09 strain.  
This shows that the formation of the M2 AH upon binding with lipids is well conserved 
among influenza virus strains. STD NMR experiments have shown that hydrophobic 
residues in the helix are responsible for interaction of the peptide with lipid membranes 




mutants. As expected, formation of the M2 AH in presence of LUVs was significantly 
reduced in the case of the 5 point mutant (F47A F48A I51A Y52A F55A) (Fig. 3.2-
12). Additionally, formation of the helix was slightly reduced in two of the other 
mutant peptides: F47A F48A, which was designed to weaken hydrophobic face, and 
L46K C50K Y57K which was designed to enhance polar face by making it completely 
charged (Fig. 3.2-12). These results correspond well to the STD NMR data (Fig. 3.1-
10), which shows that residues in the hydrophobic face of the helix at positions 48, 51, 
54, 55, 58 and the hydrophobic residue in the polar face at residue 57 are responsible 
for binding with lipid membranes. These two mutations, which cause a slight reduction 
in helix formation, contained one change at a position shown to be responsible for 
binding with membranes (position 48 and 57 respectively).  
The 5 point mutant, by comparison, contained changes in three of those positions (48, 
51 and 55) which caused significant reduction in helix percentage. In opposite to the 
changes in M2 AH sequence between influenza virus strains, which do not affect 
formation of the helix (as discussed above), changes introduced in these mutations 
were significant in changing properties of the peptide (reducing helix formation to 
different degree), as in the F47A F48A mutant and the 5 point mutant bulky 
hydrophobic residues were replaced with alanine and in the L46K C50K Y57K 
mutant, the hydrophobic residue at the crucial position (57) was replaced with 
positively charged residue. This confirms that residues 48, 51, 54-55 and 57-58 as well 
as the overall hydrophobicity is crucial for the M2 AH formation and binding with 
lipid membranes.  
 
4.2.2 Membrane activity 
Properties of the membrane such as lipid composition, presence of defects, changes to 
the line tension between different domains and the curvature of the membrane affect 
structure and functions of the M2 AH. On the other hand insertion of the helix itself 
into the lipid membrane also causes changes to the membrane. First the lipid 
composition of the membrane was varied, testing the effect of different lipids on the 
M2 AH, followed by structural changes in the membrane such as curvature or presence 




The polar face of the helix contains, depending on a strain, 6 or 7 of cationic residues 
(A/Udorn/72 and A/England/09 respectively), which may interact with anionic lipids 
present in the membrane. However, presence of different anionic lipids in the 
membrane do not affect the M2 AH formation as shown by CD spectroscopy (Fig. 
3.3-1). In contrast, the presence of the zwitterionic PE reduces helix formation (Fig. 
3.3-1), which could be caused either by charge difference in the lipid headgroup or by 
changes to the structure of the membrane caused by the cone shape of PE. 
Interestingly, a two fold increase in binding activity was detected in presence of 
different anionic lipids (PA and PS) compared to PG containing membranes, but when 
PE was present binding activity was reduced nearly by half (Fig. 3.3-2). These show 
that different anionic lipids do not influence formation of the M2 AH but they may 
facilitate binding of the peptide with membranes and that PE does not support any of 
those functions. Additionally, higher concentrations of PS present in the membrane 
(40 molar %) slightly supports helix formation (Fig. 3.3-3), but significantly increases 
binding with the membranes (Fig. 3.3-4), suggesting that anionic lipids present in the 
membrane support M2 AH binding in a dose dependent manner. However, the exact 
concentration of anionic lipids required to support the M2 AH is not known and it is 
not known if the concentration differs for helix formation compared to binding with 
membranes. On the other hand, removal of anionic lipids from the membrane caused 
reduction of estimated helix percentage by about 20% (Fig. 3.3-5), which suggests that 
anionic lipids support the formation of the M2 AH, but are not essential for its 
formation as their removal from the membrane did not inhibit helix formation 
completely.  
Surprisingly removal of anionic lipids from the membrane increased average fold 
binding (Fig. 3.3-6) with similar effect being observed when different types of anionic 
lipids were used instead of PG (Fig. 3.3-2) and higher molar % of PS were present in 
the membrane (Fig. 3.3-4). This suggest that concentration and type of anionic lipid 
present in the membrane as well as lack of any anionic lipids in the membrane may 
affect binding ability of the M2 AH, but more research is needed to fully understand 
this relationship. Binding between the M2 AH and lipid membranes may also be 
affected by charges in the environment, which may inhibit charged interactions 
between the polar face of the helix and the lipid headgroups, and therefore inhibit 




M2 AH with lipid membranes as an increase in ionic strength of the buffer did not 
cause any drastic changes in binding activity associated with any particular 
concentration (Fig. 3.3-8). This confirms that interaction of the M2 AH with lipid 
membrane is not dependent on charge-charge interactions. 
 
As mentioned before, some lipids affect functions of the M2 AH, such as cholesterol 
which has been shown to inhibit M2 AH mediated budding in LUVs in a dose 
dependent manner, with budding observed with up to 17 molar % of cholesterol 
present in the membrane (Rossman et al. 2010b). Surprisingly formation of the M2 
AH is not affected by cholesterol concentration in the membrane (Fig. 3.3-9), but the 
ability to bind with membranes may be affected instead (Fig. 3.3-10). Initial increases 
in cholesterol concentration increases binding activity, but a further increase causes a 
reduction, which suggest that low levels of cholesterol present in the membrane (up to 
10 molar %) support the M2 AH but higher concentrations (above 20 molar %) affect 
its ability to bind with membranes (Fig. 3.3-10) which correlates well with previous 
budding research (Rossman et al. 2010b). 
 
Another lipid which may affect the M2 AH structure and function is PIP2, as it has 
been shown that it plays an important role in assembly of other viruses, such as HIV 
(Carlson and Hurley 2012). Immunofluorescence microscopy has shown that PIP2 and 
M2 do not co-localise in cells, but often are proximal to each other (Fig. 3.3-11) which 
suggest it may support the M2 AH and can be involved in the M2 mediated budding. 
However, further investigation has shown that presence of PIP2 do not affect the M2 
AH formation (Fig. 3.3-12) and binding (Fig. 3.3-13) with membranes. 
 
The next step in investigating the effect of the lipid membrane on the M2 AH structure 
and function was to vary structural characteristics of the membrane by changing the 
line tension between domains, the membrane curvature or by introducing packing 
defects. During late stages of budding M2 is localised on the boundary between lipid 
rafts and plasma membrane which is a region of high line tension (Rossman et al. 




enriched in sphingolipids and cholesterol (Brown 2001). Therefore an increase in line 
tension between lipid ordered and lipid disordered phases may have an effect on the 
M2 AH. Increase in line tension between domains increases formation of the M2 AH 
(Fig. 3.3-14). However, changes in line tension do not affect binding ability of the 
peptide as the values for most of the samples are similar and the only increase is with 
DeisPC, which is the second lowest value lipid in the series for forming vesicles with 
line tension, and may be a characteristic specific for this lipid (Fig. 3.3-15).  
 
In the last stage of viral budding M2 is localised to the neck of budding virion 
(Rossman et al. 2010b). This is a region of high positive membrane curvature which 
suggests that membrane curvature may affect the structure and function of the M2 AH. 
Both CD spectroscopy and binding assays have shown, using a range a different size 
vesicles with decrease in positive membrane curvature, that the M2 AH forms best 
and preferentially binds to highly curved membranes (Fig. 3.3-17 and 3.3-18). 
However, the AH can work in wide range of positively curved membranes and is 
inhibited only with the largest vesicles where positive membrane curvature is the 
smallest (Fig. 3.3-17 and 3.3-18). These observations have been confirmed by 
molecular dynamic simulations on a buckled lipid bilayers containing regions of 
positive, negative and neutral curvature. Results have shown that the M2 AH is mostly 
associated with positively curved membranes and it is not associated with negatively 
curved regions (Fig. 3.3-19). Maximum binding occurred at regions of the membrane 
corresponding to a 20 nm vesicle (Fig. 3.3-19) which corresponds well to CD and 
binding assay data (Fig. 3.3-17 and 3.3-18). Similar results have been observed when 
anionic lipids have been removed from the simulated lipid membrane (Fig. 3.3-20 and 
3.3-21), further confirming that charge interactions do not affect the M2 AH 
formation, binding with the membranes or LQIOXHQFHWKH0$+¶VFXUYDWXUHVHQVLQJ 
ability. Membranes with high positive curvature can be detected by peptides or AHs 
either by directly sensing membrane curvature or by sensing lipid packing defects 
associated with high curvature. The M2 AH senses membranes with high levels of 
positive membrane curvature by sensing lipid packing defects associated with those 
membranes as helix formation increases by 10% and binding activity is 6 fold greater 




As described above, the M2 AH structure and function can be affected by different 
properties of the membrane however, the lipid membrane can also be affected by the 
M2 AH activity. Insertion of the helix into the membrane increases Laurdan GP, as 
detected by Laurdan dye (Parasassi et al. 1990, Sanchez et al. 2007) (Fig. 3.4-2), which 
means it increases lipid ordering of the membrane and decrease its fluidity. Ability of 
the M2 AH to increase lipid ordering of the membrane is conserved among different 
influenza virus strains, but different strains induce it to a different degrees. The wild 
type peptide based on A/England/09 strain increased Laurdan GP (Fig. 3.4-4), but not 
as much as the peptide based on the A/Udorn/72 strain (Fig. 3.4-2). This appears to be 
caused by differences in the sequence, especially if these differences are in the regions 
of the peptide responsible for binding with membranes, as in case of A/Udorn/72 and 
A/England/09 strains (Fig. 3.2-8). On the other hand, introduction of a 5 point mutant 
into the M2 AH inhibited the ability to increase lipid ordering. Interestingly, the double 
mutation on the helix interface (R54A  R61A) introduced to the peptide based on the 
A/England/09 strain increased Laurdan GP to the levels observed with the wild type 
peptide based on A/Udorn/72 strain, which suggest that this mutation compensates for 
the sequence differences between strains (Fig. 3.4-4).   
 
The lipid composition of the membrane does not only influence the M2 AH structure 
and function, but may also alter the effect the helix has following insertion into the 
membrane. The M2 AH increases lipid ordering in presence of LUVs without anionic 
lipids present to a similar level as in presence of standard LUVs (Fig. 3.4-5 and 3.4-2 
respectively), which shows that charged interactions do not affect the M2 AH ability 
to increase lipid ordering and change membrane fluidity. Low concentrations of 
cholesterol in the membrane (up to 10 molar %) supports the M2 AH ability to increase 
lipid ordering and change membrane fluidity but higher concentrations reduce this 
ability which is inhibited with the highest concentration tested (40 molar %) (Fig. 3.4-
6). This correlates well with previous research and shows that cholesterol inhibits the 
M2 AH ability to induce lipid ordering in dose dependent manner. Increase in line 
tension between domains in lipid membrane also increases lipid ordering caused by 
the M2 AH (Fig. 3.4-7), but increase in levels of lipid packing defects in the membrane 
do not change the increase in lipid ordering (Fig. 3.4-8). This shows that although the 




amount of defects in the membrane do not affect its ability to induce lipid ordering 
and changing membrane fluidity. Analysis of lipid transition temperature by DSC has 
shown that addition of the M2 AH into the membrane increases transition temperature 
of the membrane (Fig. 3.4-9) which confirms earlier observations that insertion of the 
M2 AH into the lipid membrane increases lipid ordering and changes membrane 
fluidity.  
 
4.2.3 Membrane scission 
Changes to the membrane fluidity are not the only ones that the M2 AH causes to the 
membrane. It has been proposed that in the final stages of budding M2 AH, which is 
localised to the neck of budding virion, mediates membrane scission by inducing 
positive membrane curvature leading to release of new virion into the environment 
(Rossman and Lamb 2011, Martyna and Rossman 2014). Analysis of TEM results 
confirmed that the M2 AH induces positive membrane curvature in a lipid membrane. 
It is a dose dependent process, at higher concentrations the M2 AH forms tubes and 
blebs on the surface of vesicles which are not visible in control samples and at low 
concentrations of the peptide (Fig. 3.4-10).  
It has been shown before that the M2 AH mediates virus budding (Rossman et al. 
2010b). An attempt has been made to quantify M2 AH mediated budding and identify 

















IRUDORQJWLPH (Fig. 3.5-4) 
,Q WKH QH[W VWHS PHPEUDQH VFLVVLRQ PHGLDWHG E\ WKH 0$+ KDV EHHQ LQYHVWLJDWHG
XVLQJ683(5WHPSODWHVV\VWHP5HVXOWVVKRZHGWKDWWKH0$+PHGLDWHVPHPEUDQH
VFLVVLRQ EXW RQO\ LQ specially scaffolded or pre-constricted lipid domains and this 
function can be inhibited by introduction of 5 point mutations into the helix (Fig. 3.5-
5).  
As discussed above, the M2 AH mediates budding in GUVs, which are artificial lipid 
membranes. However, it has been shown previously that cellular proteins, such as 
Rab11 (Bruce et al. 2010) may play a role in influenza virus budding and the cellular 
environment may affect the ability of the M2 AH to mediate budding. Analysis of 
virus-like particles released from transfected cells confirmed that the M2 mediates 
budding not only in artificial systems but also in vivo and that introduction of 5 point 
mutations in the M2 AH impairs M2 mediated budding (Fig. 3.6-1).  
 
Further investigation of the M2 mediated budding in vivo and the effect of cellular 
environment on it, have shown that further parts of the CT may compensate for the 
loss of function by the M2 AH restoring viral growth and functions. Two point 
mutations have been detected in M segment coding for CT of the M2 protein after 
repeated passaging of Influenza A virus with 5 point mutants (Fig. 3.6-3). Those two 
point mutations introduced two single mutations in the CT of the M2 protein: E66G 
and S71F (see appendix 6.5). Interestingly previous research has shown that mutations 
at residue 71 of the M2 protein showed resistance to the 14C2 antibody, moreover one 
of the identified mutations responsible for this was S71F (Zebedee and Lamb 1989). 
However, further research is needed to investigate the molecular mechanism behind 
the restoration of budding, including the potential role of cellular factors.  
 
The M2 AH has been shown to bind with lipid membranes through hydrophobic 
interactions (see chapter 3.1.3). It preferentially binds with membranes that contain 




virion, which is detected by the AH sensing lipid packing defects associated with 
highly curved membrane (see chapter 3.3.7). Insertion of the helix into the membrane 
increases lipid ordering in the membrane (see chapter 3.4.2) which increases 
constriction of the neck of the budding virion and in this condition, induction of 
positive membrane curvature by the M2 AH (see chapter 3.4.4) leads to membrane 
scission of the pre-constricted neck and facilitates budding of a new virion (see 






















4.3 M2 AH AS A PART OF A BIGGER PROTEIN FAMILY  
 
Membrane budding is a complex, multistage process that is important for viruses as 
well as many biological processes, such as endocytosis and vesicle trafficking. In all 
of these processes, multiple different proteins and AHs are involved, but exact details 
are not fully understood. Many of those AHs either sense membrane curvature using 
different domains, such as BAR (Peter et al. 2004) or by using hydrophobic 
interactions after insertion into the membrane (Drin and Antonny 2010); and generate 
membrane curvature by insertion of the AH into the membrane (Ford et al. 2002, Peter 
et al. 2004, Boucrot et al. 2012). Many proteins involved in membrane budding contain 
BAR domains and AHs that can generate membrane curvature but typically, sensing 
and curvature generation activities are associated with different domains. The M2 AH 
has been shown to have both features as it is able to sense and induce membrane 
curvature and therefore may belong to a novel group of AHs. 
To see if other proteins may function similarly to M2, we examined cellular proteins 
and saw that four of them Arf 1, Endophillin A3, Epsin 1 and CHMP4b have similar 
features as the M2 AH (Fig. 3.7-1) and therefore were tested to determine if their 
mechanism of membrane scission is the same as the M2 AH and all belong to a novel 
group of AHs. Three cellular AHs, Arf 1, Endophillin A3 and Epsin 1 may work in 
similar way as the M2 AH as they all KDYHEHHQVKRZQWRIRUPDQĮ-helix upon binding 
with membranes, with exception of Epsin 1 which is also partially formed in solution 
(Fig. 3.7-2 and 3.7-3). They all preferentially bind with membranes with high positive 
curvature, but can work in wide range of positively curved membranes (Fig. 3.7-4 to 
3.7-7). Anionic lipids support formation of the Arf 1, Endophillin A3 and Epsin 1 AHs 
but are not essential (Fig. 3.7-4 to 3.7-7). Increases in line tension between domains 
increases helix formation in Arf 1, Endophillin A3 and Epsin 1 AHs (Fig. 3.7-8) and 
insertion of these three AHs into the membrane also increases lipid ordering of the 
membrane (Fig. 3.7-9) changing its fluidity and induces positive membrane curvature 
(Fig. 3.7-10). On the other side CHMP4b AH does not work in the same way, as a 
helix is not formed upon binding with membranes (Fig. 3.7-3) and curvature of the 




induce changes to the lipid ordering in the membrane (Fig. 3.7-9) or induce positive 
membrane curvature (Fig. 3.7-10).  
 
Overall those results show that three out of four cellular AHs tested: Arf 1, Endophillin 
A3 and Epsin 1 may work in a similar way as the M2 AH and therefore would all 
appear to belong to a novel group of AHs. However, further research is needed to 
investigate properties of all those AHs in more details and molecular mechanism of 
their action, especially that in few cases results showed a similar trend for cellular AHs 





















4.4 CONCLUSIONS AND FUTURE WORK 
 
Summarising, all of these results gives new insights into an overall model of influenza 
A virus budding mediated by the M2 AH underlying its molecular mechanism. The 
M2 AH is normally unVWUXFWXUHGZLWKDQĮ-helix is being formed and stabilised upon 
binding with lipid membranes (see chapters 3.1.2 and 3.2), which is a well conserved 
function among influenza virus strains (see chapter 3.2.3.2). The M2 AH binds well 
with membranes composed of PC, PG and low levels of cholesterol through 
hydrophobic interactions (see chapter 3.1.3). Interaction of the M2 AH with lipid 
membranes is not dependent on charge-charge interactions, however, the presence of 
anionic lipids in the membrane enhances formation of the helix, but it is not essential 
(see chapter 3.3.2). Low levels of cholesterol present in the membrane (up to 10 molar 
%) support the M2 AH binding with the membranes and high levels (above 20 molar 
%) inhibit binding and may also affect formation of the helix (see chapter 3.3.3), 
corresponding well to earlier research showing that cholesterol inhibits M2 AH 
mediated budding in dose dependent manner (Rossman et al. 2010b).  Formation of 
the M2 AH increases with an increase in line tension between domains in the lipid 
membrane (see chapter 3.3.5). The M2 AH preferentially binds with highly curved 
membranes but can work in a wide range of positively curved membranes and it is not 
associated with negatively curved membranes (see chapter 3.3.6). Curvature of the 
membrane is sensed by the M2 AH by sensing lipid packing defects associated with 
membranes with high positive curvature (see chapter 3.3.7) and is not affected by 
charged interactions (see chapter 3.3.6). Insertion of the M2 AH into the membrane 
increases lipid ordering of the membrane and decreases fluidity of the membrane (see 
chapter 3.4.2), which can be affected by properties of the membrane. Low levels of 
cholesterol and an increase in line tension between domains support increase in lipid 
ordering by the M2 AH but high levels of cholesterol in the membrane inhibit increase 
in lipid ordering (see chapter 3.4.2). Charge interactions and the presence of lipid 
packing defects in the membrane do not affect the ability to increase lipid ordering 
(see chapter 3.4.2). The M2 AH can also induce positive membrane curvature in LUVs 
(see chapter 3.4.4), mediate membrane scission and budding both in artificial 
membranes and in vivo (see chapters 3.5 and 3.6). Budding mediated by the M2 AH 




and the loss of function of the M2 AH might be compensated by further parts of the 
M2 CT to restore viral growth (see chapter 3.6.3). Some cellular peptides, such as Arf 
1, Endophillin A3 and Epsin 1, which mediate membrane scission in biological 
processes appear to work in a similar manner to the M2 AH and therefore belong to a 
novel group of AHs (see chapter 3.7). 
An overall model of influenza virus budding shows that the M2 AH induces membrane 
scission and mediates budding. During last stages of viral budding M2 protein is 
localised to the neck of the budding virion, which is a region on the boundary of 
plasma membrane made up of lipid rafts with high positive membrane curvature. At 
this stage curvature sensing preferences should localise the M2 AH to the middle of 
the pre-constricted neck of budding virion where positive membrane curvature is the 
highest (Fig. 4.4-1 A). Insertion of the helix into the membrane increases lipid 
ordering, placing the membrane under strain and constricts the neck even further by 
inducing positive membrane curvature (Fig. 4.4-1 B). This causes membrane scission 
and leads to the release of the new virion into the environment (Fig. 4.4-1 C). 
However, the full details of the molecular mechanism of M2 AH mediated membrane 
scission are still not known. Further research into the interaction of the M2 AH with 
the membranes, especially an inhibitory role of high cholesterol levels is needed. Also 
depth of the M2 AH insertion into the membrane and the structural effect on the lipid 
membrane need to be investigated. Determining the high resolution structure of the 
full length M2 protein in the presence of a lipid membrane would also be important as 
presence of a full length protein could influence the structure and functions of the M2 
AH and it would be much more physiologically relevant. Further characterisation of 
the three identified cellular AHs, which appear to work in the same way as the M2 
AH, is also needed. Full understanding of the process is extremely important as it 
would not only broaden the knowledge about influenza virus budding but also allow 
for inhibition of this process which could lead to the development of new anti-
microbial strategies against influenza virus infections. Additionally, studies of the M2 
AH mediated membrane scission also would bring an insight into cellular membrane 













Figure 4. 4 - 1 Model of influenza virus membrane scission mediated by the M2 AH. A) In the 
late stage of budding M2 is localised to the neck of the budding virion, which is a region of high 
positive membrane curvature. B) Insertion of the M2 AH into the membrane increases lipid 
ordering and induces positive membrane curvature, further constricting the membrane (as 
indicated by red arrows). C) M2 AH then induces membrane scission allowing for release of the 
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6.3 DLS data 
A. Standard vesicles 
 


































LUVs ± 350.4 d. nm 
 
 
B. Vesicles without anionic lipids 
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6.5 Protein sequences comparison 
 
 
A. Sequence of the M2 CT with 5 PM: 
 

















































































































B. Sequence of the M2 CT with 5 PM after 14 passages detected with M_UTR_R 
primer: 
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